{"meta":{"query_hash":"3e9b50bef42a","filters":{"venue":"Cancer Immunology Immunotherapy"},"cohort_total":148,"direct_labels_cover":0,"predictions_cover":148,"exported":148,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/3e9b50bef42a","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Immunology+Immunotherapy"},"results":[{"id":"W1522355061","doi":"10.1007/s00262-002-0357-4","title":"Exposure to paclitaxel or vinblastine down-regulates CD11a and CD54 expression by P815 mastocytoma cells and renders the tumor cells resistant to killing by nonspecific cytotoxic T lymphocytes induced with anti-CD3 antibody","year":2003,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Mastocytoma; Vinblastine; Cytotoxic T cell; Paclitaxel; Cancer research; CD3; Cytotoxicity; In vitro; Immunology; Biology; Tumor cells; Chemistry; Medicine; Chemotherapy; CD8; Immune system; Internal medicine; Biochemistry","score_opus":0.017310360743286776,"score_gpt":0.28743186376468083,"score_spread":0.27012150302139404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1522355061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706602,0.025732057,0.00021722968,0.00094406464,0.00016383035,0.0019373382,0.00022236846,0.000080968006,0.00004191081],"genre_scores_gemma":[0.9894743,0.0070852856,0.0009791745,0.0007016226,0.00003720634,0.00042713518,0.00004765466,0.00011327723,0.0011343417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970066,0.00029104127,0.0004999472,0.0008808488,0.00038916818,0.00093239424],"domain_scores_gemma":[0.99818105,0.0003285747,0.00019055516,0.0008294523,0.00016276454,0.00030763086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002990718,0.00058647443,0.0007770832,0.00023731013,0.0005240985,0.000114186485,0.000264412,0.00020218898,0.00027141263],"category_scores_gemma":[0.000050333325,0.00034811368,0.00007133036,0.0005213201,0.00041547455,0.00013631645,0.00007953745,0.00034829156,0.000019427598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011622077,0.00023783138,0.0028865766,0.000047420664,0.0005769396,0.00009773,0.0012278059,0.0000085281,0.9774236,0.0000042501892,0.0020335587,0.003833675],"study_design_scores_gemma":[0.010896675,0.004349333,0.016909337,0.0005187877,0.00005628893,0.00013758475,0.0011815617,0.000011632438,0.952581,0.0000072652956,0.01291271,0.00043784003],"about_ca_topic_score_codex":0.00037424255,"about_ca_topic_score_gemma":0.000043311567,"teacher_disagreement_score":0.024842624,"about_ca_system_score_codex":0.00034297502,"about_ca_system_score_gemma":0.00032374501,"threshold_uncertainty_score":0.99989706},"labels":[],"label_agreement":null},{"id":"W1964892365","doi":"10.1007/s002620000121","title":"Modulation of interleukin-12 synthesis by DNA lacking the CpG motif and present in a mycobacterial cell wall complex","year":2000,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"","keywords":"DNA; CpG site; DNA methylation; Biology; Mycobacterium phlei; Molecular biology; Cell biology; Mycobacterium; Biochemistry; Gene; Bacteria; Genetics; Gene expression","score_opus":0.0225285911055001,"score_gpt":0.28756314286416684,"score_spread":0.26503455175866675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964892365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879719,0.007707093,0.000012689005,0.0028984966,0.00012347031,0.00058097776,0.000052068313,0.000025621555,0.00062768883],"genre_scores_gemma":[0.980081,0.018539121,0.00004358657,0.00044251303,0.000072425384,0.00035978685,0.00003214641,0.00003340633,0.00039600625],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99845684,0.00023948544,0.00043125343,0.00029465868,0.00017744725,0.0004003194],"domain_scores_gemma":[0.9989964,0.00032124718,0.000121673336,0.0004498563,0.00006272279,0.00004809542],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002516979,0.00020568699,0.00045623982,0.00012524857,0.00007849298,0.000030440217,0.00022802109,0.00015440061,0.005138973],"category_scores_gemma":[0.000033987544,0.00015376022,0.000089366324,0.00016225222,0.00033753525,0.00011062807,0.000040576328,0.00026226311,0.000013464666],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034652445,0.000260531,0.033031937,0.00005934929,0.0002321464,0.0000054702446,0.001092984,0.000009545756,0.8478141,0.000012692031,0.0015067087,0.112509325],"study_design_scores_gemma":[0.0051212874,0.00053089263,0.7975096,0.00023092223,0.000044262393,0.000022187545,0.00014922998,0.00046615573,0.14819962,0.00008695873,0.0474122,0.00022669762],"about_ca_topic_score_codex":0.0025729202,"about_ca_topic_score_gemma":0.00007803704,"teacher_disagreement_score":0.76447767,"about_ca_system_score_codex":0.00015301484,"about_ca_system_score_gemma":0.000095496696,"threshold_uncertainty_score":0.99577045},"labels":[],"label_agreement":null},{"id":"W1966217582","doi":"10.1007/s00262-004-0572-2","title":"Antibody-targeted chemotherapy of B-cell lymphoma using calicheamicin conjugated to murine or humanized antibody against CD22","year":2004,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Calicheamicin; CD22; Conjugate; Antibody; Monoclonal antibody; Epitope; Saporin; Linker; Chemistry; Immunotoxin; Humanized antibody; Molecular biology; Biochemistry; Cancer research; Biology; Immunology","score_opus":0.03108353627508348,"score_gpt":0.36627156694315505,"score_spread":0.33518803066807157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966217582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98189586,0.013045743,0.00075630506,0.0018684936,0.0004951305,0.0012499155,0.00010506091,0.00013338361,0.0004500954],"genre_scores_gemma":[0.966459,0.021550763,0.003304741,0.005586004,0.0002255746,0.000064543325,0.00037953028,0.00018406179,0.0022458304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99675024,0.00014074166,0.0009639868,0.000683726,0.000463061,0.0009982433],"domain_scores_gemma":[0.9980639,0.0000958368,0.00032064097,0.00082406425,0.0005006597,0.00019487702],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029536235,0.0005794409,0.0013299144,0.0005149017,0.0002642036,0.000027589636,0.00052999303,0.00036323417,0.0011575037],"category_scores_gemma":[0.000038097318,0.00045912055,0.00032658922,0.0009980225,0.0006201905,0.00011881785,0.00010980862,0.00039801383,0.000068218396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015685463,0.0011713012,0.0031496144,0.0001512799,0.001092635,0.00013173647,0.0011746342,0.00008495476,0.9685798,0.000077076606,0.000053963005,0.008647501],"study_design_scores_gemma":[0.02984025,0.0020631177,0.035203956,0.0005224157,0.000068742294,0.00015659691,0.000271814,0.00013579016,0.9101242,0.00005777661,0.020965673,0.00058969704],"about_ca_topic_score_codex":0.0043103658,"about_ca_topic_score_gemma":0.0000557848,"teacher_disagreement_score":0.05845567,"about_ca_system_score_codex":0.0005701997,"about_ca_system_score_gemma":0.0011530711,"threshold_uncertainty_score":0.9997861},"labels":[],"label_agreement":null},{"id":"W1970361217","doi":"10.1007/s00262-012-1301-x","title":"EGCG targeting efficacy of NF-κB downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelocytic leukemia cells","year":2012,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Montréal","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Monocytic leukemia; Acute promyelocytic leukemia; Biology; Cancer research; Microglia; Promyelocytic leukemia protein; Leukemia; Cellular differentiation; Inflammation; In vitro; Neuroinflammation; Cell biology; Immunology; Cell culture; Gene; Biochemistry; Retinoic acid","score_opus":0.008818941915864353,"score_gpt":0.2503635377057203,"score_spread":0.24154459578985593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970361217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8545148,0.14391188,0.00038888687,0.00006517822,0.0005000866,0.0004545869,0.0000688298,0.00001714273,0.000078620826],"genre_scores_gemma":[0.9680391,0.030548135,0.00031956087,0.000118194585,0.0001484084,0.00010382192,0.00023437281,0.00005861041,0.0004297768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979233,0.00019085238,0.0006119719,0.00039330203,0.00018700333,0.0006935752],"domain_scores_gemma":[0.99832135,0.000047265938,0.0005974587,0.0007015183,0.0002806441,0.000051772382],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023189685,0.0003285193,0.0003966667,0.000058573452,0.00013916541,0.000015962969,0.0004886679,0.00028776834,0.000106341286],"category_scores_gemma":[0.00007283115,0.00024880655,0.00014002764,0.00026795059,0.00051882863,0.000018483048,0.000100827085,0.00023667698,0.000005979851],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005275192,0.00015718317,0.0030862135,0.000081231665,0.0006160834,2.5970033e-7,0.0010787459,0.000033018674,0.98286676,0.000012148862,0.0010398907,0.010500914],"study_design_scores_gemma":[0.0021028577,0.00028459,0.0030612333,0.00003214337,0.00007380467,0.000006420908,0.00016871611,0.000023495662,0.98272955,0.000019693516,0.011240871,0.00025661674],"about_ca_topic_score_codex":0.00027292813,"about_ca_topic_score_gemma":0.0000010219728,"teacher_disagreement_score":0.11352433,"about_ca_system_score_codex":0.00019894645,"about_ca_system_score_gemma":0.0005430579,"threshold_uncertainty_score":0.9999964},"labels":[],"label_agreement":null},{"id":"W1970846528","doi":"10.1007/s00262-009-0802-8","title":"IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo","year":2009,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"In vivo; Medicine; Proinflammatory cytokine; Immune system; Cytokine; Melanoma; Immunotherapy; Cancer research; Pharmacology; Immunology; Biology; Inflammation","score_opus":0.015989217561995468,"score_gpt":0.25141568541364157,"score_spread":0.2354264678516461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970846528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9367166,0.058188826,0.0000189836,0.0009314672,0.001834,0.00078950124,0.00012605781,0.00027858777,0.0011159695],"genre_scores_gemma":[0.9885682,0.0064530433,0.0001288246,0.0014628287,0.000119440476,0.00025200826,0.00010552913,0.000072236864,0.0028379168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970755,0.00037401356,0.0007251456,0.0007267144,0.000071792965,0.0010268415],"domain_scores_gemma":[0.99865645,0.00012677825,0.00030816693,0.0007791433,0.000096256554,0.00003322204],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002672664,0.0006149103,0.0008830149,0.00043616843,0.00037332025,0.000049671573,0.0006522642,0.0004641144,0.0012768584],"category_scores_gemma":[0.000035264453,0.00056349335,0.00027638883,0.00048103096,0.00049483374,0.0002488301,0.000052105403,0.00055944396,0.00047292546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027983664,0.000603661,0.0053768763,0.000010412825,0.00086871244,0.00013208423,0.0009793071,0.000047111807,0.8983343,0.00032875335,0.0018213958,0.08869897],"study_design_scores_gemma":[0.018545086,0.0009450069,0.25212878,0.00022453425,0.00010743268,0.0002120546,0.00015744673,0.000007874196,0.5210465,0.0002402376,0.20526132,0.0011236743],"about_ca_topic_score_codex":0.0001686977,"about_ca_topic_score_gemma":0.0000846908,"teacher_disagreement_score":0.3772878,"about_ca_system_score_codex":0.0003047995,"about_ca_system_score_gemma":0.00042516092,"threshold_uncertainty_score":0.99968165},"labels":[],"label_agreement":null},{"id":"W1972057331","doi":"10.1007/s00262-011-1180-6","title":"Epidemiology: allergy history, IgE, and cancer","year":2011,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health; University of Ottawa","funders":"","keywords":"Allergy; Epidemiology; Medicine; Immunology; Cancer; Immunoglobulin E; Internal medicine; Antibody","score_opus":0.12772817679672357,"score_gpt":0.37119056783823046,"score_spread":0.24346239104150688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972057331","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033967972,0.9939541,0.00007205656,0.00029763096,0.0027056346,0.0009458313,0.000041206542,0.00013963209,0.0018098946],"genre_scores_gemma":[0.0000041633066,0.98737043,0.00019768756,0.0021309631,0.0003849499,0.00077978364,0.00019495837,0.0001953271,0.008741746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99675566,0.0005058003,0.0011513222,0.0008388982,0.00009406381,0.00065426197],"domain_scores_gemma":[0.99775606,0.00025036625,0.0008814327,0.0008260166,0.0001727548,0.00011334],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035022094,0.0007672395,0.0037185769,0.00032759644,0.00012552558,0.00000470794,0.00027304678,0.0012751515,0.0044662575],"category_scores_gemma":[0.00006836415,0.00061560026,0.00053721434,0.00015939811,0.0007507853,0.00007853034,0.00007650247,0.00096569787,0.00007080227],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018599638,0.000059507696,0.00006175866,0.0011895214,0.0036398212,0.00003028523,0.00037220103,1.4310585e-7,0.000014273543,0.0013837161,0.006358585,0.9867042],"study_design_scores_gemma":[0.001205142,0.00023368868,0.00048804193,0.005446279,0.0005149479,0.00043377644,0.000015489128,0.0000033054962,0.0000015485638,0.00009059192,0.9910328,0.00053442584],"about_ca_topic_score_codex":0.001623907,"about_ca_topic_score_gemma":0.00006046968,"teacher_disagreement_score":0.98616976,"about_ca_system_score_codex":0.0012025664,"about_ca_system_score_gemma":0.0013097465,"threshold_uncertainty_score":0.99962956},"labels":[],"label_agreement":null},{"id":"W1974625087","doi":"10.1007/s00262-006-0243-6","title":"Alveolar macrophage cytotoxic activity is inhibited by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a carcinogenic component of cigarette smoke","year":2006,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Chemistry; Cytotoxicity; Carcinogen; Cytotoxic T cell; Reactive oxygen species; Tumor necrosis factor alpha; Alveolar macrophage; Lipopolysaccharide; Molecular biology; Cell culture; DNA damage; Pharmacology; Cancer research; Macrophage; Biochemistry; Immunology; Biology; In vitro; DNA","score_opus":0.008906055607518249,"score_gpt":0.2500969224728424,"score_spread":0.24119086686532412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974625087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.935617,0.061121047,0.00080796966,0.00029906473,0.0003633333,0.00051160593,0.001119939,0.000033422584,0.00012656461],"genre_scores_gemma":[0.9917606,0.0057528135,0.00016381402,0.00073620304,0.00017683466,0.00017408197,0.00055236986,0.00009932334,0.0005839269],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973354,0.00022859435,0.00064020656,0.0008474802,0.0002254135,0.00072293135],"domain_scores_gemma":[0.99809027,0.00003912315,0.00050921354,0.0010619427,0.000229748,0.000069707115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020255796,0.0005474532,0.00071065454,0.0001296538,0.00017836418,0.000027181526,0.00064790377,0.00057279476,0.00028138654],"category_scores_gemma":[0.000018013461,0.0005789719,0.00039017323,0.00023879291,0.0007809606,0.000015520623,0.0001907106,0.00042987015,0.000008251576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011292765,0.0003282774,0.007495465,0.000027808497,0.0007836292,0.0000042633205,0.00012825405,0.000014068488,0.98442996,0.000010685342,0.0027191325,0.0029291876],"study_design_scores_gemma":[0.0030771063,0.00038574132,0.04168339,0.000029444047,0.00005240178,0.00001585707,0.000039497205,0.000012320951,0.9397382,0.00010814065,0.014328487,0.00052937574],"about_ca_topic_score_codex":0.0014395191,"about_ca_topic_score_gemma":0.00004635704,"teacher_disagreement_score":0.05614358,"about_ca_system_score_codex":0.0001752735,"about_ca_system_score_gemma":0.0001786154,"threshold_uncertainty_score":0.99966615},"labels":[],"label_agreement":null},{"id":"W1978607297","doi":"10.1007/s00262-010-0929-7","title":"Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909","year":2010,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"National Cancer Institute; National Institutes of Health; Leukemia and Lymphoma Society","keywords":"Vaccination; Immunology; Epitope; Antigen; Immunogenicity; Immunotherapy; Medicine; T cell; CD8; Virology; Biology; Cancer research; Immune system","score_opus":0.006159829555518113,"score_gpt":0.23266311830948155,"score_spread":0.22650328875396344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978607297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95711577,0.040578473,0.000119366676,0.0007615428,0.00024898537,0.0009652552,0.000022557795,0.000066839064,0.00012121226],"genre_scores_gemma":[0.9908383,0.007457885,0.0004564798,0.00013945968,0.000008565349,0.0004023704,0.000029264327,0.00006241645,0.00060527003],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981548,0.00029642959,0.000508007,0.00048022653,0.00006455745,0.0004959876],"domain_scores_gemma":[0.9986006,0.00028595948,0.0003591993,0.0005243379,0.00021075914,0.000019149356],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034218913,0.00041113773,0.00065742823,0.0004163774,0.000277609,0.000032628308,0.00029395786,0.0004103482,0.00032631838],"category_scores_gemma":[0.000039760336,0.0003234084,0.000050362098,0.0003607034,0.0010807909,0.0003321885,0.000055760047,0.0007922219,0.0000070970336],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005879449,0.0002994249,0.021080535,0.000029715658,0.0006025579,0.000006580904,0.0024090365,0.0000027728518,0.93343073,0.0016082113,0.0000140700095,0.034636945],"study_design_scores_gemma":[0.013793106,0.002362918,0.49310243,0.00019360252,0.000046196834,0.0003447693,0.0009853458,0.000004784837,0.4839688,0.00035571997,0.0043399488,0.0005023615],"about_ca_topic_score_codex":0.0014242238,"about_ca_topic_score_gemma":0.0011115925,"teacher_disagreement_score":0.4720219,"about_ca_system_score_codex":0.0000541675,"about_ca_system_score_gemma":0.00022228803,"threshold_uncertainty_score":0.9999218},"labels":[],"label_agreement":null},{"id":"W1979479636","doi":"10.1007/s00262-015-1662-z","title":"The safety of allogeneic innate lymphocyte therapy for glioma patients with prior cranial irradiation","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Elsa U. Pardee Foundation","keywords":"Radiation therapy; Cytotoxic T cell; Glioma; Immunotherapy; Temozolomide; Medicine; Cell therapy; Cancer research; CD8; Immune system; Parenchyma; Immunology; Cell; Pathology; Biology; Internal medicine; In vitro","score_opus":0.025060749338043902,"score_gpt":0.30951494330881996,"score_spread":0.28445419397077604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979479636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96211123,0.032583334,0.00019268336,0.0014773742,0.00071371807,0.0026280219,0.00005642633,0.000060418075,0.0001767997],"genre_scores_gemma":[0.9491724,0.042747237,0.0006374653,0.0010859919,0.0003592204,0.001537599,0.00017053414,0.00025161353,0.004037932],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978841,0.00018741097,0.0005424312,0.00036641932,0.00044428292,0.0005753487],"domain_scores_gemma":[0.9975162,0.00026203855,0.0003228293,0.0007932396,0.0010201989,0.00008549705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006379073,0.00029892393,0.0005462327,0.00017361526,0.0002632458,0.00003203118,0.0004189317,0.00022294479,0.0003341505],"category_scores_gemma":[0.000062790845,0.00017232448,0.00017610415,0.00040396288,0.000595025,0.000119309545,0.000032900836,0.00022742571,0.000011074282],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10649996,0.00032230644,0.017515212,0.000016489907,0.0018808703,0.0000027228339,0.0012205282,0.000018899404,0.20756763,0.0000869336,0.00031540138,0.66455305],"study_design_scores_gemma":[0.093361646,0.008025368,0.30636218,0.000098298,0.00007944142,0.00003341746,0.00022748059,0.00007361876,0.096785486,0.00029442937,0.4941941,0.00046452656],"about_ca_topic_score_codex":0.00024452113,"about_ca_topic_score_gemma":0.00003543842,"teacher_disagreement_score":0.6640885,"about_ca_system_score_codex":0.0007005363,"about_ca_system_score_gemma":0.0012165587,"threshold_uncertainty_score":0.7027188},"labels":[],"label_agreement":null},{"id":"W1981785446","doi":"10.1007/s00262-009-0752-1","title":"Autophagy facilitates major histocompatibility complex class I expression induced by IFN-γ in B16 melanoma cells","year":2009,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Program for New Century Excellent Talents in University; Chinese Academy of Medical Sciences; Chinese Academy of Sciences; National Natural Science Foundation of China; Academy of Medical Sciences","keywords":"Autophagy; Major histocompatibility complex; MHC class I; Cell biology; Biology; CTL*; Regulator; Antigen; Cytolysis; Antigen processing; Immunology; Melanoma; Cytotoxic T cell; Cancer research; Apoptosis; CD8; Genetics","score_opus":0.02402543236678481,"score_gpt":0.3092619242453719,"score_spread":0.28523649187858713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981785446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95805436,0.03738639,0.000088174034,0.0016385661,0.00046566955,0.0012129032,0.000085525346,0.00021904091,0.0008493902],"genre_scores_gemma":[0.9924948,0.0018406546,0.0002349907,0.003856667,0.000065526925,0.00026498432,0.00012717127,0.000052015555,0.0010631674],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971852,0.00028512755,0.00079983904,0.00073080935,0.00026637505,0.00073265133],"domain_scores_gemma":[0.99835634,0.000114499446,0.00025183085,0.0010402433,0.000112813424,0.00012425016],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024362234,0.0005003303,0.0009503806,0.00024402887,0.00017141431,0.00002367221,0.00043521027,0.0004355982,0.002598939],"category_scores_gemma":[0.000016275639,0.0004478203,0.00024354395,0.0003517722,0.0002963,0.00018705521,0.000034925928,0.0006357958,0.00008757269],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002807946,0.00083511666,0.0014709334,0.000021089796,0.00020757238,0.00002926351,0.0011377103,0.0000042356514,0.940841,0.0000649168,0.002670846,0.049909346],"study_design_scores_gemma":[0.011005618,0.0014221608,0.30629304,0.00014664429,0.000033199085,0.000014840178,0.00018588454,0.000081627586,0.64933985,0.0010569734,0.029922916,0.00049723627],"about_ca_topic_score_codex":0.00046145177,"about_ca_topic_score_gemma":0.000021612288,"teacher_disagreement_score":0.30482212,"about_ca_system_score_codex":0.0006841598,"about_ca_system_score_gemma":0.0002778838,"threshold_uncertainty_score":0.99979734},"labels":[],"label_agreement":null},{"id":"W1985361047","doi":"10.1007/s00262-011-1054-y","title":"Th17 and Th17-stimulated CD8+ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Canadian Institutes of Health Research; University of Saskatchewan","keywords":"Cytotoxic T cell; Immunology; CD8; Immunity; CTL*; CCL20; CD40; Immune system; Interleukin 17; Biology; Cancer research; In vitro; Chemokine","score_opus":0.022262624137514717,"score_gpt":0.26466978817854075,"score_spread":0.24240716404102602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985361047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80688816,0.18997401,0.000048770675,0.00012371369,0.0011278907,0.0010250527,0.00006278653,0.00017704614,0.0005725879],"genre_scores_gemma":[0.97607327,0.021301897,0.00008458616,0.00045336023,0.000024996136,0.0003370389,0.00004808017,0.00013794942,0.0015388443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.994919,0.0015779807,0.0010770337,0.0010115141,0.00009555033,0.0013189077],"domain_scores_gemma":[0.9976272,0.00051980803,0.0005288778,0.0011204979,0.00015369755,0.00004992094],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00083740486,0.00093978056,0.0013020409,0.00058159075,0.0007065363,0.00006974653,0.00085848576,0.0009284034,0.0019344237],"category_scores_gemma":[0.000052408403,0.00084789755,0.00023182372,0.0005416053,0.0015427255,0.0003876014,0.00028433272,0.001488655,0.0001248986],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069373325,0.0005701098,0.008747646,0.00002657234,0.0018160191,0.00002408822,0.01266514,0.0000017807981,0.9129458,0.00035942596,0.000030686122,0.055875394],"study_design_scores_gemma":[0.011443007,0.001634998,0.39083293,0.0002817648,0.00013776548,0.00026719112,0.0021505004,0.000021290796,0.58209944,0.0011050835,0.0088129025,0.0012131196],"about_ca_topic_score_codex":0.0043385136,"about_ca_topic_score_gemma":0.00022184491,"teacher_disagreement_score":0.3820853,"about_ca_system_score_codex":0.00019142427,"about_ca_system_score_gemma":0.00029541666,"threshold_uncertainty_score":0.99939716},"labels":[],"label_agreement":null},{"id":"W1986527011","doi":"10.1007/s00262-011-1108-1","title":"Integrin alphavbeta6 promotes tumor tolerance in colorectal cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; General Hospital of People’s Liberation Army","keywords":"Colorectal cancer; Immune tolerance; Immune system; Granzyme B; CD8; Cancer research; T cell; Flow cytometry; Cytotoxic T cell; Medicine; Tumor microenvironment; Immunology; Peripheral tolerance; Cancer; Metastasis; Biology; Internal medicine; In vitro","score_opus":0.035642921361739084,"score_gpt":0.32476055564479683,"score_spread":0.28911763428305776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986527011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.947674,0.04746793,0.000031556938,0.0007702591,0.0005700096,0.0010047404,0.000014777681,0.00011120551,0.002355529],"genre_scores_gemma":[0.9837204,0.011646416,0.00053956744,0.0011038623,0.00008860435,0.0013501011,0.00001061279,0.000100292404,0.001440104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976406,0.00016772917,0.0005410308,0.0005863259,0.00026774305,0.00079657533],"domain_scores_gemma":[0.9989737,0.000066144115,0.00014889502,0.00051032816,0.00020814933,0.00009275486],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026285814,0.00035130364,0.0006776723,0.0003750883,0.00008614711,0.000016668882,0.00045251966,0.00022948181,0.007356045],"category_scores_gemma":[0.0000512186,0.000307544,0.00016489804,0.0006150057,0.00052581343,0.00012590148,0.000093635084,0.0009405649,0.00014477292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004325182,0.00045286297,0.082164854,0.000043979722,0.00031127522,0.0002148937,0.0024078535,0.0000024939136,0.8414697,0.00009686805,0.00026576308,0.068244286],"study_design_scores_gemma":[0.0047804816,0.0007453034,0.40566114,0.00026689455,0.000020169196,0.00010341042,0.00021443072,0.000093799375,0.57863194,0.00011988697,0.009048525,0.00031402917],"about_ca_topic_score_codex":0.004027024,"about_ca_topic_score_gemma":0.00052093726,"teacher_disagreement_score":0.32349628,"about_ca_system_score_codex":0.00055822806,"about_ca_system_score_gemma":0.00065166503,"threshold_uncertainty_score":0.99993765},"labels":[],"label_agreement":null},{"id":"W1986659029","doi":"10.1007/s00262-014-1597-9","title":"Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma","year":2014,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Mesothelioma; Immune system; Cancer research; Natural killer T cell; Natural killer cell; CD1D; Chemotherapy; Immunology; Biology; T cell; Cytotoxic T cell; Medicine; Pathology; Internal medicine; In vitro","score_opus":0.00585166177811634,"score_gpt":0.24617989010386745,"score_spread":0.24032822832575113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986659029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97857434,0.017214533,0.000013717169,0.0028149774,0.00035647693,0.0009010938,0.000026278953,0.000047185702,0.000051400963],"genre_scores_gemma":[0.9905557,0.0062785465,0.000043370666,0.00069713715,0.00009308422,0.00039731592,0.00007949393,0.000058951955,0.0017964192],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818766,0.000267916,0.00058940856,0.0003435088,0.0002634215,0.000348068],"domain_scores_gemma":[0.99897295,0.00014351477,0.00037212123,0.00039259912,0.00008139537,0.000037393515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000215335,0.00028646734,0.00041002355,0.0001480754,0.0001632537,0.000017262575,0.00019764583,0.00015296317,0.00044414197],"category_scores_gemma":[0.000035222794,0.00021332815,0.000117994685,0.00035123905,0.00023706575,0.0001609062,0.00003601651,0.00032240644,0.0000036059773],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004945059,0.0003529978,0.03295822,0.00007478312,0.00018092232,0.000001009134,0.0011418619,0.000058294863,0.9489409,0.000008835607,0.00010418302,0.011232978],"study_design_scores_gemma":[0.003714179,0.00021080552,0.38254875,0.00015991848,0.000020617246,0.000003920669,0.00010834327,0.0001816142,0.61190856,0.000013534548,0.0009835133,0.00014626374],"about_ca_topic_score_codex":0.002525512,"about_ca_topic_score_gemma":0.00008998875,"teacher_disagreement_score":0.34959054,"about_ca_system_score_codex":0.0004805851,"about_ca_system_score_gemma":0.0001475176,"threshold_uncertainty_score":0.869927},"labels":[],"label_agreement":null},{"id":"W1991758119","doi":"10.1007/s00262-005-0010-0","title":"Monoclonal antibody therapy of chronic lymphocytic leukemia","year":2005,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Georgetown Hospital","funders":"","keywords":"Alemtuzumab; Chronic lymphocytic leukemia; Rituximab; Medicine; Fludarabine; Monoclonal antibody; Monoclonal antibody therapy; Immunology; Chemotherapy; Oncology; Leukemia; Antibody; Cancer research; Internal medicine; Cyclophosphamide","score_opus":0.06360689097298267,"score_gpt":0.4219103626378996,"score_spread":0.35830347166491694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991758119","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00110347,0.9940185,0.000038120237,0.000046047626,0.0010768805,0.00273166,0.00011195218,0.00020276978,0.0006706298],"genre_scores_gemma":[0.000117086674,0.9936287,0.00015658858,0.0002163182,0.0011850392,0.00097365654,0.00040943368,0.00043046242,0.002882751],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99407953,0.0004217922,0.002074519,0.0012094214,0.0007554824,0.001459283],"domain_scores_gemma":[0.99527586,0.00048043157,0.001180049,0.0025271103,0.00036259045,0.00017399037],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0005211292,0.0013229547,0.00547395,0.0009420359,0.00016449142,0.000038159695,0.0013993166,0.0017120533,0.0035800915],"category_scores_gemma":[0.00004905596,0.0010561051,0.0018523032,0.0011510933,0.001408376,0.00015081938,0.000213995,0.0015519785,0.0003831686],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0008605806,0.00012462738,0.0000024210328,0.004587393,0.00609766,0.0001062939,0.00013708236,0.000022786544,0.0013565131,0.0000830681,0.00055498653,0.9860666],"study_design_scores_gemma":[0.022768555,0.0011109329,0.000016382375,0.0127452575,0.00048224602,0.0015487486,0.000013214961,0.00027070288,0.0005128243,0.000013186159,0.95973754,0.0007804052],"about_ca_topic_score_codex":0.0017935836,"about_ca_topic_score_gemma":0.000016614542,"teacher_disagreement_score":0.9852862,"about_ca_system_score_codex":0.20142466,"about_ca_system_score_gemma":0.18907407,"threshold_uncertainty_score":0.9999522},"labels":[],"label_agreement":null},{"id":"W1993461896","doi":"10.1007/s00262-005-0088-4","title":"Photodynamic therapy-generated vaccine for cancer therapy","year":2005,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Photodynamic therapy; Cancer therapy; Medicine; Vaccine therapy; Cancer; Internal medicine; Immunotherapy; Chemistry","score_opus":0.029245854917919967,"score_gpt":0.35418348161245405,"score_spread":0.3249376266945341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993461896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72434425,0.26225576,0.00008004707,0.009340081,0.00069308985,0.0025889548,0.00014771958,0.00031472693,0.00023539229],"genre_scores_gemma":[0.4961497,0.48136386,0.0005727644,0.0077067786,0.0007567612,0.0061533423,0.000101604855,0.00025441305,0.0069407853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965765,0.00011994753,0.0007560448,0.00088719785,0.00035864476,0.0013016718],"domain_scores_gemma":[0.99778086,0.0002079585,0.00029629684,0.00088815775,0.0006887669,0.00013796736],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043291916,0.00072846847,0.0012002693,0.00040641506,0.0004745711,0.000058733523,0.00060835003,0.0004065047,0.0037459484],"category_scores_gemma":[0.000029879731,0.00058381,0.000480812,0.00063882826,0.00035971086,0.00024685898,0.000057460635,0.00066402706,0.000042306798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009951529,0.0003691733,0.0007147846,0.000014803113,0.0029778825,0.0000031997856,0.0005196816,0.000036972917,0.635131,0.00004954568,0.002322241,0.34790918],"study_design_scores_gemma":[0.026715169,0.0016546854,0.02896915,0.00010555048,0.00004595717,0.00004590628,0.000102369864,0.00041849285,0.47340047,0.00012435374,0.46777865,0.00063921337],"about_ca_topic_score_codex":0.0007333147,"about_ca_topic_score_gemma":0.0002893851,"teacher_disagreement_score":0.46545643,"about_ca_system_score_codex":0.00091372046,"about_ca_system_score_gemma":0.0006301097,"threshold_uncertainty_score":0.9996613},"labels":[],"label_agreement":null},{"id":"W1995856925","doi":"10.1007/s002620100209","title":"ALVAC-mediated gene transfer is efficient in lymphoid malignancies of T-and early B-cell origin, but not in tumors arising from mature B-cells","year":2001,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Gene transfer; Biology; B cell; Gene; Cancer research; Immunology; Genetics; Antibody","score_opus":0.01283724045608944,"score_gpt":0.265895345861642,"score_spread":0.25305810540555257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995856925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94284624,0.056009017,0.00009355271,0.00027018,0.00017331252,0.0004110829,0.00015103961,0.000013765709,0.00003180699],"genre_scores_gemma":[0.9663456,0.032345694,0.000087565146,0.00070566195,0.000049998507,0.00010054683,0.00004954514,0.0000691271,0.0002462578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977532,0.00021830648,0.0005767757,0.0006221563,0.00019960292,0.00062995363],"domain_scores_gemma":[0.9990933,0.000048067675,0.00010735478,0.00059867656,0.00010159591,0.000051021125],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029834537,0.00035120762,0.00052036496,0.0002696816,0.00006024218,0.000023884835,0.0004496951,0.0004475903,0.00013975086],"category_scores_gemma":[0.000009278554,0.0003516555,0.000120918725,0.0003847139,0.00032443588,0.000009238279,0.000059338676,0.00033746072,0.000009829592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072471704,0.00023604964,0.0129659185,0.000012798356,0.00016505216,0.000026838641,0.0011529323,0.000313976,0.974476,0.0000017502307,0.000033950586,0.0033676056],"study_design_scores_gemma":[0.006717576,0.0008775681,0.019860104,0.000068078785,0.00000878534,0.00001111903,0.00019614925,0.00006178238,0.9698393,0.000015312875,0.0020032849,0.0003409431],"about_ca_topic_score_codex":0.0025334887,"about_ca_topic_score_gemma":0.00039010186,"teacher_disagreement_score":0.023663323,"about_ca_system_score_codex":0.00012322591,"about_ca_system_score_gemma":0.00030869537,"threshold_uncertainty_score":0.99989355},"labels":[],"label_agreement":null},{"id":"W2000236470","doi":"10.1007/s00262-010-0864-7","title":"Inhibition of in vitro tumor cell growth by RP215 monoclonal antibody and antibodies raised against its anti-idiotype antibodies","year":2010,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Epitope; Antibody; Monoclonal antibody; Polyclonal antibodies; Molecular biology; Hybridoma technology; In vitro; Antiserum; Biology; Monoclonal; Idiotype; Chemistry; Biochemistry; Immunology","score_opus":0.007873734694821182,"score_gpt":0.255271408390457,"score_spread":0.24739767369563578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000236470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8140478,0.18267192,0.000024186884,0.00033924417,0.00162413,0.0005792446,0.0002853515,0.00010998873,0.00031811153],"genre_scores_gemma":[0.93087864,0.06726059,0.00012263212,0.0005080773,0.000035841793,0.00009819387,0.00037236922,0.00010314096,0.00062053854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963174,0.0005622805,0.0011663142,0.00080584915,0.000111630696,0.0010365492],"domain_scores_gemma":[0.99791485,0.00038734637,0.0006709312,0.00068650744,0.00030749803,0.000032838376],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060654443,0.00074514473,0.0013558224,0.0006721076,0.0004060428,0.00004844928,0.00057316123,0.00076499075,0.00060281635],"category_scores_gemma":[0.000100507255,0.00071394246,0.00025843727,0.0004965984,0.0017695002,0.00049892504,0.00015926608,0.0013916045,0.00006515354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004813262,0.0005388848,0.014749318,0.00009549485,0.00058432104,0.000015468073,0.001460099,0.0000015157789,0.9716243,0.00012322885,0.0003522519,0.005641839],"study_design_scores_gemma":[0.007695774,0.00034350966,0.06983858,0.00012583545,0.000027518921,0.00007819028,0.0003163748,0.0000057383118,0.91073245,0.000086110806,0.010076356,0.0006735708],"about_ca_topic_score_codex":0.00045926473,"about_ca_topic_score_gemma":0.000014058115,"teacher_disagreement_score":0.116830796,"about_ca_system_score_codex":0.00008202645,"about_ca_system_score_gemma":0.00029558354,"threshold_uncertainty_score":0.99953115},"labels":[],"label_agreement":null},{"id":"W2001989483","doi":"10.1007/s00262-006-0158-2","title":"Targeted and shielded adenovectors for cancer therapy","year":2006,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute","funders":"","keywords":"Viral vector; Virology; Oncolytic virus; Vector (molecular biology); Virotherapy; Biology; Context (archaeology); Neutralizing antibody; Transduction (biophysics); Virus; Recombinant DNA; Genetics","score_opus":0.045714452088127154,"score_gpt":0.37577552125980956,"score_spread":0.33006106917168243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001989483","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005259718,0.9904809,0.000040127117,0.00013085763,0.00087297836,0.0025009909,0.00059810537,0.000057387326,0.000058907004],"genre_scores_gemma":[0.000041885225,0.9885427,0.00008686495,0.00040671442,0.0007374934,0.005444709,0.0007556039,0.0003455987,0.0036384556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966588,0.00027752927,0.00075391686,0.0011705931,0.00018445753,0.0009546732],"domain_scores_gemma":[0.99819237,0.00010513,0.0004854393,0.00091221527,0.00022533335,0.000079510806],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00034648812,0.0009437505,0.0017116597,0.00028188212,0.00028487318,0.00008237683,0.0009077454,0.00132338,0.00028757055],"category_scores_gemma":[0.000020696272,0.00081470044,0.00070535863,0.0003194384,0.00051051256,0.000009420374,0.000117086005,0.0005660371,0.000008233057],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022107565,0.00008287506,0.00001594502,0.00059981795,0.0027270708,0.0000013872968,0.000030481979,0.0000024538267,0.059494574,0.000013493104,0.003958074,0.9308631],"study_design_scores_gemma":[0.0025402715,0.0022418695,0.000022607855,0.00060227525,0.00012700954,0.000015768372,0.0000111627405,9.465627e-7,0.014736304,0.00003517685,0.97880864,0.00085794705],"about_ca_topic_score_codex":0.00027287297,"about_ca_topic_score_gemma":0.00028954743,"teacher_disagreement_score":0.9748506,"about_ca_system_score_codex":0.0001834944,"about_ca_system_score_gemma":0.0010087809,"threshold_uncertainty_score":0.9999731},"labels":[],"label_agreement":null},{"id":"W2004009702","doi":"10.1007/s00262-002-0315-1","title":"Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma","year":2002,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Ligue Contre le Cancer; Institut National de la Santé et de la Recherche Médicale","keywords":"Medicine; Melanoma; Lymph; Lymph node; Adjuvant therapy; Stage (stratigraphy); Population; Clinical endpoint; Adjuvant; Confidence interval; Oncology; Internal medicine; Surgery; Randomized controlled trial; Pathology; Cancer; Cancer research; Biology","score_opus":0.02387573056888997,"score_gpt":0.2750086496644934,"score_spread":0.2511329190956034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004009702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7295115,0.26312846,0.00051953393,0.00021767279,0.0018750215,0.0036780066,0.00023669084,0.00010727564,0.00072584645],"genre_scores_gemma":[0.928623,0.06338992,0.00016818577,0.00045954654,0.00007010962,0.002043556,0.000089295085,0.00015069517,0.005005703],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99406004,0.0016160953,0.002363094,0.0007551744,0.00016064667,0.0010449379],"domain_scores_gemma":[0.99473053,0.0024954889,0.0011121231,0.0011331063,0.00049781834,0.000030955813],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001390049,0.00086688553,0.0031779543,0.00052692095,0.00041177092,0.000026353346,0.0010795359,0.0007457756,0.007178604],"category_scores_gemma":[0.00022428697,0.0007233706,0.0014228805,0.000451906,0.002462341,0.00030135538,0.000052889227,0.000543801,0.00005181152],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.504341,0.00058073166,0.000030535088,0.000030677853,0.0038862813,0.0000023222306,0.0033903874,0.000008945457,0.44925684,0.0011750318,0.00009580058,0.03720148],"study_design_scores_gemma":[0.4961908,0.0038177439,0.00009332945,0.00011803008,0.00010017953,0.000039460472,0.0006338696,0.000013325666,0.4830589,0.00012204548,0.015380991,0.0004313335],"about_ca_topic_score_codex":0.0011166866,"about_ca_topic_score_gemma":0.000012515137,"teacher_disagreement_score":0.19973853,"about_ca_system_score_codex":0.00017163853,"about_ca_system_score_gemma":0.00043503253,"threshold_uncertainty_score":0.99952173},"labels":[],"label_agreement":null},{"id":"W2009827668","doi":"10.1007/s00262-013-1416-8","title":"An introduction to mass cytometry: fundamentals and applications","year":2013,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":162,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mass cytometry; Cytometry; Mass spectrometry; Flow cytometry; Physics; Inductively coupled plasma mass spectrometry; Chemistry; Analytical Chemistry (journal); Computer science; Nanotechnology; Materials science; Chromatography; Biology; Molecular biology","score_opus":0.025788554107201704,"score_gpt":0.3311461908520582,"score_spread":0.3053576367448565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009827668","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046871748,0.99056774,0.006504211,0.00015233981,0.0006981847,0.001430574,0.00010666916,0.00003754256,0.00003401054],"genre_scores_gemma":[0.00007728158,0.99373263,0.0007286577,0.00031867993,0.0013146903,0.0024166321,0.0005929061,0.000114170405,0.0007043613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981904,0.00015422326,0.00043987468,0.0007858646,0.00007625854,0.00035340386],"domain_scores_gemma":[0.998719,0.000012846293,0.00019989283,0.00090212096,0.00008358706,0.00008256038],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012980113,0.0004473349,0.0008074094,0.00019760629,0.00016025695,0.00008086031,0.00047296204,0.00058498775,0.00018396701],"category_scores_gemma":[0.0000057715597,0.00041143576,0.00017844552,0.00025588088,0.00019657258,0.000009865803,0.000046096593,0.00027169325,0.000047916572],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037549144,0.000051919716,0.0000135522805,0.00025771678,0.00044923575,1.9748022e-7,0.00002006121,0.0000010460999,0.22625713,0.000040593946,0.00053034467,0.77234066],"study_design_scores_gemma":[0.0003413613,0.00039303303,0.000018078967,0.00013405737,0.000104513165,0.000024747562,0.000022752014,4.5436948e-7,0.0033551455,0.000019428602,0.9951486,0.00043783273],"about_ca_topic_score_codex":0.00006941567,"about_ca_topic_score_gemma":0.000008755378,"teacher_disagreement_score":0.99461824,"about_ca_system_score_codex":0.000103950566,"about_ca_system_score_gemma":0.00015956422,"threshold_uncertainty_score":0.99983376},"labels":[],"label_agreement":null},{"id":"W2009871132","doi":"10.1007/s00262-014-1555-6","title":"Altered chemokine production and accumulation of regulatory T cells in intestinal adenomas of APCMin/+ mice","year":2014,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ruth och Richard Julins Stiftelse; Cancerfonden; Cancer Research Society","keywords":"FOXP3; Chemokine; Biology; CCL17; Immunology; Cancer research; Population; Regulatory T cell; Immune system; T cell; Medicine; IL-2 receptor; CXCL10","score_opus":0.022766435703176328,"score_gpt":0.2699485758962462,"score_spread":0.2471821401930699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009871132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96473265,0.032500267,0.0001273847,0.00031241623,0.0017181097,0.00038540317,0.000012828009,0.000047712216,0.00016323905],"genre_scores_gemma":[0.99572927,0.0029784786,0.00019740584,0.0000833403,0.000050323026,0.00006215903,0.00003309434,0.000039037815,0.0008269079],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977157,0.00041032955,0.00087559444,0.00050971925,0.000050494582,0.00043813096],"domain_scores_gemma":[0.998359,0.00020306036,0.0006475327,0.0005923832,0.00018510093,0.0000129219525],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048092942,0.0003224214,0.0007633309,0.00038811468,0.00009184691,0.0000052551527,0.0003653819,0.0004903942,0.0003441233],"category_scores_gemma":[0.0000922112,0.00031485537,0.0001019864,0.00031131154,0.0012012081,0.00014942563,0.000097339034,0.00047791537,0.00001934079],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013352409,0.00024195679,0.007439938,0.000066442495,0.00030580242,5.0811093e-7,0.000970078,0.000045609326,0.9645524,0.00037601936,0.00015129773,0.024514727],"study_design_scores_gemma":[0.003149831,0.00053758494,0.051235043,0.00017939058,0.000038142767,0.00006241958,0.00018585571,0.000013514788,0.9388766,0.00024224159,0.0052170316,0.0002623016],"about_ca_topic_score_codex":0.000623768,"about_ca_topic_score_gemma":0.000059837683,"teacher_disagreement_score":0.043795105,"about_ca_system_score_codex":0.000088276465,"about_ca_system_score_gemma":0.00010127501,"threshold_uncertainty_score":0.9999304},"labels":[],"label_agreement":null},{"id":"W2013102110","doi":"10.1007/s00262-006-0269-9","title":"Assessment of CD4+  T cells specific for the tumor antigen SSX-1 in cancer-free individuals","year":2006,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Epitope; Antigen; Biology; Immunology; Cancer research; Molecular biology","score_opus":0.01781743128537293,"score_gpt":0.29625226828824136,"score_spread":0.2784348370028684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013102110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6078581,0.3842122,0.0007958706,0.0011643899,0.0034330888,0.0016359751,0.0005211113,0.00008176634,0.00029750325],"genre_scores_gemma":[0.9213819,0.07148793,0.0005074129,0.0006611254,0.00014591048,0.002199032,0.00012066352,0.00015015715,0.0033458727],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961257,0.0006057103,0.0013540647,0.00066579337,0.00012393558,0.001124824],"domain_scores_gemma":[0.9961241,0.0012507498,0.0007976781,0.0015846447,0.00023009315,0.00001274483],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010358231,0.0006078123,0.0010930296,0.00045760383,0.0005062455,0.000045761404,0.0019358549,0.00048045954,0.0020806731],"category_scores_gemma":[0.000029051005,0.00047496473,0.0004506674,0.0006149462,0.0012984239,0.00020461387,0.00016606368,0.00076411315,0.000030101008],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015287239,0.0004991527,0.016077967,0.000025158057,0.0012574845,0.0000027977917,0.0004746482,0.00025279785,0.9516386,0.0033679535,0.006894067,0.017980665],"study_design_scores_gemma":[0.0077027236,0.0003919941,0.27150732,0.00011263227,0.000040609662,0.000018720566,0.00030755118,0.00000670073,0.3897541,0.0005110257,0.32922718,0.00041943692],"about_ca_topic_score_codex":0.0041981754,"about_ca_topic_score_gemma":0.00033419312,"teacher_disagreement_score":0.5618845,"about_ca_system_score_codex":0.00033786855,"about_ca_system_score_gemma":0.00060879067,"threshold_uncertainty_score":0.9997702},"labels":[],"label_agreement":null},{"id":"W2013475297","doi":"10.1007/s00262-005-0014-9","title":"Nitroreductase-based therapy of prostate cancer, enhanced by raising expression of heat shock protein 70, acts through increased anti-tumour immunity","year":2005,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kinexus Bioinformatics Corporation (Canada); Vancouver Biotech (Canada)","funders":"Science Foundation Ireland","keywords":"Bystander effect; Immune system; Heat shock protein; Cancer research; Cytotoxic T cell; CTL*; Genetic enhancement; CD8; Immunology; Adenoviridae; Suicide gene; Biology; Antigen; Immunity; Prostate cancer; Cancer; In vitro; Gene","score_opus":0.018975968104635477,"score_gpt":0.3149503204333605,"score_spread":0.29597435232872504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013475297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90933,0.08682347,0.0010212603,0.00059087854,0.00012838043,0.0016289889,0.0003662536,0.000037309226,0.000073435636],"genre_scores_gemma":[0.96904695,0.02816098,0.0008216565,0.0002879175,0.000112443915,0.0009829107,0.00030965047,0.000119068456,0.00015842218],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965701,0.000702358,0.0008613544,0.00066896965,0.00038005086,0.00081717264],"domain_scores_gemma":[0.99777347,0.000050967978,0.00040849458,0.0011707498,0.0005147234,0.00008159633],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000467342,0.00051227387,0.0007697065,0.00015243454,0.00024168144,0.000024800447,0.000871146,0.00049222476,0.00037099034],"category_scores_gemma":[0.00008236564,0.00047326178,0.00024873822,0.00038810784,0.00078310637,0.00004613749,0.00014056262,0.00051286456,0.0000037109482],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004941157,0.0005711077,0.00049565436,0.00006672831,0.00034438598,8.524205e-7,0.00043284337,0.0003316266,0.97340006,0.0000042931742,0.00039727363,0.019014038],"study_design_scores_gemma":[0.0063998485,0.0010277906,0.00074360694,0.00031684228,0.000009364508,0.0000026950254,0.00009902847,0.000021306836,0.97176516,0.000026704658,0.019152252,0.0004353847],"about_ca_topic_score_codex":0.0024764286,"about_ca_topic_score_gemma":0.00003965896,"teacher_disagreement_score":0.059716925,"about_ca_system_score_codex":0.00018283898,"about_ca_system_score_gemma":0.0011795126,"threshold_uncertainty_score":0.9997719},"labels":[],"label_agreement":null},{"id":"W2014153856","doi":"10.1007/s00262-008-0502-9","title":"Virulizin® induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; Health Canada","funders":"","keywords":"Eosinophil; Cytokine; Proinflammatory cytokine; Cancer research; In vivo; Melanoma; Immune system; Eosinophilia; Medicine; Immunology; Biology; Inflammation","score_opus":0.03501808798597774,"score_gpt":0.3459635204963543,"score_spread":0.3109454325103766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014153856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96208066,0.033405326,0.00006267306,0.002504561,0.0007524272,0.0009868412,0.000029273395,0.000051424915,0.00012679002],"genre_scores_gemma":[0.9870928,0.011126269,0.00023241193,0.00053287216,0.00004627353,0.0003734867,0.000014990308,0.000031057778,0.0005498536],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984571,0.00014507644,0.00048931176,0.00040959736,0.00019331268,0.00030560576],"domain_scores_gemma":[0.99869305,0.000053271368,0.00035134604,0.0006223472,0.00022044287,0.000059529626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013409943,0.00024624856,0.0007763608,0.00020782444,0.00013099395,0.0000025226248,0.00022544335,0.00017523636,0.00016535414],"category_scores_gemma":[0.00008281166,0.00022647521,0.00013478722,0.00037775538,0.0007396219,0.00014713297,0.00004043057,0.00024146757,0.000017732847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032554327,0.00069249916,0.010876311,0.000084399675,0.0005017682,0.000017552584,0.0013580255,0.0000036496078,0.9493573,0.00001781438,0.005212304,0.028622968],"study_design_scores_gemma":[0.0008963045,0.0004657319,0.13866302,0.0002018027,0.00003963272,0.000116644114,0.00008262559,5.7959267e-7,0.8515617,0.00005876587,0.0077504925,0.00016269984],"about_ca_topic_score_codex":0.0003475141,"about_ca_topic_score_gemma":0.0000061436,"teacher_disagreement_score":0.12778671,"about_ca_system_score_codex":0.00013273767,"about_ca_system_score_gemma":0.0003580326,"threshold_uncertainty_score":0.9235391},"labels":[],"label_agreement":null},{"id":"W2014709975","doi":"10.1007/s00262-004-0626-5","title":"A phase I/II trial of oxidized autologous tumor vaccines during the “watch and wait” phase of chronic lymphocytic leukemia","year":2004,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Chronic lymphocytic leukemia; Stage (stratigraphy); Leukemia; Internal medicine; Clinical trial; Vaccination; Cancer; Gastroenterology; Surgery; Oncology; Immunology","score_opus":0.019490794958685425,"score_gpt":0.3403630314449678,"score_spread":0.3208722364862824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014709975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94270325,0.054130234,0.000047620808,0.0006295012,0.0005104172,0.0018069851,0.000031711246,0.000086183056,0.000054082735],"genre_scores_gemma":[0.9823161,0.016251838,0.0000885083,0.00014085117,0.00021335218,0.00039956332,0.000012023752,0.00008069243,0.0004971172],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99710786,0.00016423233,0.0010516064,0.00052509946,0.00039488444,0.00075633253],"domain_scores_gemma":[0.99771947,0.00023888523,0.0005330178,0.0011704112,0.0002514594,0.00008677467],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046214685,0.00041922604,0.0012439393,0.00022622902,0.00027485605,0.000014574354,0.000525787,0.00026759203,0.00033940878],"category_scores_gemma":[0.00014414545,0.00029893473,0.0002828864,0.00054558145,0.0012495534,0.00012181299,0.00018690336,0.00045842858,0.000006486782],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.15157327,0.0010325174,0.000008493259,0.0002669807,0.001427515,0.000102450256,0.0015876117,0.0001627974,0.8261986,0.00012164733,0.000038045066,0.017480075],"study_design_scores_gemma":[0.5920479,0.010035962,0.00011159305,0.00029212274,0.00014463536,0.0007492713,0.00014174992,0.0006108146,0.39418167,0.00012228149,0.0013629149,0.00019906998],"about_ca_topic_score_codex":0.0043529384,"about_ca_topic_score_gemma":0.00006568637,"teacher_disagreement_score":0.44047466,"about_ca_system_score_codex":0.033258945,"about_ca_system_score_gemma":0.029141033,"threshold_uncertainty_score":0.9999463},"labels":[],"label_agreement":null},{"id":"W2015348628","doi":"10.1007/s00262-010-0823-3","title":"Growth inhibition of tumor cells in vitro by using monoclonal antibodies against gonadotropin-releasing hormone receptor","year":2010,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Hypothalamic control of reproductive hormones","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Monoclonal antibody; Gonadotropin-releasing hormone receptor; Receptor; Molecular biology; Antibody; Growth hormone receptor; Biology; Western blot; MTT assay; Hybridoma technology; Cell growth; Gonadotropin-releasing hormone; Endocrinology; Hormone; Immunology; Luteinizing hormone; Biochemistry; Gene","score_opus":0.012007769206107495,"score_gpt":0.2624601781923464,"score_spread":0.2504524089862389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015348628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9578661,0.039388712,0.00012043884,0.00091027515,0.0008435787,0.00062387076,0.00011245852,0.00006380613,0.00007081223],"genre_scores_gemma":[0.98652184,0.009365104,0.003247053,0.00038453136,0.00018991421,0.000062405816,0.000063926935,0.00008459122,0.00008063034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978726,0.00011989116,0.00070159667,0.00055322185,0.00022478889,0.00052792544],"domain_scores_gemma":[0.99858725,0.000083159604,0.00041210643,0.000546502,0.00032099604,0.00005000324],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022336774,0.0003642556,0.00086649583,0.00036691464,0.000101248734,0.000015964815,0.00017883781,0.00024273757,0.00010392878],"category_scores_gemma":[0.000079692865,0.00035775133,0.00018419327,0.00031741813,0.0006876613,0.00022261392,0.000048647846,0.0008211257,0.000012259481],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034059566,0.00027663363,0.003120588,0.00003152288,0.00033433127,0.000014822586,0.00035187765,0.000004857133,0.9698972,0.000023614253,0.000161464,0.022377105],"study_design_scores_gemma":[0.0055239336,0.00021513861,0.05102354,0.00010444397,0.000040228406,0.000049725888,0.00012268059,0.00009655635,0.93993664,0.000052885192,0.0025299122,0.00030429158],"about_ca_topic_score_codex":0.00086719246,"about_ca_topic_score_gemma":0.000008933386,"teacher_disagreement_score":0.04790295,"about_ca_system_score_codex":0.0002883569,"about_ca_system_score_gemma":0.0003203936,"threshold_uncertainty_score":0.99988747},"labels":[],"label_agreement":null},{"id":"W2016064123","doi":"10.1007/s002620000157","title":"4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone modulation of cytokine release in U937 human macrophages","year":2001,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Cancer Research Society","keywords":"Chemistry; Cytokine; Immune system; Carcinogen; Tumor necrosis factor alpha; Nitrosamine; Carcinogenesis; Cancer research; Biochemistry; Immunology; Biology","score_opus":0.013128372068523719,"score_gpt":0.2874231714665887,"score_spread":0.27429479939806495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016064123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97838277,0.019835984,0.00070269965,0.00016299856,0.00023080531,0.00029084514,0.00008754531,0.000016114007,0.00029026414],"genre_scores_gemma":[0.9869284,0.011451045,0.00030534755,0.00022933962,0.00014910268,0.00010149147,0.00026447963,0.000050192248,0.00052059983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983561,0.00012997349,0.00052662153,0.0004792327,0.0001022164,0.00040583816],"domain_scores_gemma":[0.9988897,0.00002035609,0.00027356166,0.0006401743,0.00013894303,0.00003728614],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015771919,0.00028102222,0.00040629384,0.00014874665,0.000084634485,0.00001169145,0.000392561,0.00029558523,0.0002091691],"category_scores_gemma":[0.000032893222,0.0002982495,0.00013818212,0.0002119769,0.00037632816,0.0000110705505,0.000085996515,0.00021568069,0.0000066845514],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008367261,0.00016539377,0.019701213,0.000012724407,0.00019151672,0.000006321217,0.00013649525,0.00020110152,0.96810657,0.00005326547,0.000099348166,0.010489347],"study_design_scores_gemma":[0.0027150107,0.0003257059,0.1312753,0.00003135977,0.000011432619,0.000013167429,0.00008264084,0.000022773114,0.8569262,0.00046079312,0.007846701,0.0002889023],"about_ca_topic_score_codex":0.00035102238,"about_ca_topic_score_gemma":0.0001061984,"teacher_disagreement_score":0.111574076,"about_ca_system_score_codex":0.000078622,"about_ca_system_score_gemma":0.00008160892,"threshold_uncertainty_score":0.99994695},"labels":[],"label_agreement":null},{"id":"W2017174620","doi":"10.1007/s00262-008-0630-2","title":"TGF-alpha as a candidate tumor antigen for renal cell carcinomas","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Montreal General Hospital; McGill University Health Centre; Université de Montréal; Hôpital Notre-Dame","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Health Research Foundation","keywords":"Immunotherapy; Immunogenicity; Cancer research; Cancer immunotherapy; Antigen; Renal cell carcinoma; Major histocompatibility complex; Transforming growth factor; Kidney cancer; Cancer; Biology; Medicine; Immunology; Immune system; Pathology; Internal medicine","score_opus":0.012716227679694492,"score_gpt":0.2680008353082106,"score_spread":0.2552846076285161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017174620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9105666,0.0871968,0.00066138216,0.00011415775,0.0005356857,0.0004821702,0.00010723324,0.000052869727,0.00028308507],"genre_scores_gemma":[0.9881944,0.0058403765,0.000556569,0.001316291,0.00033651962,0.0005462195,0.00022822297,0.000103907834,0.0028774883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982488,0.000085717875,0.00036550956,0.00058428134,0.00011776098,0.0005979109],"domain_scores_gemma":[0.99879795,0.000030113339,0.00020546676,0.0007258355,0.0001654994,0.00007510743],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000107740685,0.00034042654,0.00033536067,0.00008739362,0.00038007647,0.000019430392,0.00055390905,0.00022156998,0.00025087505],"category_scores_gemma":[0.00003068787,0.00034222662,0.0002369558,0.00010711132,0.00039679377,0.000008883514,0.00007498174,0.00014993433,0.0000409924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016011654,0.0001232548,0.0060869823,0.000015394473,0.00038634654,0.000017923947,0.00030344352,0.00004007358,0.9852319,0.000014497807,0.0044088825,0.0017701854],"study_design_scores_gemma":[0.0025827286,0.0005369638,0.011764892,0.000016113283,0.00001889222,0.00007163003,0.000044369237,0.000005700935,0.72345984,0.00003488822,0.2611136,0.0003503687],"about_ca_topic_score_codex":0.00034816132,"about_ca_topic_score_gemma":0.000033549615,"teacher_disagreement_score":0.261772,"about_ca_system_score_codex":0.00006809353,"about_ca_system_score_gemma":0.0007760997,"threshold_uncertainty_score":0.99990296},"labels":[],"label_agreement":null},{"id":"W2022215700","doi":"10.1007/s00262-013-1420-z","title":"Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models","year":2013,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision BioLogic (Canada)","funders":"Public Health Agency of Canada","keywords":"Antigen; Pancreatic tumor; Monoclonal antibody; Tumor antigen; Antibody; Pancreatic cancer; Cancer research; Flow cytometry; Immunohistochemistry; Tumor M2-PK; Biology; Pathology; Immunotherapy; Cancer; Medicine; Molecular biology; Colorectal cancer; Immunology; Immune system; Internal medicine","score_opus":0.055090801880527444,"score_gpt":0.3320206182949923,"score_spread":0.27692981641446485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022215700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9426863,0.0406932,0.01179898,0.0003692345,0.00140617,0.002411629,0.00046043034,0.000081125494,0.00009293398],"genre_scores_gemma":[0.9834215,0.010722981,0.0036651273,0.00034219457,0.000036737023,0.0011803473,0.00020327939,0.000120001314,0.00030784376],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99563456,0.00071070524,0.0017557532,0.0007911184,0.00010679257,0.0010010942],"domain_scores_gemma":[0.9959956,0.0011532665,0.0012997978,0.00095440855,0.00056872703,0.000028207149],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010064825,0.0006319975,0.0019558335,0.0006026295,0.0002034678,0.000024299054,0.0008910114,0.0006695003,0.0015513495],"category_scores_gemma":[0.00018159405,0.00059529557,0.0006125047,0.00049940374,0.0012414765,0.00065828866,0.000129166,0.0007530524,0.000039574315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013710036,0.0019838356,0.0006925175,0.0000805884,0.0018491405,0.00000384651,0.00081878767,0.0002742058,0.95254076,0.00020555468,0.00012089554,0.027719835],"study_design_scores_gemma":[0.033622343,0.0020144994,0.04965261,0.0005813666,0.00010726527,0.00022802586,0.00033198018,0.0013880619,0.907395,0.0011541818,0.0025436678,0.000981005],"about_ca_topic_score_codex":0.003297198,"about_ca_topic_score_gemma":0.000019833557,"teacher_disagreement_score":0.04896009,"about_ca_system_score_codex":0.00014309121,"about_ca_system_score_gemma":0.0006429017,"threshold_uncertainty_score":0.9996498},"labels":[],"label_agreement":null},{"id":"W2023606464","doi":"10.1007/s00262-005-0043-4","title":"Morphological appearance, content of extracellular matrix and vascular density of lung metastases predicts permissiveness to infiltration by adoptively transferred natural killer and T cells","year":2005,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Stiftelsen Jubileumsklinikens Forskningsfond mot Cancer; Cancer Research Society","keywords":"Infiltration (HVAC); Lewis lung carcinoma; Extracellular matrix; Pathology; Lung; Laminin; Fibronectin; Carcinoma; Adoptive cell transfer; Biology; CD8; Cancer research; Chemistry; Medicine; Immune system; Metastasis; T cell; Cancer; Immunology; Cell biology; Internal medicine; Materials science","score_opus":0.013741179310353333,"score_gpt":0.2512170495308257,"score_spread":0.23747587022047234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023606464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76854736,0.22765896,0.0018561159,0.00020550593,0.0011995401,0.00046102575,0.000030259605,0.000031414955,0.000009825372],"genre_scores_gemma":[0.982866,0.014243803,0.00015361543,0.00014445945,0.00001553225,0.0000651919,0.000071677685,0.00002405605,0.002415689],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982843,0.00032067005,0.0006155418,0.00039810047,0.00006518264,0.0003162118],"domain_scores_gemma":[0.99914575,0.0000738444,0.00025186833,0.0002732761,0.0002289505,0.00002628835],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002509463,0.0002977172,0.0006410515,0.0001676648,0.00014476434,0.0000125116285,0.00017031912,0.00031692593,0.00047586393],"category_scores_gemma":[0.00002604159,0.00026171823,0.00014109212,0.00014596232,0.00054965087,0.00022554489,0.000040685896,0.00036038217,0.000010022941],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002273705,0.00019035721,0.0013998151,0.000040004437,0.00090175285,0.0000011273934,0.00091638067,0.000043311502,0.9810582,0.00012512413,0.00072172843,0.012328542],"study_design_scores_gemma":[0.0044533988,0.0006084307,0.046702314,0.00012109344,0.00010825621,0.000072915325,0.00045959206,0.000043316133,0.90843403,0.0000039272077,0.03869821,0.0002945317],"about_ca_topic_score_codex":0.0002990373,"about_ca_topic_score_gemma":0.0000075218127,"teacher_disagreement_score":0.21431862,"about_ca_system_score_codex":0.000066775014,"about_ca_system_score_gemma":0.000051250434,"threshold_uncertainty_score":0.9999835},"labels":[],"label_agreement":null},{"id":"W2026118569","doi":"10.1007/s00262-003-0465-9","title":"A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells","year":2004,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Chemistry; Immunotherapy; Cancer research; Antigen; Antibody; Effector; Molecular biology; Cancer immunotherapy; In vitro; Immune system; Immunology; Biology; Biochemistry","score_opus":0.012509150809547977,"score_gpt":0.30198856096472776,"score_spread":0.2894794101551798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026118569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7345612,0.25920796,0.00020308873,0.002908429,0.0004418565,0.0019479394,0.0005674962,0.00009003438,0.00007195761],"genre_scores_gemma":[0.7554957,0.23885259,0.00058783445,0.00082816306,0.00021122945,0.001767929,0.0001155308,0.00021962226,0.0019213742],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971055,0.00014215661,0.0006878864,0.00078795024,0.00033242715,0.0009440743],"domain_scores_gemma":[0.9982525,0.00034509305,0.0003145708,0.00055549596,0.0003722124,0.0001600973],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033231522,0.00058865256,0.0012547515,0.00035757746,0.00030258467,0.00005591571,0.000305035,0.000353263,0.00028302422],"category_scores_gemma":[0.000015388629,0.000489347,0.00023427156,0.00053413573,0.0013238075,0.00018560635,0.00008554367,0.0005721628,0.0000056606204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007901988,0.00039642627,0.006168971,0.00027370313,0.0017369785,0.000012858002,0.0014721593,0.000012638277,0.9168475,0.0006446671,0.0011013286,0.063430734],"study_design_scores_gemma":[0.017575528,0.0033128527,0.053383537,0.0006824322,0.00012850024,0.00005389677,0.0005222663,0.000032370663,0.55787003,0.0008043194,0.3648641,0.0007701534],"about_ca_topic_score_codex":0.0057164324,"about_ca_topic_score_gemma":0.0001559608,"teacher_disagreement_score":0.3637628,"about_ca_system_score_codex":0.00033833785,"about_ca_system_score_gemma":0.00038546466,"threshold_uncertainty_score":0.9997558},"labels":[],"label_agreement":null},{"id":"W2028889402","doi":"10.1007/s00262-006-0221-z","title":"Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy","year":2006,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Photodynamic therapy; Cancer research; Lewis lung carcinoma; Complement system; Gene; Heat shock protein; Biology; CD46; TLR4; Gene expression; Molecular biology; Antibody; Immunology; Cancer; Immune system; Chemistry; Metastasis","score_opus":0.016356166312462776,"score_gpt":0.3135551602929163,"score_spread":0.2971989939804535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028889402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93290734,0.064950354,0.000014747689,0.0007527525,0.00005894041,0.0009941086,0.00005807688,0.0000531537,0.00021050448],"genre_scores_gemma":[0.9459735,0.052620903,0.00004968167,0.00023810615,0.000023711795,0.00037279635,0.00009690581,0.00004933995,0.0005750302],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831116,0.00010594276,0.00054159336,0.00037063658,0.00020949246,0.00046116367],"domain_scores_gemma":[0.99920124,0.00010892182,0.0002128188,0.00031781368,0.00013132725,0.000027854443],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020962571,0.00029744714,0.0006782468,0.00031159696,0.000094750474,0.000012072987,0.00016598235,0.00013335962,0.00027799438],"category_scores_gemma":[0.0000073270303,0.00025476282,0.0000854129,0.0003867082,0.0005175492,0.000098684046,0.000035186855,0.00026450158,0.0000017262555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027563602,0.00035007103,0.027515663,0.000023853445,0.0004874487,0.00000411395,0.0002989582,0.000006124159,0.9304182,0.000057798752,0.00024340786,0.037837997],"study_design_scores_gemma":[0.010105403,0.0008149362,0.3682779,0.00014553407,0.000011081482,0.00001431356,0.00022253141,0.00007063644,0.61396736,0.00020817494,0.005943102,0.00021904672],"about_ca_topic_score_codex":0.008538797,"about_ca_topic_score_gemma":0.00022186803,"teacher_disagreement_score":0.34076223,"about_ca_system_score_codex":0.00037478204,"about_ca_system_score_gemma":0.00011262395,"threshold_uncertainty_score":0.99999046},"labels":[],"label_agreement":null},{"id":"W2029582744","doi":"10.1007/s00262-011-1125-0","title":"Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; Canadian Institutes of Health Research","keywords":"Myeloid-derived Suppressor Cell; Immunosuppression; Immunology; Immune system; Cancer research; In vitro; T cell; Tumor microenvironment; Suppressor; Biology; Cancer","score_opus":0.016464510460400216,"score_gpt":0.22549443356793644,"score_spread":0.20902992310753624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029582744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8527213,0.13535254,0.00040540402,0.00020135795,0.008764292,0.00093598414,0.00029274158,0.00023283246,0.0010935761],"genre_scores_gemma":[0.9897036,0.00675194,0.00013229142,0.0009369688,0.00009110394,0.00040875695,0.000118554424,0.0001717567,0.0016850249],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955394,0.0008817312,0.0013184514,0.0009442461,0.00013156542,0.0011845562],"domain_scores_gemma":[0.99607897,0.0004580821,0.0011808687,0.0018143923,0.00043742833,0.00003025244],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041207654,0.0008019909,0.0011015843,0.00026618782,0.0006428705,0.00003661419,0.0018300267,0.0008460274,0.012540145],"category_scores_gemma":[0.000040182364,0.0006540906,0.000438461,0.00051273394,0.0019331751,0.00040530303,0.0004293731,0.0015448813,0.0005846218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005326651,0.00024769886,0.000813321,0.000022405517,0.0036527321,0.000007014749,0.007579015,0.000021754211,0.96957445,0.00012415576,0.0010891189,0.011541679],"study_design_scores_gemma":[0.0051733255,0.00057564385,0.03298781,0.00019701388,0.00024194486,0.000037068574,0.0015344541,0.000007324165,0.93842703,0.00041607604,0.019739367,0.00066296034],"about_ca_topic_score_codex":0.00452313,"about_ca_topic_score_gemma":0.00007621923,"teacher_disagreement_score":0.13698234,"about_ca_system_score_codex":0.0002446048,"about_ca_system_score_gemma":0.00033011756,"threshold_uncertainty_score":0.99959105},"labels":[],"label_agreement":null},{"id":"W2032554019","doi":"10.1007/s00262-004-0518-8","title":"The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patients","year":2004,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"University of Chicago; Northwestern University; Coleman Foundation","keywords":"Monocyte; Chemistry; Cancer research; Cell biology; Immunology; Biology","score_opus":0.005959138944381274,"score_gpt":0.23799786486019942,"score_spread":0.23203872591581814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032554019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87465274,0.121988826,0.00005729123,0.00027480547,0.0022366433,0.0006573957,0.0000451976,0.000037555368,0.00004956839],"genre_scores_gemma":[0.98665553,0.0127740735,0.00003530404,0.00008190122,0.000017675038,0.00018353866,0.00006007794,0.000055764198,0.00013615929],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996934,0.0009172817,0.0010837292,0.0003907097,0.00008621601,0.00058807165],"domain_scores_gemma":[0.9975424,0.0008433337,0.0006522157,0.0008053811,0.00014572387,0.00001098312],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045691963,0.00041403613,0.00084978,0.00026715675,0.0002800951,0.00001946819,0.0007537478,0.00055092835,0.0002169958],"category_scores_gemma":[0.00008992004,0.00030556292,0.00025318595,0.00038960917,0.00073678634,0.00021171416,0.000081873295,0.0006176449,0.000047845362],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010185446,0.0001587366,0.0037597027,0.000018450693,0.0008871257,0.0000014271378,0.0019457043,0.00006212541,0.94654,0.00009380171,0.000028271535,0.036319192],"study_design_scores_gemma":[0.011610481,0.0013337597,0.07617538,0.00026059474,0.000040061786,0.000003986731,0.00021679903,6.2541744e-7,0.9063552,0.00017116038,0.0035761744,0.00025580073],"about_ca_topic_score_codex":0.0024505486,"about_ca_topic_score_gemma":0.000117418895,"teacher_disagreement_score":0.11200279,"about_ca_system_score_codex":0.00026203992,"about_ca_system_score_gemma":0.00019545305,"threshold_uncertainty_score":0.9999396},"labels":[],"label_agreement":null},{"id":"W2034550161","doi":"10.1007/s00262-011-0970-1","title":"Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Institutes of Health; Pharmaceutical Research and Manufacturers of America Foundation","keywords":"Adjuvant; Cationic polymerization; Cancer research; Chemistry; Medicine; Oncology; Organic chemistry","score_opus":0.030620574768450603,"score_gpt":0.28220292600818275,"score_spread":0.25158235123973216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034550161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7869707,0.20845328,0.000077019686,0.0003001422,0.0026939644,0.000579578,0.00006625405,0.00010393077,0.0007551762],"genre_scores_gemma":[0.9123889,0.08408729,0.000051825577,0.00020642647,0.00003943604,0.0005302923,0.00002851452,0.000089028435,0.002578267],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965407,0.00069701654,0.0010398205,0.00067328295,0.00008301562,0.00096612977],"domain_scores_gemma":[0.9977067,0.00021254028,0.0006912395,0.0011354676,0.00023251711,0.000021510506],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052357966,0.00056849996,0.0011630512,0.0006474566,0.00024000855,0.000013006135,0.000963244,0.0006671351,0.010981872],"category_scores_gemma":[0.000040874165,0.0005213667,0.00031526628,0.0008052072,0.000654214,0.00036904722,0.00010993189,0.0008659913,0.00018212074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074730613,0.0007852568,0.01670697,0.000027280195,0.0011239949,0.0000048805928,0.003072947,0.000007147093,0.8449002,0.0005319977,0.00028626638,0.12508003],"study_design_scores_gemma":[0.0058817086,0.00052809913,0.3357482,0.0001723058,0.000038925475,0.000035583456,0.00019357353,0.0000018617941,0.6218809,0.0001418144,0.03492089,0.00045615493],"about_ca_topic_score_codex":0.006788403,"about_ca_topic_score_gemma":0.0004973631,"teacher_disagreement_score":0.31904122,"about_ca_system_score_codex":0.00033984936,"about_ca_system_score_gemma":0.00051990995,"threshold_uncertainty_score":0.9998255},"labels":[],"label_agreement":null},{"id":"W2035883420","doi":"10.1007/s00262-009-0800-x","title":"Activation of innate immunity to reduce lung metastases in breast cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Fungal Biology and Applications","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Metastasis; Innate immune system; Breast cancer; Cancer research; Immune system; Lung cancer; Cancer; In vivo; Lung; Immunology; Oncology; Biology; Internal medicine","score_opus":0.018901890313624478,"score_gpt":0.3393542446060559,"score_spread":0.3204523542924314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035883420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9677888,0.011679287,0.000081539685,0.019331327,0.00015040289,0.00056994776,0.00008874746,0.00004584743,0.0002640772],"genre_scores_gemma":[0.990421,0.005582439,0.00022334074,0.0032318898,0.000046972047,0.00028340815,0.000035500376,0.000016453649,0.00015900165],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998873,0.00010358809,0.00039287398,0.00025945526,0.00007977724,0.0002913122],"domain_scores_gemma":[0.9991303,0.00006357189,0.00015358451,0.00047027646,0.00014516662,0.000037118476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018092872,0.00018388004,0.00044923378,0.00025469053,0.000082175575,0.000004550951,0.00020743701,0.00018494307,0.0004782227],"category_scores_gemma":[0.00002151883,0.00016487246,0.00008107385,0.0006561191,0.00015828734,0.00009391119,0.00002149247,0.00037070073,0.0000085903785],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002370234,0.000273452,0.011178799,0.000011800564,0.00023356837,0.000001350053,0.0004832443,0.00004372615,0.9156348,0.0007436064,0.00045406798,0.06857137],"study_design_scores_gemma":[0.00187398,0.00020707492,0.67413837,0.0001782308,0.000029744135,0.00001989206,0.00009856876,0.000010459968,0.3207073,0.00019792214,0.002399201,0.0001392848],"about_ca_topic_score_codex":0.0011872826,"about_ca_topic_score_gemma":0.00002009058,"teacher_disagreement_score":0.6629596,"about_ca_system_score_codex":0.00023849584,"about_ca_system_score_gemma":0.00023033287,"threshold_uncertainty_score":0.6723304},"labels":[],"label_agreement":null},{"id":"W2036493466","doi":"10.1007/s002620000117","title":"A low-level expression of human MUC1 mucin enhances lethality of murine tumor cells","year":2000,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"MUC1; Mucin; Cell culture; Biology; Transfection; Cancer research; In vitro; Cell; Immune system; Molecular biology; Immunology","score_opus":0.019691908200398664,"score_gpt":0.31393363001880764,"score_spread":0.29424172181840896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036493466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903307,0.0080952225,0.00012301614,0.000070581045,0.000116852025,0.00031240066,0.00009613118,0.0000115052835,0.0008436206],"genre_scores_gemma":[0.99298126,0.0037448157,0.00024718282,0.00011528865,0.000057194677,0.000097452124,0.00006067906,0.000028631854,0.0026675076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853635,0.00018138942,0.00046713388,0.0003415276,0.00017177436,0.0003017976],"domain_scores_gemma":[0.99891764,0.000016735343,0.00021256185,0.000644864,0.00017411147,0.000034086584],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022928804,0.00019288673,0.00033597575,0.00008256784,0.00009142614,0.000006983127,0.0004211315,0.00018116274,0.0036348985],"category_scores_gemma":[0.000013710694,0.00017645846,0.00014679547,0.0001448778,0.00042960915,0.000008474696,0.000059932438,0.00016616538,0.000013676758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073833077,0.00021447663,0.00022956719,0.000042218773,0.00010838501,0.0000014289471,0.00015856078,0.00002242076,0.9744556,0.000020262798,0.00023693261,0.023771837],"study_design_scores_gemma":[0.001714154,0.0005716232,0.0056082066,0.0000703856,0.0000046240566,0.0000037206369,0.000050385755,0.0000031057282,0.97658813,0.00007747607,0.015142648,0.00016551666],"about_ca_topic_score_codex":0.00045372045,"about_ca_topic_score_gemma":0.000046069268,"teacher_disagreement_score":0.02360632,"about_ca_system_score_codex":0.00002344719,"about_ca_system_score_gemma":0.0001302308,"threshold_uncertainty_score":0.9972759},"labels":[],"label_agreement":null},{"id":"W2039121998","doi":"10.1007/s00262-012-1206-8","title":"Photodynamic therapy–generated cancer vaccine elicits acute phase and hormonal response in treated mice","year":2012,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Immune system; Glucocorticoid; Downregulation and upregulation; Cancer research; Hormone; Cancer vaccine; Immunology; Acute-phase protein; Vaccination; Photodynamic therapy; Medicine; Serum amyloid P component; Biology; Immunotherapy; Gene; Internal medicine; Chemistry; Inflammation","score_opus":0.023214393484940015,"score_gpt":0.3639522562686452,"score_spread":0.34073786278370516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039121998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7562262,0.24000926,0.000008173334,0.0020267894,0.00031258396,0.0010834911,0.00016321146,0.00012016966,0.000050117294],"genre_scores_gemma":[0.79098856,0.20530933,0.00004399967,0.0014073267,0.00010792302,0.0010860957,0.00006419364,0.000104453015,0.000888086],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99668443,0.00052804966,0.0006486493,0.0005792397,0.00028158253,0.0012780331],"domain_scores_gemma":[0.99856496,0.00024827773,0.00021160177,0.0005803186,0.00022007679,0.00017477837],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007522237,0.000593371,0.0010279476,0.0006120271,0.00022471075,0.00002849085,0.0002905272,0.00034528453,0.0012085056],"category_scores_gemma":[0.000045294568,0.00049050705,0.00014478737,0.0008909834,0.00037390148,0.00028974164,0.00007661105,0.0007655,0.000015629084],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0734413,0.00074990996,0.009894571,0.0000124929165,0.0029106296,0.000048037542,0.0018139286,0.000003329121,0.85788953,0.000007636777,0.00024211606,0.052986525],"study_design_scores_gemma":[0.045030493,0.0028549342,0.5580701,0.00018776591,0.00012439997,0.00023789029,0.00022903869,0.00025802728,0.37611187,0.000017104603,0.016218629,0.00065973005],"about_ca_topic_score_codex":0.002305411,"about_ca_topic_score_gemma":0.00018991188,"teacher_disagreement_score":0.5481755,"about_ca_system_score_codex":0.0008515803,"about_ca_system_score_gemma":0.0003804934,"threshold_uncertainty_score":0.99975467},"labels":[],"label_agreement":null},{"id":"W2039696496","doi":"10.1007/s00262-008-0476-7","title":"TARC and RANTES enhance antitumor immunity induced by the GM-CSF-transduced tumor vaccine in a mouse tumor model","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Atomic Energy of Canada Limited","keywords":"Immunity; Immunology; Cancer research; Virology; Medicine; Immune system","score_opus":0.01697777195574972,"score_gpt":0.26551415149597196,"score_spread":0.24853637954022223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039696496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8063275,0.18994161,0.00018684285,0.001357858,0.00069775636,0.0010508627,0.0001273234,0.0001951633,0.00011505073],"genre_scores_gemma":[0.94389945,0.047955025,0.000075981254,0.0027107082,0.00002978086,0.00073941133,0.00007612388,0.00015513116,0.0043583685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99484426,0.0012679527,0.0012984488,0.00096313684,0.00013689807,0.0014893021],"domain_scores_gemma":[0.99709755,0.0005993693,0.00053715694,0.0015099503,0.0002142076,0.000041779604],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0008453346,0.0009641326,0.0013843555,0.0005526439,0.0013605189,0.00006168064,0.0014895122,0.0004916915,0.00076291774],"category_scores_gemma":[0.00013612077,0.0007634533,0.00030766186,0.00083385996,0.0014340589,0.0005839703,0.00019644851,0.002010529,0.00010755414],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0078408895,0.0004910703,0.001397738,0.000023038634,0.000875436,0.000023367356,0.004534367,0.000022821594,0.97405475,0.000116256044,0.0008323508,0.009787933],"study_design_scores_gemma":[0.013157463,0.0008383477,0.019662421,0.00015398505,0.00004881794,0.00093029713,0.0007682866,0.00009506017,0.94510984,0.00016706326,0.017917784,0.0011506231],"about_ca_topic_score_codex":0.0032059143,"about_ca_topic_score_gemma":0.00020069283,"teacher_disagreement_score":0.1419866,"about_ca_system_score_codex":0.00025256837,"about_ca_system_score_gemma":0.00057140656,"threshold_uncertainty_score":0.99993956},"labels":[],"label_agreement":null},{"id":"W2040005202","doi":"10.1007/s00262-009-0698-3","title":"Mammary tumors with diverse immunological phenotypes show differing sensitivity to adoptively transferred CD8+ T cells lacking the Cbl-b gene","year":2009,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria; BC Cancer Agency","funders":"National Cancer Institute","keywords":"CD8; Null cell; Biology; Cytotoxic T cell; Adoptive cell transfer; Infiltration (HVAC); Phenotype; Cancer research; T lymphocyte; Immunology; Mammary tumor; Immune system; Cell culture; T cell; In vitro; Gene; Cancer; Genetics; Breast cancer","score_opus":0.01716905634115013,"score_gpt":0.2431229921209047,"score_spread":0.2259539357797546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040005202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9112716,0.07219847,0.007944853,0.004478219,0.0015910458,0.0015686073,0.00009517562,0.0005685418,0.00028352864],"genre_scores_gemma":[0.9825738,0.009957726,0.00055802177,0.0044640107,0.00008882396,0.000270483,0.000058090893,0.000114472685,0.0019145677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9946009,0.0014638692,0.00087777246,0.0011382251,0.00018704557,0.0017322158],"domain_scores_gemma":[0.99709505,0.0005970264,0.00034427378,0.0016286946,0.00027473687,0.000060248258],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00079900667,0.0010879887,0.0012883879,0.00039081025,0.0014439465,0.00015999441,0.0014936273,0.00071389554,0.00062968617],"category_scores_gemma":[0.00005075274,0.00075624353,0.00044595165,0.0008363305,0.0011645998,0.00049302913,0.00018706874,0.0015345436,0.00029733524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008303437,0.0003423491,0.00022069948,0.0000069430876,0.0015697103,0.00008407096,0.0032962142,0.00016789832,0.8459016,0.00058032124,0.00020530594,0.13932143],"study_design_scores_gemma":[0.0065067615,0.0029799116,0.0945075,0.00023218174,0.0001275173,0.0006382552,0.0012246602,0.000012428317,0.84552276,0.00014600669,0.046677012,0.0014250145],"about_ca_topic_score_codex":0.00042981753,"about_ca_topic_score_gemma":0.000048168407,"teacher_disagreement_score":0.13789642,"about_ca_system_score_codex":0.00035760735,"about_ca_system_score_gemma":0.00034519704,"threshold_uncertainty_score":0.99985605},"labels":[],"label_agreement":null},{"id":"W2041507780","doi":"10.1007/s00262-010-0861-x","title":"Phenotypic characterization of chronic inflammation in a rare case of endobronchial carcinoma","year":2010,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame; Centre Hospitalier de l’Université de Montréal","funders":"Institut Du Cancer de Montréal","keywords":"Phenotype; Inflammation; Medicine; Carcinoma; Pathology; Biology; Internal medicine; Genetics; Gene","score_opus":0.009713388647332986,"score_gpt":0.2675888687790458,"score_spread":0.2578754801317128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041507780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911427,0.006454042,0.00009201452,0.00035564473,0.0010119975,0.00071101217,0.00004959512,0.00003039605,0.00015262926],"genre_scores_gemma":[0.99686563,0.0024138973,0.00009947365,0.000072927694,0.0001915347,0.00014103872,0.000073005715,0.00003940089,0.000103071994],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984277,0.00008417855,0.00079667085,0.00026968657,0.00012561798,0.00029616145],"domain_scores_gemma":[0.9986958,0.00004968207,0.00048919406,0.0005565591,0.00018069675,0.000028070106],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024634722,0.00022627984,0.0005711998,0.00036058237,0.00005193301,0.000006327758,0.00016642064,0.0003021305,0.0010891419],"category_scores_gemma":[0.000022203603,0.00021549653,0.00016540603,0.00044709785,0.00041873945,0.00015876305,0.000024669134,0.00041856294,0.0000028990737],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042435904,0.00013746168,0.016389193,0.00010811422,0.0002290691,0.00004772391,0.0011982844,0.0000015849345,0.8220762,0.0001696144,0.000004053685,0.15539509],"study_design_scores_gemma":[0.008680452,0.0006328094,0.30747133,0.00013646613,0.000038111575,0.0005374267,0.00009883233,0.00009885918,0.6797565,0.000040308,0.0023356136,0.0001732796],"about_ca_topic_score_codex":0.001636362,"about_ca_topic_score_gemma":0.0007794509,"teacher_disagreement_score":0.29108214,"about_ca_system_score_codex":0.00022379884,"about_ca_system_score_gemma":0.00058848027,"threshold_uncertainty_score":0.999824},"labels":[],"label_agreement":null},{"id":"W2043730939","doi":"10.1007/s00262-008-0534-1","title":"MSI-H colorectal cancers preferentially retain and expand intraepithelial lymphocytes rather than peripherally derived CD8+ T cells","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Intraepithelial lymphocyte; CD8; Colorectal cancer; Cancer research; Medicine; Biology; Immunology; Internal medicine; Immune system; Cancer","score_opus":0.01566053570161138,"score_gpt":0.25379718272415674,"score_spread":0.23813664702254536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043730939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92928547,0.06620925,0.0001391555,0.000835552,0.001350319,0.0010923309,0.00006720591,0.0002355953,0.0007851438],"genre_scores_gemma":[0.88030046,0.113312855,0.00047855012,0.0017902825,0.0003386273,0.0004306148,0.0000372054,0.00015951485,0.0031519143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968331,0.0002371722,0.0007710531,0.00086981995,0.00035217378,0.00093672075],"domain_scores_gemma":[0.99844986,0.00010980968,0.00035103838,0.0006987415,0.00023133335,0.00015919363],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002582815,0.00070434815,0.0010401591,0.0002428104,0.00055619265,0.0000634556,0.00039289164,0.0005284764,0.0023500342],"category_scores_gemma":[0.000018695559,0.000620802,0.0003557478,0.00037295368,0.0016888139,0.0002535032,0.000079874764,0.0005188634,0.000024754167],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02182587,0.00015735901,0.008618989,0.000041495477,0.0022699672,0.0000617183,0.0047721574,0.0000088024235,0.9256681,0.000022511795,0.0010869793,0.03546605],"study_design_scores_gemma":[0.027601028,0.0026998501,0.19004977,0.00029696018,0.00020310855,0.00080435973,0.0008315184,0.00007891922,0.72646004,0.00006195425,0.049730953,0.0011815185],"about_ca_topic_score_codex":0.0024420682,"about_ca_topic_score_gemma":0.00035286037,"teacher_disagreement_score":0.19920804,"about_ca_system_score_codex":0.0011004178,"about_ca_system_score_gemma":0.0017394497,"threshold_uncertainty_score":0.9996243},"labels":[],"label_agreement":null},{"id":"W2047936140","doi":"10.1007/s00262-011-0988-4","title":"Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Air (Canada)","funders":"","keywords":"Paclitaxel; Prostate cancer; Medicine; In vivo; CD8; Cancer research; Granulocyte macrophage colony-stimulating factor; Prostate; Cancer vaccine; Cancer; Immune system; Immunology; Immunotherapy; Pharmacology; Internal medicine; Biology; Cytokine","score_opus":0.021770899518367692,"score_gpt":0.26841634934599146,"score_spread":0.24664544982762376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047936140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85343456,0.14320835,0.00007791284,0.00025881967,0.0010596539,0.0013150724,0.0003551654,0.00008860677,0.0002018719],"genre_scores_gemma":[0.95942956,0.03501197,0.00009577148,0.00046190683,0.000019329096,0.00039160473,0.000041900188,0.00013914712,0.0044088117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948494,0.0010250269,0.0019168687,0.000810696,0.00014762099,0.001250409],"domain_scores_gemma":[0.99594647,0.0004875133,0.0014609481,0.0016694058,0.00040604328,0.000029644105],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000947738,0.0008368045,0.0016945197,0.00042255205,0.00032221124,0.000021200354,0.0017272055,0.00049565005,0.0010242803],"category_scores_gemma":[0.00007349394,0.0006391121,0.0004773033,0.000696602,0.0015778919,0.00039866866,0.00020287244,0.0011253814,0.000063110296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016832246,0.001577199,0.0034398746,0.000108092645,0.0012763526,0.000005154675,0.01019828,0.0011836694,0.95936346,0.00019227478,0.00016054173,0.0056628715],"study_design_scores_gemma":[0.014444343,0.0008228814,0.023220459,0.00030333473,0.0000791388,0.000017015513,0.0010523495,0.000082403814,0.95764357,0.00015410784,0.0015188069,0.0006615859],"about_ca_topic_score_codex":0.00444259,"about_ca_topic_score_gemma":0.00017413437,"teacher_disagreement_score":0.10819638,"about_ca_system_score_codex":0.00019091713,"about_ca_system_score_gemma":0.0008274276,"threshold_uncertainty_score":0.9998889},"labels":[],"label_agreement":null},{"id":"W2048296690","doi":"10.1007/s00262-015-1689-1","title":"Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case report","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"Cancer Research UK","keywords":"Nivolumab; Pembrolizumab; Medicine; Diabetes mellitus; Ipilimumab; Immunology; Type 1 diabetes; Adverse effect; Immune system; Insulin; Antibody; Immunotherapy; Internal medicine; Endocrinology","score_opus":0.04472514907973334,"score_gpt":0.30520106641164596,"score_spread":0.2604759173319126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048296690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7595817,0.23579676,0.000056998408,0.0015231364,0.0011481082,0.0010183709,0.000023226197,0.00022844336,0.00062326336],"genre_scores_gemma":[0.933065,0.060684305,0.0007757774,0.0031064295,0.00024614405,0.00057139667,0.000054442695,0.00014814567,0.0013483773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99678475,0.00019430066,0.00089175237,0.0008561692,0.0003700773,0.00090295135],"domain_scores_gemma":[0.9976767,0.00009073117,0.00042921823,0.0011738573,0.00037012083,0.00025937852],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008249446,0.00060184015,0.0009985047,0.00030128684,0.00025144397,0.000095229276,0.00026926596,0.0004753643,0.00031905205],"category_scores_gemma":[0.000042474483,0.00051034486,0.0002707311,0.00044301705,0.0005993055,0.00021826736,0.00008078657,0.00059377594,0.000024984789],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011902422,0.0012688929,0.07408907,0.0001001082,0.0037410494,0.02506712,0.004106839,0.000004907109,0.36504737,0.00004636298,0.0016202335,0.5130056],"study_design_scores_gemma":[0.09944972,0.007856263,0.09497809,0.0004289801,0.00045832095,0.1201861,0.0041247224,0.00014787797,0.22656266,0.00044719406,0.44259238,0.0027676867],"about_ca_topic_score_codex":0.0015357629,"about_ca_topic_score_gemma":0.000041004503,"teacher_disagreement_score":0.51023793,"about_ca_system_score_codex":0.00043444743,"about_ca_system_score_gemma":0.0007660238,"threshold_uncertainty_score":0.9997348},"labels":[],"label_agreement":null},{"id":"W2049238163","doi":"10.1007/s00262-007-0442-9","title":"Different immune correlates associated with tumor progression and regression: implications for prevention and treatment of cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Immune system; Isotype; Antibody; Immunotherapy; Immunology; Cancer; Cytotoxic T cell; Biology; Tumor progression; Monoclonal antibody; Cancer research; In vitro; Genetics","score_opus":0.02348148156817673,"score_gpt":0.30540169978430703,"score_spread":0.2819202182161303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049238163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8334229,0.16405709,0.0001354041,0.00051376934,0.0009378955,0.00080756063,0.000031265918,0.000061694955,0.00003241007],"genre_scores_gemma":[0.94037145,0.053600423,0.000038007645,0.000055112727,0.000017874396,0.0013351738,0.00018251699,0.00003793476,0.0043614856],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987376,0.00014052031,0.00043286826,0.00035976534,0.000028202961,0.00030107348],"domain_scores_gemma":[0.9988277,0.00018583846,0.0005011013,0.000279754,0.00018928385,0.000016356176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059109672,0.00030195853,0.00054165133,0.00013292542,0.0004992122,0.000009420809,0.000096256925,0.00023441181,0.0002778413],"category_scores_gemma":[0.000018416167,0.0002049281,0.000107069485,0.00011505484,0.00060574856,0.00012739749,0.000024275396,0.00015534322,0.0000022518705],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033560987,0.0005945946,0.08187419,0.000014498463,0.0016206175,6.678947e-7,0.0010711623,0.0000024458673,0.80379546,0.00016481898,0.0002728042,0.10723267],"study_design_scores_gemma":[0.010418938,0.0040211286,0.6905342,0.00041115584,0.00015490872,0.00013807548,0.00021962574,0.000010683363,0.27686113,0.00009335503,0.016812155,0.0003246353],"about_ca_topic_score_codex":0.00014209963,"about_ca_topic_score_gemma":0.000051411138,"teacher_disagreement_score":0.60866,"about_ca_system_score_codex":0.00016650357,"about_ca_system_score_gemma":0.000088166016,"threshold_uncertainty_score":0.83567256},"labels":[],"label_agreement":null},{"id":"W2049948883","doi":"10.1007/s00262-010-0934-x","title":"Natural antibodies against nerve growth factor inhibit in vitro prostate cancer cell metastasis","year":2010,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Nerve injury and regeneration","field":"Neuroscience","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Bayer Canada","keywords":"Nerve growth factor; Metastasis; Prostate cancer; Antibody; Matrigel; Cancer research; Cell migration; In vitro; Cancer; Cancer cell; Autocrine signalling; Prostate; Monoclonal antibody; Cell culture; Medicine; Chemistry; Biology; Internal medicine; Immunology; Receptor; Angiogenesis; Biochemistry","score_opus":0.016448437575376337,"score_gpt":0.28272034889987985,"score_spread":0.2662719113245035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049948883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705785,0.022706348,0.00000640071,0.0012103441,0.0043425797,0.0005394802,0.00023540598,0.00012640907,0.0002545436],"genre_scores_gemma":[0.97987384,0.0165558,0.00013216138,0.0015273553,0.00015677344,0.0003426116,0.000023382134,0.00006750978,0.0013205454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975971,0.00027303988,0.0005216014,0.0007012915,0.00021214059,0.00069480465],"domain_scores_gemma":[0.99894536,0.00012358474,0.0002907404,0.0004787069,0.000115549316,0.00004606991],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015666227,0.00041722527,0.00046694212,0.00020601453,0.00032349976,0.0000984092,0.00054377393,0.00025131815,0.00037148938],"category_scores_gemma":[0.00005096533,0.00034744616,0.00017107195,0.0004467624,0.0005359105,0.000680613,0.000082355386,0.0009852361,0.000028931287],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007222181,0.00012579582,0.001331355,0.000018420356,0.000048863596,0.000020901598,0.0010596558,0.000014344072,0.9643317,0.00015771756,0.00010920292,0.032059826],"study_design_scores_gemma":[0.0018751863,0.00006721059,0.0054653375,0.000024090808,0.000009656801,0.000010256275,0.00006681521,0.00006176505,0.9879188,0.00010883276,0.003966476,0.0004255834],"about_ca_topic_score_codex":0.0012774997,"about_ca_topic_score_gemma":0.0006680505,"teacher_disagreement_score":0.03163424,"about_ca_system_score_codex":0.00019000203,"about_ca_system_score_gemma":0.00021311101,"threshold_uncertainty_score":0.9998978},"labels":[],"label_agreement":null},{"id":"W2052261454","doi":"10.1007/s00262-013-1412-z","title":"EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors","year":2013,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ludwig Institute for Cancer Research; Cancer Research Society","keywords":"Antigen; Biology; Cancer research; Molecular biology; Telomerase; Gene; Cell culture; Lymphoblast; Virology; Immunology; Genetics","score_opus":0.00772460788773911,"score_gpt":0.24856657095736326,"score_spread":0.24084196306962416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052261454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71566445,0.27569315,0.000098668184,0.0023458884,0.00310211,0.0013996883,0.00014339483,0.00040959372,0.0011430515],"genre_scores_gemma":[0.82618207,0.14746344,0.00009926904,0.0043778135,0.00016747342,0.002272701,0.0002332003,0.0002725561,0.018931456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9945374,0.00075411185,0.0014065971,0.00117189,0.000155875,0.0019741128],"domain_scores_gemma":[0.9967229,0.0005834046,0.00068559893,0.0012713183,0.0006610475,0.00007572538],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032323878,0.0012610677,0.001478755,0.00062734453,0.0011503584,0.00014673173,0.0014935733,0.0010843987,0.014021367],"category_scores_gemma":[0.00007251811,0.00112278,0.0006007749,0.0008261621,0.001200342,0.00083804235,0.0001497082,0.0011097643,0.0033651502],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002419963,0.0004301983,0.0032642728,0.000031836178,0.0018857942,0.0000148328345,0.0020112467,0.00003668328,0.86318815,0.00009311765,0.0032364835,0.12338742],"study_design_scores_gemma":[0.008634741,0.0009211465,0.08129072,0.00034782113,0.000068960166,0.00017387768,0.00088122307,0.000008249259,0.8033822,0.00017289951,0.1027919,0.0013262467],"about_ca_topic_score_codex":0.00923367,"about_ca_topic_score_gemma":0.00009529331,"teacher_disagreement_score":0.12822971,"about_ca_system_score_codex":0.0004927649,"about_ca_system_score_gemma":0.0010670946,"threshold_uncertainty_score":0.9991222},"labels":[],"label_agreement":null},{"id":"W2053039983","doi":"10.1007/s00262-011-1088-1","title":"Widespread expressions of immunoglobulin superfamily proteins in cancer cells","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; National Yang-Ming University","keywords":"Immunoglobulin superfamily; Biology; T-cell receptor; Antibody; Molecular biology; CD3; Monoclonal antibody; Cancer cell; CD8; Epitope; Cell adhesion molecule; Immune system; T cell; Cancer; Cell biology; Immunology; Genetics","score_opus":0.06949275593754785,"score_gpt":0.3452892438547073,"score_spread":0.27579648791715944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053039983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9211336,0.07427963,0.000026406513,0.00060958636,0.0005550296,0.0008509674,0.00007957608,0.000044111603,0.0024211],"genre_scores_gemma":[0.93513966,0.05932492,0.00109502,0.0005237059,0.000073442265,0.0007353837,0.000014649104,0.000063857304,0.003029387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99784666,0.00015324427,0.0006656311,0.0004077564,0.00027489493,0.0006517944],"domain_scores_gemma":[0.9988038,0.00009805012,0.00017199978,0.0006347723,0.00021127649,0.00008009616],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022410054,0.00031301935,0.00072746654,0.0003186904,0.00009585642,0.0000066967696,0.00044765612,0.000279956,0.0051840493],"category_scores_gemma":[0.000022960681,0.00025253333,0.0002138575,0.0004484599,0.0006449999,0.00012035186,0.00010953941,0.00063302595,0.00005306507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004835448,0.0005815764,0.048709065,0.00008038771,0.00045656034,0.000041602434,0.0025766448,0.000004032115,0.9162093,0.00018998382,0.00027391574,0.02604152],"study_design_scores_gemma":[0.0028358905,0.0006446842,0.34073696,0.0005726731,0.000023998797,0.000019769333,0.00025256714,0.000010294825,0.6434132,0.00016441206,0.011101483,0.00022408967],"about_ca_topic_score_codex":0.018979909,"about_ca_topic_score_gemma":0.00021218139,"teacher_disagreement_score":0.2920279,"about_ca_system_score_codex":0.00019652957,"about_ca_system_score_gemma":0.0005531997,"threshold_uncertainty_score":0.99999267},"labels":[],"label_agreement":null},{"id":"W2061990495","doi":"10.1007/s00262-008-0586-2","title":"Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Terry Fox Research Institute","funders":"","keywords":"Paclitaxel; FOXP3; CD8; TLR9; Cytotoxic T cell; Immune system; IL-2 receptor; Agonist; Cancer research; Biology; T cell; Immunology; Pharmacology; Receptor; Internal medicine; Medicine; Cancer; Gene expression; In vitro","score_opus":0.005736430475352894,"score_gpt":0.21111194420224988,"score_spread":0.205375513726897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061990495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85662705,0.14071321,0.000006777556,0.0008553277,0.0010267361,0.00061943044,0.000004917856,0.000025349262,0.00012116585],"genre_scores_gemma":[0.9757733,0.022435026,0.000003833182,0.0006072258,0.00003908338,0.00018787623,0.000008527262,0.00002517042,0.00091996253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99748635,0.0012635958,0.00048303363,0.00031631117,0.000076308716,0.00037441935],"domain_scores_gemma":[0.9983608,0.0005350142,0.00039533013,0.0006370743,0.00006404327,0.000007740712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005956704,0.0002844759,0.0003853171,0.00010704639,0.00079279003,0.000021611128,0.0004527865,0.00027001346,0.00004610863],"category_scores_gemma":[0.00005191299,0.0001583365,0.00011619337,0.00025160148,0.0024799542,0.00019114719,0.00008571863,0.0005932021,0.000011780238],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075909117,0.000089505746,0.0033653048,0.000035932808,0.00024932536,0.0000021515416,0.0059314584,0.0000024313572,0.98471034,0.00019245231,0.0007367035,0.0039252825],"study_design_scores_gemma":[0.0020633521,0.00022469007,0.25789732,0.000064814085,0.00003985172,0.00009385209,0.0012090923,6.402719e-7,0.72714895,0.000100917554,0.010997613,0.00015889821],"about_ca_topic_score_codex":0.00052595633,"about_ca_topic_score_gemma":0.00004475018,"teacher_disagreement_score":0.25756142,"about_ca_system_score_codex":0.000059107788,"about_ca_system_score_gemma":0.00016968703,"threshold_uncertainty_score":0.9137494},"labels":[],"label_agreement":null},{"id":"W2065093310","doi":"10.1007/s00262-005-0698-x","title":"Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages","year":2005,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Cytotoxic T cell; Interleukin 12; Cancer research; Cytotoxicity; Macrophage; Melanoma; Antibody; Immunology; Immunotherapy; Cancer immunotherapy; Biology; Chemistry; Immune system; In vitro","score_opus":0.022763342405974458,"score_gpt":0.2807844999294116,"score_spread":0.2580211575234372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065093310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9115299,0.07424735,0.0020920353,0.000697947,0.009212236,0.0008280771,0.000050706192,0.00021080916,0.0011309208],"genre_scores_gemma":[0.9487526,0.039885554,0.0007451919,0.0011190003,0.00015145501,0.00035833643,0.000114905204,0.00013548753,0.008737496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996733,0.00040135847,0.0012109157,0.0007303651,0.000107914544,0.00081644824],"domain_scores_gemma":[0.9979498,0.00016943418,0.0007876174,0.0008863278,0.00018751864,0.00001931844],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033378266,0.0006099904,0.0009092563,0.0004920837,0.00029578924,0.000031982163,0.0006435481,0.00086272514,0.006477714],"category_scores_gemma":[0.000027183021,0.0005747596,0.00033251612,0.0004654134,0.0005987161,0.000867099,0.00010170642,0.0011136258,0.0003909142],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036634365,0.0007692522,0.0006338106,0.000023380784,0.0006138213,0.0000015023221,0.0035863684,0.00016965605,0.94754845,0.00009465094,0.0029002363,0.03999546],"study_design_scores_gemma":[0.0061354544,0.00035265143,0.0059724525,0.000161273,0.000015236735,0.00004200816,0.00076200475,0.0000056950335,0.7224053,0.000036150534,0.2637166,0.000395154],"about_ca_topic_score_codex":0.00085552095,"about_ca_topic_score_gemma":0.000054806227,"teacher_disagreement_score":0.26081637,"about_ca_system_score_codex":0.0004800628,"about_ca_system_score_gemma":0.00015758791,"threshold_uncertainty_score":0.9996704},"labels":[],"label_agreement":null},{"id":"W2075251333","doi":"10.1007/s00262-004-0582-0","title":"NK cell activation and tumor infiltration are involved in the antitumor mechanism of Virulizin","year":2004,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; Western University","funders":"","keywords":"Infiltration (HVAC); Apoptosis; Natural killer cell; Cancer research; Cell; Immune system; Cytotoxicity; Chemistry; In vitro; Biology; Immunology","score_opus":0.014507130838923436,"score_gpt":0.24399563942463437,"score_spread":0.22948850858571093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075251333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98093235,0.014590975,0.0009506761,0.00092499284,0.0016879656,0.00048468908,0.0000060993902,0.000045490942,0.00037675674],"genre_scores_gemma":[0.99407506,0.0040196837,0.000039705505,0.0013407966,0.000020804331,0.00014089856,0.000047213445,0.000023214114,0.0002925951],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99861735,0.0002768596,0.0004846489,0.00028515377,0.000049893908,0.00028608952],"domain_scores_gemma":[0.9989991,0.00010278467,0.0004329241,0.00035927628,0.00009935547,0.0000065590434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029967446,0.00022931793,0.0003472343,0.00023987521,0.00018542995,0.00002119732,0.00026380038,0.00023057128,0.0003851389],"category_scores_gemma":[0.000030510446,0.000183681,0.00008118454,0.00027732106,0.00028099588,0.00030050054,0.000028853316,0.0005038376,0.000049644244],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070630095,0.00021605134,0.0012051319,0.000022017308,0.00010419961,0.000001670903,0.0019744616,0.000028051101,0.99130535,0.0031232173,0.00019202539,0.0011215082],"study_design_scores_gemma":[0.0046906564,0.00039395993,0.02735092,0.00012226636,0.000015300591,0.00003717882,0.0033343602,0.000002930003,0.9545524,0.00095760083,0.008337962,0.00020446329],"about_ca_topic_score_codex":0.0010603053,"about_ca_topic_score_gemma":0.00011088149,"teacher_disagreement_score":0.03675296,"about_ca_system_score_codex":0.00013402857,"about_ca_system_score_gemma":0.00010935108,"threshold_uncertainty_score":0.7490294},"labels":[],"label_agreement":null},{"id":"W2078410536","doi":"10.1007/s00262-014-1630-z","title":"N-3 polyunsaturated fatty acids inhibit IFN-γ-induced IL-18 binding protein production by prostate cancer cells","year":2014,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Institute for Nanotechnology; National Research Council Canada; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Cancer research; Signal transduction; Kinase; STAT1; Cancer cell; IRF8; Biology; STAT3; Interferon; Cell biology; Chemistry; Internal medicine; Transcription factor; Cancer; Medicine; Immunology; Biochemistry; Gene","score_opus":0.01014323759916386,"score_gpt":0.2552685686839767,"score_spread":0.24512533108481283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078410536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9560826,0.02636019,0.00015008678,0.0009879353,0.014889126,0.0011166828,0.00016569754,0.000105126426,0.00014259393],"genre_scores_gemma":[0.95158345,0.02566961,0.00019081829,0.00092271506,0.006994515,0.0017484385,0.0003367692,0.00021153434,0.012342132],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971639,0.00027551572,0.00053670205,0.0009832645,0.00020454566,0.00083609455],"domain_scores_gemma":[0.998381,0.0000086544405,0.00039008257,0.0008652829,0.0002658186,0.00008914323],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003385487,0.00054155075,0.00052430533,0.0001437776,0.00033766968,0.000072492934,0.00044962432,0.00053825445,0.00023200558],"category_scores_gemma":[0.000038967228,0.00052120636,0.00018349239,0.00036640305,0.00032548263,0.00003403752,0.00009095919,0.0004588196,0.000031261083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010158581,0.000087838926,0.00036564053,0.000021954778,0.00038809446,8.79076e-8,0.0002865978,0.000015088689,0.9263388,0.000012833834,0.016407724,0.055059474],"study_design_scores_gemma":[0.0015382086,0.0002456541,0.0005632518,0.000054110384,0.000022888278,0.0000059715444,0.000058254016,0.0000040443797,0.60042346,0.000012855505,0.39667335,0.0003979564],"about_ca_topic_score_codex":0.0007850427,"about_ca_topic_score_gemma":0.00011331688,"teacher_disagreement_score":0.38026562,"about_ca_system_score_codex":0.00017411057,"about_ca_system_score_gemma":0.00037900722,"threshold_uncertainty_score":0.999724},"labels":[],"label_agreement":null},{"id":"W2079310034","doi":"10.1007/pl00006690","title":"Murine hypodense eosinophils induce tumour cell apoptosis by a granzyme B-dependent mechanism","year":2001,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Dalhousie Medical Research Foundation","keywords":"Granzyme B; Cytotoxicity; Granzyme; Perforin; Eosinophil; Biology; Apoptosis; Molecular biology; Immunology; Biochemistry; In vitro","score_opus":0.013860942428479262,"score_gpt":0.260084338807258,"score_spread":0.24622339637877874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079310034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9272648,0.061225254,0.00035789402,0.006408093,0.0009983627,0.0007776348,0.00004412961,0.0002422108,0.002681629],"genre_scores_gemma":[0.92564607,0.056775995,0.00014743421,0.0037359707,0.00011891388,0.00032820026,0.000065398366,0.00013778877,0.013044253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99717194,0.00013705844,0.00065868907,0.0007393251,0.00038389367,0.0009090865],"domain_scores_gemma":[0.99844384,0.00006270831,0.00026231696,0.0009104631,0.00017476933,0.00014589282],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024468382,0.00056877587,0.00094125915,0.0002643477,0.00027236613,0.00005117281,0.000464262,0.0004499983,0.0023792237],"category_scores_gemma":[0.000017114258,0.000519212,0.00029595,0.0004258467,0.0002807577,0.00017103348,0.0000779055,0.0006909106,0.00020927012],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011902348,0.00089653285,0.0010807187,0.00002991542,0.00062723504,0.00008102423,0.000634083,0.0000017783495,0.9769411,0.00072993233,0.0040276195,0.013759838],"study_design_scores_gemma":[0.024351511,0.003134958,0.010122978,0.0002455766,0.00034189216,0.0013509721,0.0010022358,0.00003524088,0.85104406,0.0050971927,0.10169256,0.0015808118],"about_ca_topic_score_codex":0.00085490895,"about_ca_topic_score_gemma":0.000015586045,"teacher_disagreement_score":0.12589702,"about_ca_system_score_codex":0.00027007185,"about_ca_system_score_gemma":0.00022999824,"threshold_uncertainty_score":0.99972594},"labels":[],"label_agreement":null},{"id":"W2080601172","doi":"10.1007/s00262-008-0453-1","title":"TGFβ secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effect","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Bystander effect; Immune system; Immunotherapy; Cancer research; Immunology; Cancer immunotherapy; Biology; Cytokine; Cancer; Melanoma; Cancer cell","score_opus":0.011808396773576518,"score_gpt":0.26217129636619746,"score_spread":0.2503628995926209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080601172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56285197,0.42993775,0.00031720984,0.0007849973,0.003771564,0.0010623873,0.00037328992,0.000528522,0.00037230668],"genre_scores_gemma":[0.71291196,0.26135916,0.00007986769,0.0026494048,0.00018108134,0.0018610407,0.0006022711,0.00042370276,0.01993148],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9920974,0.0019749913,0.0016566876,0.0015760306,0.00027549925,0.0024193865],"domain_scores_gemma":[0.9957599,0.0007990039,0.00089704536,0.0020769641,0.0003825569,0.00008452321],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0007928164,0.0016862776,0.0022552372,0.00061821117,0.0020650907,0.000091044465,0.0019613383,0.0016879204,0.013253338],"category_scores_gemma":[0.000067731715,0.0014864161,0.0009049745,0.0009856691,0.0026143305,0.0006439248,0.00018944478,0.0017889475,0.0008405999],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013210909,0.00037646663,0.009629924,0.00002693186,0.0062886737,0.00004719823,0.0019859837,0.000010246956,0.89979464,0.000079525234,0.017201712,0.051347815],"study_design_scores_gemma":[0.014354239,0.0015465198,0.010846933,0.00011170814,0.00009409559,0.00070237066,0.00013350463,0.0000035477192,0.6172648,0.000046015437,0.35356277,0.0013334993],"about_ca_topic_score_codex":0.002600576,"about_ca_topic_score_gemma":0.000034874967,"teacher_disagreement_score":0.33636105,"about_ca_system_score_codex":0.0007619362,"about_ca_system_score_gemma":0.00082258397,"threshold_uncertainty_score":0.99993736},"labels":[],"label_agreement":null},{"id":"W2083355262","doi":"10.1007/s00262-015-1657-9","title":"Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Stichting Kinderen Kankervrij; KWF Kankerbestrijding","keywords":"NKG2D; Cytotoxicity; Cytolysis; Lymphokine-activated killer cell; Immunotherapy; Natural killer cell; Biology; dNaM; Cancer research; NK-92; Immunology; Cell biology; Interleukin 21; T cell; In vitro; Immune system; Biochemistry","score_opus":0.013202965102467636,"score_gpt":0.2531609153311134,"score_spread":0.23995795022864577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083355262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9160363,0.078344956,0.000007750659,0.00025885136,0.0045774053,0.0004956898,0.000019541785,0.00011585725,0.00014365483],"genre_scores_gemma":[0.9926976,0.0038311048,0.000047677968,0.00030393575,0.000033362976,0.0000860041,0.00022730711,0.000061473635,0.002711538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99714375,0.000618188,0.00087191747,0.0006300386,0.00009028177,0.0006458249],"domain_scores_gemma":[0.998465,0.00028108456,0.00055544433,0.00038865866,0.000264059,0.00004573273],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042581928,0.00051577104,0.00083003595,0.00037009557,0.00023956627,0.00003358641,0.00033962826,0.00064564194,0.0003734184],"category_scores_gemma":[0.00011661821,0.00047847215,0.000110725894,0.00037005282,0.0008324534,0.00039138715,0.00015602386,0.001277705,0.000024668536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023226687,0.00021945946,0.0071850824,0.000024273551,0.0003079019,0.0000019245322,0.0022204088,0.0000038937924,0.98226905,0.000016673393,0.0028256767,0.002602962],"study_design_scores_gemma":[0.0065389895,0.0005367465,0.01449012,0.000087921195,0.000021349862,0.00003880077,0.0018567294,0.0000265527,0.947269,0.00003923842,0.028602187,0.0004923186],"about_ca_topic_score_codex":0.0023401421,"about_ca_topic_score_gemma":0.000111058944,"teacher_disagreement_score":0.0766613,"about_ca_system_score_codex":0.00026334682,"about_ca_system_score_gemma":0.00012214234,"threshold_uncertainty_score":0.9997667},"labels":[],"label_agreement":null},{"id":"W2085731453","doi":"10.1007/s00262-012-1230-8","title":"CA215 and GnRH receptor as targets for cancer therapy","year":2012,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"British Columbia Centre of Excellence for Women's Health; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Monoclonal antibody; Epitope; Cancer; Cancer research; Cancer cell; Antibody; Ovarian cancer; Biology; Cytotoxicity; Targeted therapy; Medicine; Immunology; Internal medicine; In vitro; Biochemistry","score_opus":0.044804329150822726,"score_gpt":0.3792224906728907,"score_spread":0.334418161522068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085731453","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6288985,0.36144257,0.000018559955,0.0071525117,0.0009068572,0.0007257372,0.00007368982,0.000051073737,0.0007305033],"genre_scores_gemma":[0.39010543,0.5556156,0.0012244221,0.009514678,0.0016705383,0.0024823078,0.00009986795,0.00016360388,0.03912356],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982827,0.000055287466,0.00029724368,0.00032666407,0.00019036558,0.0008477555],"domain_scores_gemma":[0.9990955,0.00015790468,0.000103616556,0.00027321,0.00020979713,0.00015997676],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026325716,0.00030050252,0.0005157698,0.0001294924,0.00026473362,0.000022936158,0.0001777289,0.00023786543,0.0036081874],"category_scores_gemma":[0.000024334418,0.00023037201,0.00016737,0.00015499476,0.00041038397,0.00016505794,0.000044130553,0.0003435943,0.000073249495],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073531503,0.00023713897,0.048953295,0.000058026522,0.0013570159,0.0000018780321,0.0014128755,3.1523052e-7,0.6049504,0.0012107317,0.009084733,0.3253804],"study_design_scores_gemma":[0.004030912,0.0006929981,0.06328428,0.00006309397,0.000024437752,0.000052037,0.00013445668,0.000004910154,0.09310044,0.00018857537,0.8381631,0.00026078575],"about_ca_topic_score_codex":0.0014800463,"about_ca_topic_score_gemma":0.000018401848,"teacher_disagreement_score":0.8290783,"about_ca_system_score_codex":0.00016180197,"about_ca_system_score_gemma":0.00022542359,"threshold_uncertainty_score":0.99730265},"labels":[],"label_agreement":null},{"id":"W2089081257","doi":"10.1007/s00262-010-0887-0","title":"Aminobisphosphonate-pretreated dendritic cells trigger successful Vγ9Vδ2 T cell amplification for immunotherapy in advanced cancer patients","year":2010,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"Immunotherapy; Cancer research; Cytotoxic T cell; Isopentenyl pyrophosphate; T cell; Peripheral blood mononuclear cell; Cancer immunotherapy; Cancer; Medicine; Cancer cell; Immune system; Immunology; Biology; In vitro; Internal medicine","score_opus":0.008097310660771144,"score_gpt":0.25239929525632576,"score_spread":0.2443019845955546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089081257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9292722,0.05556731,0.00016475112,0.0005347066,0.010918417,0.002492669,0.0004463057,0.00030559718,0.00029804997],"genre_scores_gemma":[0.96845853,0.017582886,0.00024669632,0.0008066705,0.00007643858,0.0037741181,0.00065636705,0.00025419806,0.008144077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99442434,0.00040398075,0.0015800038,0.0015158885,0.00013288691,0.0019428773],"domain_scores_gemma":[0.9964053,0.0005668156,0.00086501124,0.0014723074,0.00062962004,0.0000609538],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044715853,0.0010877271,0.0014250209,0.00067503046,0.0006580097,0.000081052596,0.0016481037,0.0017466424,0.004223314],"category_scores_gemma":[0.000051512627,0.0010564215,0.00047932952,0.0008196631,0.0011493774,0.00047715742,0.00012811253,0.0018952752,0.00041162744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039682062,0.0013983048,0.019288562,0.00005051705,0.00067493855,0.0000038291055,0.00092128443,0.000037455782,0.9261058,0.00020799202,0.001163876,0.046179224],"study_design_scores_gemma":[0.020857185,0.0007510215,0.018630607,0.00007863384,0.00006977375,0.000011478739,0.00020795657,0.000014665555,0.8111832,0.0002022315,0.14693889,0.0010543779],"about_ca_topic_score_codex":0.0029898454,"about_ca_topic_score_gemma":0.0008728574,"teacher_disagreement_score":0.145775,"about_ca_system_score_codex":0.00048590486,"about_ca_system_score_gemma":0.00049236306,"threshold_uncertainty_score":0.9995493},"labels":[],"label_agreement":null},{"id":"W2089966068","doi":"10.1007/s00262-011-1047-x","title":"Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Calreticulin; Photodynamic therapy; Expression (computer science); Surface (topology); Group (periodic table); Cancer research; Internal medicine; Medicine; Chemistry; Biology; Cell biology; Mathematics; Computer science","score_opus":0.010463634441377552,"score_gpt":0.2547351051918924,"score_spread":0.24427147075051486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089966068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99062645,0.008189567,0.0002316817,0.000060863375,0.00017380722,0.0005527224,0.00014576624,0.000009357705,0.00000978717],"genre_scores_gemma":[0.99502474,0.0042478596,0.00023855492,0.00024654216,0.00000547387,0.00010411851,0.000069883274,0.000028673874,0.00003418148],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99789643,0.0007558474,0.00048254424,0.00047436703,0.000087820976,0.00030297914],"domain_scores_gemma":[0.99891865,0.00004834619,0.00028977805,0.00057535805,0.00012526067,0.000042613414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050865574,0.00025213402,0.00042405177,0.00009247591,0.00004310001,0.0000033251592,0.00032926074,0.00027960466,0.00009536526],"category_scores_gemma":[0.00006971412,0.00022728412,0.000086449305,0.0001546294,0.00042169428,0.000008119302,0.00013188345,0.0001831544,6.737451e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011329406,0.00039366604,0.05133876,0.000016775264,0.00018446411,0.0000074361024,0.0008064431,0.000027171709,0.9351645,0.000014458458,0.000008291251,0.0007086173],"study_design_scores_gemma":[0.0021135083,0.0011409613,0.33071178,0.00007832794,0.0000054843413,0.0000010454693,0.0001958471,0.0000028752204,0.6654965,0.00003972353,0.00006418836,0.00014976483],"about_ca_topic_score_codex":0.0016057385,"about_ca_topic_score_gemma":0.00027717327,"teacher_disagreement_score":0.27937302,"about_ca_system_score_codex":0.00005117959,"about_ca_system_score_gemma":0.000091145484,"threshold_uncertainty_score":0.9268378},"labels":[],"label_agreement":null},{"id":"W2090674284","doi":"10.1007/s00262-011-1083-6","title":"Immunization with N-propionyl polysialic acid–KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Institute for Biological Sciences","funders":"National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Polysialic acid; Conjugate; Immunization; Antibody; Medicine; Group A; Immunology; Cancer research; Cell; Chemistry; Internal medicine","score_opus":0.014581903922429659,"score_gpt":0.25844688750645256,"score_spread":0.2438649835840229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090674284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96961766,0.027665196,0.00005401014,0.0003047874,0.00012321101,0.0017254076,0.0000615314,0.000059535694,0.00038868067],"genre_scores_gemma":[0.969163,0.028446525,0.00082426774,0.0006274943,0.000036665668,0.00055743585,0.00004161784,0.000110646,0.0001923454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997729,0.00015679556,0.00039482233,0.0007202192,0.00029274655,0.0007064053],"domain_scores_gemma":[0.9985925,0.000053904238,0.00037295854,0.00049736444,0.00039124952,0.000092039234],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015467845,0.000552296,0.0008518268,0.00035689512,0.0002896385,0.000053993383,0.00020347108,0.0001947869,0.00011154441],"category_scores_gemma":[0.000006668907,0.0003729423,0.00003617467,0.00050001114,0.0010961137,0.00038654596,0.000116547635,0.000600758,0.0000014053295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01612231,0.00030445895,0.72025603,0.0001992314,0.0020810792,0.00002764603,0.01693883,0.000001914802,0.23079495,0.000011989588,0.000026539448,0.013234996],"study_design_scores_gemma":[0.015483154,0.0030706488,0.8325691,0.00090688287,0.00019622782,0.000009509971,0.0014843482,0.000009113148,0.14530675,0.000005572355,0.00043152532,0.0005271323],"about_ca_topic_score_codex":0.0053543276,"about_ca_topic_score_gemma":0.0006645808,"teacher_disagreement_score":0.11231308,"about_ca_system_score_codex":0.00043188976,"about_ca_system_score_gemma":0.00036431188,"threshold_uncertainty_score":0.99987227},"labels":[],"label_agreement":null},{"id":"W2091633760","doi":"10.1007/s00262-013-1432-8","title":"Blocking retinoic acid receptor-α enhances the efficacy of a dendritic cell vaccine against tumours by suppressing the induction of regulatory T cells","year":2013,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Science Foundation Ireland","keywords":"FOXP3; Immune system; Cancer research; Biology; Retinoic acid; Immunology; Antigen; CD8; Immune tolerance; Immunotherapy; Cell culture","score_opus":0.007739142365960905,"score_gpt":0.2331736637303327,"score_spread":0.22543452136437178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091633760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7530534,0.24276747,0.000048181086,0.0009985742,0.00214356,0.000791853,0.000033256914,0.000061205115,0.00010247845],"genre_scores_gemma":[0.9744365,0.022791974,0.000043250166,0.00046816195,0.000060728085,0.00028426346,0.00004709551,0.00008735518,0.0017806244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99583435,0.0014664782,0.0012370889,0.0005113908,0.00013853356,0.0008121764],"domain_scores_gemma":[0.99611795,0.0009562096,0.001188601,0.0013812977,0.0003384016,0.000017517114],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00075036305,0.0005431817,0.000863294,0.00021226713,0.0007294527,0.00004561341,0.001457833,0.00055961293,0.0019769054],"category_scores_gemma":[0.00007437787,0.00035324556,0.000382894,0.0005143373,0.0017680475,0.0003021826,0.00013807352,0.0010163954,0.00010921224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014261606,0.00027378043,0.00028859384,0.00003245428,0.0008522356,3.1679758e-7,0.0030335658,0.00001872057,0.9582337,0.000026905955,0.0057248254,0.030088706],"study_design_scores_gemma":[0.0037955379,0.00041388985,0.009661582,0.00022275209,0.00007735236,0.00002203101,0.0017581297,0.00000236346,0.9577784,0.000038677394,0.02587101,0.00035827523],"about_ca_topic_score_codex":0.0005388821,"about_ca_topic_score_gemma":0.0000048431502,"teacher_disagreement_score":0.22138312,"about_ca_system_score_codex":0.00012747892,"about_ca_system_score_gemma":0.00025248644,"threshold_uncertainty_score":0.99989194},"labels":[],"label_agreement":null},{"id":"W2092275785","doi":"10.1007/s00262-013-1428-4","title":"Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study)","year":2013,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Sonnenfeld Stiftung","keywords":"Medicine; Melanoma; Pegylated interferon; Internal medicine; Oncology; Alpha interferon; Interferon; Gastroenterology; Immunology; Cancer research","score_opus":0.019747786874383395,"score_gpt":0.3011801274234032,"score_spread":0.28143234054901983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092275785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99601936,0.0020964884,0.00003012446,0.00007066921,0.00028685908,0.0012964562,0.00012251528,0.000022156431,0.000055377233],"genre_scores_gemma":[0.9985677,0.0006381548,0.0001473096,0.000049534978,0.0000121408175,0.00031405682,0.00009045081,0.000036826485,0.00014383455],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99767613,0.00018193485,0.001267313,0.00036788074,0.00021060545,0.0002961128],"domain_scores_gemma":[0.9983022,0.00008601349,0.00053977664,0.0006414756,0.00037466994,0.000055847],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014299965,0.00029550347,0.0013033975,0.0008051992,0.00003467371,0.0000058682444,0.00020234002,0.00011673023,0.0014382559],"category_scores_gemma":[0.000033583317,0.0002325597,0.00035526106,0.00071671477,0.00012447385,0.00010067682,0.000052614545,0.00017082297,0.0000027488318],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022657716,0.0016664569,0.48640218,0.000012686652,0.0040725083,0.000003614908,0.00204931,0.00021828574,0.4973513,3.9095957e-7,0.000006868402,0.005950632],"study_design_scores_gemma":[0.0069937767,0.0074216053,0.68408364,0.00015681107,0.0007053909,0.0000020324778,0.0006741524,0.0001294044,0.2996618,0.0000010306017,0.000047587902,0.00012281377],"about_ca_topic_score_codex":0.009545713,"about_ca_topic_score_gemma":0.0003878589,"teacher_disagreement_score":0.19768952,"about_ca_system_score_codex":0.00028221402,"about_ca_system_score_gemma":0.00009391612,"threshold_uncertainty_score":0.9994746},"labels":[],"label_agreement":null},{"id":"W2093949714","doi":"10.1007/s00262-005-0674-5","title":"Development of a whole cell vaccine for acute myeloid leukaemia","year":2005,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Immunotherapy; Minimal residual disease; Oncology; Disease; Myeloid; Internal medicine; Stem cell; Clinical trial; Haematopoiesis; Myeloid leukaemia; Immunology; Immune system; Leukemia; Biology","score_opus":0.0490583581798695,"score_gpt":0.3946298846418152,"score_spread":0.3455715264619457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093949714","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036858147,0.9935957,0.00044820207,0.0002829404,0.00057325064,0.0040180795,0.00027135998,0.000116682655,0.0003251947],"genre_scores_gemma":[0.0000035132268,0.96899164,0.015051271,0.00029038943,0.0003804943,0.0036377693,0.0007702242,0.00035510343,0.010519625],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954224,0.00014902613,0.0019931034,0.00093809306,0.0003621877,0.0011351929],"domain_scores_gemma":[0.99656063,0.00028467117,0.0010945789,0.0014795493,0.0004505558,0.00012999939],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005450708,0.0010158255,0.0046221297,0.0007886753,0.00021302728,0.000023240502,0.0010734458,0.0013004114,0.00080161507],"category_scores_gemma":[0.00003119006,0.0008290064,0.0011289361,0.0006907215,0.00024188134,0.00010346415,0.00020488304,0.0013989755,0.00020159822],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010399632,0.00021545039,0.0000029230207,0.005510752,0.007284221,0.000014919881,0.00047881185,3.3346018e-7,0.009950146,0.000017246146,0.0040223603,0.97146285],"study_design_scores_gemma":[0.006888544,0.00046080523,0.000024793431,0.0054357923,0.0016619095,0.00015943652,0.000053781365,0.0000033622794,0.0034323807,0.000005700106,0.9812218,0.0006516824],"about_ca_topic_score_codex":0.000032459797,"about_ca_topic_score_gemma":0.000013054542,"teacher_disagreement_score":0.97719944,"about_ca_system_score_codex":0.003007675,"about_ca_system_score_gemma":0.008675534,"threshold_uncertainty_score":0.9999961},"labels":[],"label_agreement":null},{"id":"W2095399328","doi":"10.1007/s00262-006-0276-x","title":"Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN","year":2007,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":132,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada); University of British Columbia","funders":"","keywords":"CpG Oligodeoxynucleotide; Adjuvant; Immune system; Antigen; Acquired immune system; Immunopotentiator; Immunology; TLR9; Innate immune system; Chemistry; CpG site; Cancer research; Biology; DNA methylation; Biochemistry","score_opus":0.014257866176892457,"score_gpt":0.2784953889808427,"score_spread":0.26423752280395024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095399328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8593458,0.13801375,0.00012927045,0.00037922623,0.001266485,0.0006840165,0.000031002644,0.00007699018,0.00007345351],"genre_scores_gemma":[0.99138296,0.0076653343,0.000033505894,0.00028759608,0.000031526204,0.00012449214,0.000015245161,0.00006479353,0.00039452076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964881,0.0007285656,0.0011048295,0.0005867992,0.000115961826,0.00097576395],"domain_scores_gemma":[0.9972169,0.0010491301,0.0006832466,0.00087311055,0.00015351888,0.000024140922],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001238962,0.0005355014,0.0009431931,0.0003801822,0.000453325,0.000037891503,0.00070580817,0.00044358836,0.0005507097],"category_scores_gemma":[0.00010681858,0.00042065553,0.00021145359,0.000517321,0.0018036198,0.00033033366,0.0001353795,0.00074266817,0.00003785078],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008234279,0.0003073819,0.007152817,0.000023397943,0.00061408826,0.000020684645,0.0022854614,0.0000128559,0.91527754,0.00035478314,0.000021782915,0.065694906],"study_design_scores_gemma":[0.0036035497,0.00063895126,0.27821782,0.00012098933,0.000036359055,0.00026338303,0.00055985636,0.0000072277703,0.7112123,0.00009909783,0.004887767,0.0003527465],"about_ca_topic_score_codex":0.0011059465,"about_ca_topic_score_gemma":0.00021076298,"teacher_disagreement_score":0.271065,"about_ca_system_score_codex":0.00015199736,"about_ca_system_score_gemma":0.0002719846,"threshold_uncertainty_score":0.9998245},"labels":[],"label_agreement":null},{"id":"W2095408752","doi":"10.1007/s00262-012-1333-2","title":"CD40 pathway activation reveals dual function for macrophages in human endometrial cancer cell survival and invasion","year":2012,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"CD40; Cancer research; Tumor necrosis factor alpha; Endometrial cancer; Biology; Apoptosis; Cancer cell; Macrophage; Cancer; Tumor progression; PI3K/AKT/mTOR pathway; Signal transduction; Immunology; Medicine; Cell biology; Internal medicine; In vitro; Cytotoxic T cell","score_opus":0.030092769943370276,"score_gpt":0.29287978309801327,"score_spread":0.262787013154643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095408752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7844467,0.20549028,0.00028533765,0.00018626607,0.007920157,0.001129236,0.000094569536,0.000093218485,0.00035421175],"genre_scores_gemma":[0.977127,0.017261565,0.00006871529,0.00036415044,0.0003836416,0.0015078769,0.00019255155,0.00010943463,0.002985046],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968783,0.0005437834,0.00078300154,0.00061235466,0.0000821735,0.0011003581],"domain_scores_gemma":[0.9982247,0.0005612124,0.0004858816,0.00054156326,0.0001551196,0.000031545114],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009806225,0.00050344394,0.0007832289,0.00035155457,0.00048387903,0.00003367618,0.00031134783,0.00081764325,0.0020439802],"category_scores_gemma":[0.00006758158,0.00049418357,0.00016925004,0.00036674016,0.0004622434,0.0005930197,0.000119785866,0.00063550496,0.000033430428],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030981638,0.00026262383,0.010221224,0.00005440978,0.00045595944,5.800192e-7,0.0011110097,0.000008310282,0.9389313,0.00066164974,0.000788773,0.044405986],"study_design_scores_gemma":[0.015296098,0.000634096,0.06791699,0.000121082994,0.00006698087,0.000011861123,0.0006905994,8.7227164e-7,0.83235574,0.0002937181,0.08198518,0.0006268111],"about_ca_topic_score_codex":0.0020341694,"about_ca_topic_score_gemma":0.00017444107,"teacher_disagreement_score":0.19268028,"about_ca_system_score_codex":0.0006992023,"about_ca_system_score_gemma":0.00016930839,"threshold_uncertainty_score":0.999751},"labels":[],"label_agreement":null},{"id":"W2130519688","doi":"10.1007/s00262-008-0456-y","title":"Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Hepatitis C virus research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Immune system; Biology; Virology; Hepatitis C virus; Humoral immunity; Proteome; Immunology; Human proteome project; Peptide sequence; Immunogenicity; Virus; Computational biology; Genetics; Proteomics; Gene","score_opus":0.10487288467256202,"score_gpt":0.4001129277995764,"score_spread":0.2952400431270144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130519688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930838,0.004937505,0.00006893555,0.0004545186,0.00018257847,0.0007322221,0.00005554837,0.000121415374,0.0003634761],"genre_scores_gemma":[0.9936215,0.005281742,0.00032326937,0.00017020889,0.000033670207,0.00010785769,0.000028011582,0.00007389146,0.00035979584],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99652636,0.0009681617,0.0008275066,0.00061893946,0.00039256326,0.0006664492],"domain_scores_gemma":[0.9975618,0.00045224183,0.0003180685,0.0011113851,0.00044711985,0.00010938555],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011878256,0.00038026524,0.0009858903,0.000307073,0.00045788434,0.000016969694,0.00040699754,0.0003554834,0.00062061066],"category_scores_gemma":[0.0005037473,0.00035525154,0.00015606423,0.00054046867,0.0023961975,0.0002583793,0.0001364645,0.00074177876,0.000009019519],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014000459,0.000101801175,0.24019898,0.00004978371,0.00025361276,0.00008161283,0.002141925,0.000007649251,0.7506081,0.0002757128,0.000005527733,0.0048752455],"study_design_scores_gemma":[0.0024035694,0.0010233828,0.66809267,0.00020553914,0.000022699376,0.00013032445,0.00018268202,0.00007634453,0.32663414,0.00038994045,0.00052270276,0.00031597796],"about_ca_topic_score_codex":0.0073059243,"about_ca_topic_score_gemma":0.000016704747,"teacher_disagreement_score":0.42789373,"about_ca_system_score_codex":0.0005267637,"about_ca_system_score_gemma":0.0010800686,"threshold_uncertainty_score":0.99988997},"labels":[],"label_agreement":null},{"id":"W2134157043","doi":"10.1007/s00262-012-1353-y","title":"Extensive expansion of primary human gamma delta T cells generates cytotoxic effector memory cells that can be labeled with Feraheme for cellular MRI","year":2012,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Western University","funders":"University Health Network","keywords":"Ferumoxytol; Cytotoxic T cell; Molecular biology; Cytotoxicity; Chemistry; Cancer research; Biology; In vitro; Medicine; Biochemistry","score_opus":0.0204625788586485,"score_gpt":0.2537292514652964,"score_spread":0.2332666726066479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134157043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8405108,0.15294108,0.0008990452,0.0002549623,0.0026152446,0.0021244716,0.00042684807,0.00017385549,0.0000537171],"genre_scores_gemma":[0.9782899,0.011844445,0.00066389417,0.0015804506,0.00016643389,0.0013780193,0.00080451224,0.00031259132,0.0049597695],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99511576,0.0010299053,0.0010409009,0.0008483905,0.0001660823,0.0017989632],"domain_scores_gemma":[0.9963123,0.00068407366,0.0009398924,0.0015102968,0.00048687693,0.0000665421],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00079904165,0.0010533845,0.0017675741,0.00047527783,0.0008417223,0.00004156794,0.0009933606,0.0009937363,0.0012959035],"category_scores_gemma":[0.000020276899,0.0008832848,0.0005204107,0.0003916351,0.0014260993,0.00039679187,0.00013812393,0.0007782915,0.000061162114],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009441275,0.00054574886,0.00064280734,0.00014438311,0.0031307815,0.000005922941,0.003055258,0.000033830005,0.9749056,0.00008471148,0.001998851,0.0060107997],"study_design_scores_gemma":[0.011776235,0.0020627212,0.0029216825,0.00020923685,0.00022788857,0.00006336859,0.0005764633,0.0000016431364,0.9415598,0.00001712506,0.039585978,0.0009978646],"about_ca_topic_score_codex":0.00071576645,"about_ca_topic_score_gemma":0.000031211795,"teacher_disagreement_score":0.14109664,"about_ca_system_score_codex":0.00041179135,"about_ca_system_score_gemma":0.0005009552,"threshold_uncertainty_score":0.99961704},"labels":[],"label_agreement":null},{"id":"W2138582752","doi":"10.1007/s00262-008-0557-7","title":"Chordoma and chondrosarcoma gene profile: implications for immunotherapy","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Chondrosarcoma; Chordoma; Cancer research; Sarcoma; Biology; Pathology; Immunohistochemistry; Extracellular matrix; Medicine; Genetics","score_opus":0.03475966836548436,"score_gpt":0.32009206877311447,"score_spread":0.2853324004076301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138582752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8531511,0.1383365,0.0003112405,0.0056151957,0.0003578558,0.0016895748,0.00014656823,0.00014829983,0.00024370427],"genre_scores_gemma":[0.86718094,0.11674566,0.0043527507,0.0023649777,0.00017001083,0.0051087625,0.00018711221,0.00015289507,0.0037368713],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983711,0.000043762968,0.0004347649,0.0005258108,0.00009600855,0.0005285104],"domain_scores_gemma":[0.9986973,0.00011679305,0.0001823469,0.00073109637,0.00018995962,0.00008251745],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000089642395,0.0003567483,0.00063691515,0.00016017412,0.0005128803,0.000019108265,0.00018124208,0.00020376494,0.0002897754],"category_scores_gemma":[0.00001538739,0.00031148916,0.00021028062,0.0002326753,0.0004926622,0.0001231181,0.000028887327,0.00021423207,0.00002351277],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023525988,0.00094152434,0.22373089,0.000034123044,0.0022832744,0.000023451234,0.00074369466,6.279203e-7,0.58453256,0.0012225073,0.0025592847,0.18157545],"study_design_scores_gemma":[0.012717275,0.0010465384,0.87878275,0.000050172825,0.00007791825,0.0010167774,0.00002590202,0.000007456933,0.039368965,0.00041540942,0.06617115,0.00031970663],"about_ca_topic_score_codex":0.00017173678,"about_ca_topic_score_gemma":0.0000070425976,"teacher_disagreement_score":0.6550518,"about_ca_system_score_codex":0.0001926742,"about_ca_system_score_gemma":0.00025158183,"threshold_uncertainty_score":0.9999337},"labels":[],"label_agreement":null},{"id":"W2141602361","doi":"10.1007/s00262-009-0711-x","title":"Soluble HLA/peptide monomers cross-linked with co-stimulatory antibodies onto a streptavidin core molecule efficiently stimulate antigen-specific T cell responses","year":2009,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; BC Cancer Agency","funders":"European Commission; Kay Kendall Leukaemia Fund","keywords":"Antigen; T cell; Major histocompatibility complex; CD8; T-cell receptor; MHC restriction; Priming (agriculture); Cytotoxic T cell; CD28; Cell biology; Chemistry; Biology; Antibody; Molecular biology; MHC class I; Immunology; Immune system; Biochemistry; In vitro","score_opus":0.02508194718086599,"score_gpt":0.30544523929108275,"score_spread":0.28036329211021677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141602361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74346155,0.25230524,0.00029096,0.00025150427,0.0013699632,0.0010295848,0.0001399246,0.0004787974,0.0006724621],"genre_scores_gemma":[0.93271583,0.050899543,0.00026412657,0.001418025,0.00006591051,0.00016726104,0.00029515216,0.00020707794,0.013967067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9939061,0.0008189224,0.0014152895,0.0015076675,0.00022985658,0.0021221894],"domain_scores_gemma":[0.9959691,0.0005695845,0.00089591544,0.002038151,0.00044747582,0.00007977247],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0007596931,0.0013377422,0.0015889687,0.00076957484,0.001536392,0.00021192436,0.0015188713,0.001060749,0.0026042878],"category_scores_gemma":[0.00004316156,0.0011965978,0.00056217104,0.0007131477,0.0023545143,0.0005796246,0.00010725846,0.0014464626,0.00072888687],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033692066,0.00086117093,0.010810639,0.00001723939,0.001524851,0.00005911186,0.0022477612,0.00077608303,0.934795,0.00017077728,0.0022571539,0.012788124],"study_design_scores_gemma":[0.016108429,0.0034285,0.14678277,0.00022073548,0.00005775265,0.00014869099,0.00058066816,0.000024996834,0.58648425,0.000057747948,0.24452077,0.0015846699],"about_ca_topic_score_codex":0.00030794312,"about_ca_topic_score_gemma":0.000014646435,"teacher_disagreement_score":0.34831074,"about_ca_system_score_codex":0.0004991963,"about_ca_system_score_gemma":0.0007432871,"threshold_uncertainty_score":0.99993736},"labels":[],"label_agreement":null},{"id":"W2153757228","doi":"10.1007/s00262-007-0391-3","title":"Vγ9Vδ2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas","year":2007,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"NKG2D; Cancer research; Immunotherapy; Cytotoxic T cell; T cell; Ex vivo; Medicine; Immunology; Biology; Immune system; In vivo; In vitro","score_opus":0.014498654562375183,"score_gpt":0.2596359900905667,"score_spread":0.24513733552819153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153757228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94485575,0.04897216,0.0018222413,0.000059838752,0.002915251,0.00091722986,0.00008670704,0.0000795928,0.0002912579],"genre_scores_gemma":[0.99359983,0.004093689,0.00011974415,0.00014647207,0.00005399887,0.0001487795,0.0005631642,0.000079905505,0.0011943954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973802,0.0002010012,0.0012520511,0.0004696123,0.00007302293,0.00062408595],"domain_scores_gemma":[0.99784863,0.00026426863,0.0009665081,0.00040761268,0.0004885478,0.000024410054],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006612244,0.00040903228,0.0008865277,0.00045147853,0.00031762352,0.000012596709,0.0003111787,0.00061839755,0.0013547976],"category_scores_gemma":[0.000034007146,0.00041325646,0.00032203065,0.0002510406,0.00084694574,0.00018827293,0.000050296883,0.00045978389,0.000028886996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063085253,0.00037430707,0.0039852667,0.00006899823,0.0008576234,0.0000024626515,0.0012925059,0.0000025230552,0.9726133,0.00007294745,0.00037154913,0.014050026],"study_design_scores_gemma":[0.008371404,0.0023570128,0.020583384,0.00008871181,0.000064769476,0.00006584147,0.00096256746,0.000021220816,0.9610408,0.00014462449,0.0059082774,0.00039139407],"about_ca_topic_score_codex":0.00080124027,"about_ca_topic_score_gemma":0.000023139302,"teacher_disagreement_score":0.048744127,"about_ca_system_score_codex":0.00013031773,"about_ca_system_score_gemma":0.00013583247,"threshold_uncertainty_score":0.9998319},"labels":[],"label_agreement":null},{"id":"W2159926306","doi":"10.1007/s00262-009-0788-2","title":"Performance of serum-supplemented and serum-free media in IFNγ Elispot Assays for human T cells","year":2009,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Leids Universitair Medisch Centrum; Universiteit Leiden; Wallace H. Coulter Foundation; Cancer Research Institute; Bill and Melinda Gates Foundation","keywords":"ELISPOT; Peripheral blood mononuclear cell; Immunology; Medicine; Antigen; Chemistry; In vitro","score_opus":0.0256241263572497,"score_gpt":0.3322961344563678,"score_spread":0.3066720080991181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159926306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98417085,0.011408747,0.000020284375,0.0020441029,0.00028023717,0.0012978947,0.00017476009,0.000050995917,0.0005521334],"genre_scores_gemma":[0.9788659,0.01769004,0.0005317406,0.00079470087,0.00011698135,0.00020090851,0.000044979446,0.00006377766,0.0016909417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99785054,0.00009950682,0.00065464777,0.0004355196,0.00027309003,0.00068667944],"domain_scores_gemma":[0.99847007,0.00016836677,0.00019197297,0.0008821779,0.00022102441,0.00006637759],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00060404796,0.00031213378,0.00075025664,0.00042077393,0.000118542506,0.000015607722,0.00044785166,0.00028359934,0.0033885972],"category_scores_gemma":[0.000033642602,0.00029630418,0.00013571294,0.0003867827,0.0003668768,0.00012912373,0.0000580238,0.0004835971,0.0000039698593],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027914005,0.0001983437,0.016836297,0.00007358189,0.00026668,0.0000054925695,0.001306164,0.000004964604,0.8138339,0.0001584383,0.00035007336,0.1641747],"study_design_scores_gemma":[0.022338104,0.0033930112,0.39222053,0.00027631354,0.00004612362,0.00002912707,0.0003206617,0.00018218077,0.56414616,0.00050691556,0.01618866,0.0003521782],"about_ca_topic_score_codex":0.00017658564,"about_ca_topic_score_gemma":0.00015912188,"teacher_disagreement_score":0.37538424,"about_ca_system_score_codex":0.00026830798,"about_ca_system_score_gemma":0.00021174208,"threshold_uncertainty_score":0.9999489},"labels":[],"label_agreement":null},{"id":"W2165709521","doi":"10.1007/s00262-001-0261-3","title":"Immune response to E7 protein of human papillomavirus type 16 anchored on the cell surface","year":2002,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation; Grantová Agentura České Republiky","keywords":"Biology; Virus; Virology; Fusion protein; Immune system; Molecular biology; Antibody; Hemagglutinin (influenza); Orthopoxvirus; Recombinant DNA; Recombinant virus; Poxviridae; Vaccinia; Gene; Immunology","score_opus":0.02861957685417678,"score_gpt":0.3068219827997302,"score_spread":0.27820240594555345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165709521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9527709,0.043374885,0.000015274305,0.0020033675,0.0002057513,0.00097207585,0.000034626195,0.000027063188,0.0005960399],"genre_scores_gemma":[0.98433316,0.0040537016,0.000051461815,0.0009830733,0.000074141324,0.00021397436,0.000017179913,0.00009523181,0.0101780975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974488,0.00078087545,0.00043799262,0.00051031326,0.00024143296,0.0005805938],"domain_scores_gemma":[0.99790365,0.00006916425,0.00019424362,0.001556334,0.00021920812,0.000057386864],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00071888254,0.0003352883,0.00036450173,0.00010589601,0.0002693156,0.000025091207,0.000981784,0.0002813462,0.0017068173],"category_scores_gemma":[0.00006189286,0.00026630785,0.00017048349,0.00037571683,0.00040256765,0.0000058047417,0.00012338652,0.0003510201,0.00015196958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023137989,0.00021098733,0.00007266362,0.000006824792,0.00028746095,0.0000025401832,0.00030226255,0.00007120671,0.9689477,0.000029630713,0.0017969231,0.005133802],"study_design_scores_gemma":[0.0018774561,0.009700774,0.0010625983,0.00003807847,0.0000065197046,0.00000241656,0.000093616,0.0000033607212,0.9477927,0.000038702634,0.039096955,0.000286819],"about_ca_topic_score_codex":0.00015365353,"about_ca_topic_score_gemma":0.000043744512,"teacher_disagreement_score":0.039321184,"about_ca_system_score_codex":0.00012542578,"about_ca_system_score_gemma":0.00012301085,"threshold_uncertainty_score":0.9999789},"labels":[],"label_agreement":null},{"id":"W2167778723","doi":"10.1007/s00262-010-0948-4","title":"Adenoviral-transduced dendritic cells are susceptible to suppression by T regulatory cells and promote interleukin 17 production","year":2010,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McMaster University; Ontario Institute for Cancer Research; Vancouver Coastal Health Research Institute; Vancouver Coastal Health; McMaster University Medical Centre; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Immunology; Context (archaeology); Dendritic cell; Immune system; Cancer research; Biology","score_opus":0.007425037414359705,"score_gpt":0.24427050321278648,"score_spread":0.23684546579842677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167778723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93668664,0.050755337,0.0001010283,0.0019874813,0.008711731,0.0012420338,0.00016575622,0.00029370893,0.000056306846],"genre_scores_gemma":[0.9722302,0.0077966317,0.00020006356,0.0011757192,0.0001197268,0.00047537836,0.00009270568,0.00017345931,0.017736146],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961564,0.0005866335,0.0008512414,0.0011405956,0.000104201536,0.0011609449],"domain_scores_gemma":[0.9977882,0.00016757606,0.00039991806,0.0013553298,0.00022130265,0.0000676901],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006026062,0.0007764881,0.00093411497,0.00045022782,0.0007329665,0.00009609147,0.0008651673,0.001006249,0.0024685976],"category_scores_gemma":[0.00005056056,0.00071519474,0.00022559612,0.0004139957,0.0010903665,0.00043050072,0.00014767313,0.0015712217,0.00030446623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030934222,0.00031138305,0.00029635095,0.000034967867,0.0006311938,0.00000444707,0.0025971262,0.0000038372427,0.93828887,0.000024850857,0.02064964,0.034063928],"study_design_scores_gemma":[0.0023805387,0.0006827928,0.0036139714,0.00015829688,0.000036341695,0.000113160015,0.00043087406,7.4646886e-7,0.73583734,0.00004004025,0.25609583,0.0006101025],"about_ca_topic_score_codex":0.00025239887,"about_ca_topic_score_gemma":0.00009201041,"teacher_disagreement_score":0.23544617,"about_ca_system_score_codex":0.00015032977,"about_ca_system_score_gemma":0.00019304945,"threshold_uncertainty_score":0.9995299},"labels":[],"label_agreement":null},{"id":"W2168311042","doi":"10.1007/s00262-011-1055-x","title":"Polyfunctionality of a DKK1 self-antigen-specific CD8+ T lymphocyte clone in lung cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Notre-Dame","funders":"Canadian Institutes of Health Research; Institut Du Cancer de Montréal","keywords":"Lung cancer; clone (Java method); Immunology; Antigen; CD8; Medicine; Virology; Biology; Gene; Oncology; Genetics","score_opus":0.02398129105500327,"score_gpt":0.27180652214474776,"score_spread":0.2478252310897445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168311042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57524854,0.42050192,0.00012364372,0.00014462053,0.0026743934,0.000522888,0.00007352645,0.00015214585,0.0005583166],"genre_scores_gemma":[0.75144124,0.24568722,0.0002115856,0.00044538913,0.000050127954,0.0006171096,0.00004948454,0.000110286106,0.0013875884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99553776,0.00091742806,0.0014277922,0.0008242577,0.0001224273,0.0011703618],"domain_scores_gemma":[0.99750596,0.0002501445,0.00070833275,0.0012244062,0.00028193282,0.000029222405],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00072002586,0.00069588376,0.00123808,0.00068165374,0.00032597,0.000017729053,0.0010674237,0.0008765848,0.012313926],"category_scores_gemma":[0.000022738934,0.0006688883,0.0004354197,0.0008824253,0.0010618847,0.00036168765,0.00013779037,0.0008250571,0.0001561243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012276146,0.00099011,0.04238455,0.000041553147,0.0032153183,0.00001282096,0.0065740016,0.000007368653,0.8901167,0.0014643349,0.0006946467,0.04222247],"study_design_scores_gemma":[0.010518025,0.00045692147,0.32096866,0.00023436527,0.00004828717,0.00009030266,0.00045566895,0.0000049473974,0.53213054,0.00019565928,0.13411155,0.00078507804],"about_ca_topic_score_codex":0.0061435155,"about_ca_topic_score_gemma":0.000111362504,"teacher_disagreement_score":0.35798615,"about_ca_system_score_codex":0.0006780985,"about_ca_system_score_gemma":0.00080267095,"threshold_uncertainty_score":0.9995762},"labels":[],"label_agreement":null},{"id":"W2234024195","doi":"10.1007/s00262-015-1785-2","title":"8th Annual Canadian Cancer Immunotherapy Consortium (CCIC) Symposium 2015—May 20–22, Vancouver, Canada","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Cancer immunotherapy; Cancer; Immunotherapy; Library science; Medicine; Internal medicine; Computer science","score_opus":0.009294974100002554,"score_gpt":0.2674305215908344,"score_spread":0.25813554749083184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2234024195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42204428,0.39052698,0.00039240578,0.11619096,0.04788168,0.0057296976,0.006413855,0.0014899111,0.00933023],"genre_scores_gemma":[0.7149323,0.1830105,0.00022850398,0.029086627,0.0013083317,0.0019917178,0.00012438967,0.0008033705,0.06851425],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936076,0.0003056709,0.0014790047,0.0013980784,0.00076285587,0.0024468238],"domain_scores_gemma":[0.9956387,0.00026859046,0.0006899001,0.002001013,0.0008280385,0.00057370187],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052717864,0.0012124114,0.0015890963,0.00063855504,0.0005996,0.00006987892,0.0011160207,0.0008275993,0.009460021],"category_scores_gemma":[0.00003884998,0.0009249245,0.00057641073,0.00089179346,0.0011701011,0.0004935925,0.000079261066,0.00082687725,0.00006292167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.009263131,0.0002023022,0.017789384,0.000049196133,0.0051997635,0.00016203614,0.00056966796,0.0000090192525,0.46211123,0.000101704594,0.3650274,0.13951516],"study_design_scores_gemma":[0.015936866,0.00066627003,0.021857316,0.0005172519,0.00017109266,0.00016218964,0.00037093644,0.000005485104,0.04602073,0.000067946086,0.91294265,0.0012812505],"about_ca_topic_score_codex":0.94758916,"about_ca_topic_score_gemma":0.9801768,"teacher_disagreement_score":0.5479153,"about_ca_system_score_codex":0.0060136,"about_ca_system_score_gemma":0.017526714,"threshold_uncertainty_score":0.99932015},"labels":[],"label_agreement":null},{"id":"W2239178350","doi":"10.1007/s00262-015-1789-y","title":"Poly(I:C) potentiates Bacillus Calmette–Guérin immunotherapy for bladder cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Bladder cancer; Immunotherapy; Cancer research; Immunogenicity; TLR2; TLR3; Cytotoxic T cell; Cancer; Adjuvant; Immune system; Medicine; Immunology; Toll-like receptor; In vitro; Chemistry; Innate immune system; Internal medicine","score_opus":0.02437876967905506,"score_gpt":0.31402596941648786,"score_spread":0.2896471997374328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2239178350","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37313533,0.5742315,0.00944677,0.030867528,0.0055028554,0.0037998296,0.0012339272,0.00070307316,0.0010791671],"genre_scores_gemma":[0.7910373,0.14573455,0.0019785895,0.015404064,0.0014702874,0.007895888,0.00010728228,0.0006410108,0.03573101],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966086,0.00011526619,0.00076901674,0.0009442943,0.00033173198,0.0012310923],"domain_scores_gemma":[0.9977895,0.00020118507,0.00032085486,0.0011252274,0.00040979785,0.00015345933],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021282565,0.000742228,0.0010791644,0.0003112749,0.00036885336,0.00004762968,0.0004934762,0.00048492564,0.00677829],"category_scores_gemma":[0.000029768478,0.00050262036,0.000616539,0.0003655583,0.0005919792,0.00027146778,0.000055837943,0.0003033033,0.00013709435],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005396856,0.00030772883,0.010415704,0.00003122714,0.0046579754,0.000014913044,0.00033380982,7.892266e-7,0.42337766,0.00021343683,0.003081437,0.5521684],"study_design_scores_gemma":[0.05068064,0.0029566616,0.09469345,0.00057612656,0.0005545985,0.0001669751,0.00015794944,0.000012752501,0.30662543,0.0011540235,0.54106176,0.0013596173],"about_ca_topic_score_codex":0.002016937,"about_ca_topic_score_gemma":0.00013764594,"teacher_disagreement_score":0.55080885,"about_ca_system_score_codex":0.0008183914,"about_ca_system_score_gemma":0.00079319126,"threshold_uncertainty_score":0.99974257},"labels":[],"label_agreement":null},{"id":"W2510568091","doi":"10.1007/s00262-016-1877-7","title":"Identification of a naturally processed HLA-A*02:01-restricted CTL epitope from the human tumor-associated antigen Nectin-4","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ligue Contre le Cancer; Institut National de la Santé et de la Recherche Médicale; CNIB","keywords":"Epitope; Human leukocyte antigen; Biology; Cytotoxic T cell; Antigen; Nectin; clone (Java method); Cancer immunotherapy; CD8; Immunology; Immunotherapy; Molecular biology; Cancer research; Cell; Immune system; Gene; Genetics; Cell adhesion; In vitro","score_opus":0.012238896327042992,"score_gpt":0.2622221440142092,"score_spread":0.24998324768716618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510568091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95424235,0.036776163,0.00024163413,0.0018450153,0.005890154,0.0005828485,0.00007025806,0.0002098978,0.00014170984],"genre_scores_gemma":[0.9879175,0.005467294,0.000005019664,0.0006804823,0.000072260234,0.00019645035,0.00020432877,0.000060370727,0.0053963223],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970769,0.0006528274,0.0010772588,0.00055210106,0.00009766389,0.00054321013],"domain_scores_gemma":[0.9968717,0.0005378882,0.0012081723,0.00087047415,0.0004966634,0.000015094081],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003462074,0.0003891023,0.000571823,0.00018331366,0.0006004964,0.00004730934,0.0008977276,0.00047245927,0.0036176904],"category_scores_gemma":[0.00028535572,0.00024776394,0.00025382286,0.00048062333,0.000658199,0.00041569595,0.00008238232,0.00059172866,0.00036217656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008681522,0.0002140129,0.0069258087,0.000004510177,0.0015091854,0.0000012773204,0.0007664851,0.0000013078006,0.9688345,0.0001600046,0.0046816766,0.01603304],"study_design_scores_gemma":[0.0040709735,0.00025034524,0.23492922,0.00013525838,0.000051262705,0.000013394889,0.00036779093,0.0000014779031,0.71873957,0.00023145725,0.040911812,0.00029742593],"about_ca_topic_score_codex":0.0018574775,"about_ca_topic_score_gemma":0.00012534225,"teacher_disagreement_score":0.25009495,"about_ca_system_score_codex":0.00027221814,"about_ca_system_score_gemma":0.0002168618,"threshold_uncertainty_score":0.99999744},"labels":[],"label_agreement":null},{"id":"W2524109460","doi":"10.1007/s00262-016-1906-6","title":"Anti-PD-1 inhibits Foxp3+ Treg cell conversion and unleashes intratumoural effector T cells thereby enhancing the efficacy of a cancer vaccine in a mouse model","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Science Foundation Ireland","keywords":"FOXP3; Cytotoxic T cell; CD8; Cancer research; Immunology; Effector; Biology; Adjuvant; T cell; Antigen; Blocking antibody; Cytokine; Immune system; In vitro","score_opus":0.009830295630320715,"score_gpt":0.26167196302427037,"score_spread":0.25184166739394964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524109460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9262459,0.069187775,0.00018199252,0.002620082,0.00046777047,0.0011103847,0.00007801363,0.00006165606,0.00004641672],"genre_scores_gemma":[0.9292288,0.06817732,0.00007799824,0.0008320941,0.00008288281,0.00020147701,0.000004573157,0.000083270825,0.0013116192],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997526,0.00022593274,0.00080132874,0.00057251396,0.00023325243,0.0006410029],"domain_scores_gemma":[0.99838567,0.00038917174,0.00042921997,0.000589269,0.00014039881,0.00006624848],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045266442,0.0004807884,0.0009487394,0.00027694993,0.00014693549,0.000022448517,0.00034834276,0.00032097683,0.00033908742],"category_scores_gemma":[0.000026387777,0.00028060123,0.000240745,0.0004242408,0.00052820443,0.00018337712,0.00007947665,0.00040353835,0.000007554587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011236581,0.000247174,0.0104744695,0.00010641173,0.00055277324,0.00000475421,0.0015554879,0.000022481066,0.9455037,0.000015503756,0.0003434161,0.029937247],"study_design_scores_gemma":[0.022260902,0.00059115246,0.04328091,0.00069729233,0.00009423036,0.000012886237,0.00024990155,0.00014896544,0.93129796,0.000029577706,0.0009825672,0.0003536689],"about_ca_topic_score_codex":0.0015852189,"about_ca_topic_score_gemma":0.00030384416,"teacher_disagreement_score":0.03280644,"about_ca_system_score_codex":0.00041606076,"about_ca_system_score_gemma":0.0004540472,"threshold_uncertainty_score":0.9999646},"labels":[],"label_agreement":null},{"id":"W2569695288","doi":"10.1007/s00262-016-1950-2","title":"Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Canadian Cancer Society","keywords":"T cell; Immune system; Cancer research; CD8; Immunotherapy; Immunology; Immunity; Cytotoxic T cell; Cancer immunotherapy; Cancer; Biology; Medicine; Internal medicine; In vitro","score_opus":0.016891490023701924,"score_gpt":0.2921629740460029,"score_spread":0.27527148402230095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569695288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92829335,0.06967123,0.000039336628,0.00039199425,0.00031321004,0.0009487083,0.00004682387,0.000040902498,0.00025442487],"genre_scores_gemma":[0.94888765,0.049609706,0.00014879237,0.00035868137,0.00002736263,0.00022111116,0.000008699851,0.000064211934,0.0006737853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980429,0.00013265637,0.00056187855,0.00056233193,0.00018533334,0.0005149138],"domain_scores_gemma":[0.9978539,0.0001874209,0.0005363534,0.0012622079,0.000086947635,0.000073212046],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025000903,0.00049472507,0.0009821195,0.00031949807,0.00042734275,0.000049099577,0.0003176112,0.00018873574,0.00003881394],"category_scores_gemma":[0.00006621415,0.00037783018,0.0001506002,0.00012741954,0.0010548682,0.0001612006,0.00008869801,0.0003505781,0.0000022855534],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071622375,0.00079788413,0.014232701,0.00025202276,0.00025068605,0.00005713273,0.0009754928,0.000012145807,0.95444167,0.00006390748,0.000017854252,0.02173624],"study_design_scores_gemma":[0.02387958,0.0033877578,0.2512073,0.0010435731,0.00011102775,0.00004211691,0.00019675857,0.00051202875,0.7186666,0.00006643126,0.00040981936,0.00047701833],"about_ca_topic_score_codex":0.0029015304,"about_ca_topic_score_gemma":0.00009779319,"teacher_disagreement_score":0.23697458,"about_ca_system_score_codex":0.00034320707,"about_ca_system_score_gemma":0.00024900876,"threshold_uncertainty_score":0.9998674},"labels":[],"label_agreement":null},{"id":"W2593397963","doi":"10.1007/s00262-017-1977-z","title":"Myeloid cells in circulation and tumor microenvironment of breast cancer patients","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"United Arab Emirates University; Terry Fox Foundation","keywords":"Tumor microenvironment; Myeloid-derived Suppressor Cell; Myeloid; Breast cancer; Immune system; Cancer research; Cancer; Medicine; Immunology; Biology; Suppressor; Internal medicine","score_opus":0.007806617644043184,"score_gpt":0.23955849471584395,"score_spread":0.23175187707180075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593397963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93881977,0.05706964,0.000009143937,0.0004505171,0.002725879,0.0005166547,0.00023386072,0.000024615127,0.0001499358],"genre_scores_gemma":[0.9781403,0.020716028,0.000032062806,0.00028000103,0.000027158852,0.00022981307,0.000026102181,0.000057097513,0.0004914648],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980045,0.00017282968,0.00064653036,0.00053413445,0.00006307108,0.0005789377],"domain_scores_gemma":[0.99809045,0.000064593616,0.0007715621,0.00096067507,0.00009634012,0.000016368178],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021242641,0.00036358376,0.0006356144,0.00019037048,0.00037745287,0.000029629706,0.0007109774,0.00033504367,0.0015530875],"category_scores_gemma":[0.000012934753,0.00036129524,0.000109012384,0.000075938595,0.0013965641,0.000263472,0.00021547159,0.00046241735,0.000052194704],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000645324,0.00019968976,0.22865415,0.000028019049,0.0003411883,0.0000017180139,0.0005737127,0.00002200983,0.73471665,0.000032383326,0.00014759904,0.034637574],"study_design_scores_gemma":[0.004960804,0.00008726525,0.74390185,0.00014840235,0.000026977586,0.000012745847,0.00006408281,0.0000025731692,0.24373086,0.000053376465,0.0067279064,0.00028313143],"about_ca_topic_score_codex":0.0029769258,"about_ca_topic_score_gemma":0.00014813413,"teacher_disagreement_score":0.51524776,"about_ca_system_score_codex":0.00035904683,"about_ca_system_score_gemma":0.00012937753,"threshold_uncertainty_score":0.9998839},"labels":[],"label_agreement":null},{"id":"W2606571211","doi":"10.1007/s00262-017-1996-9","title":"The Summit for Cancer Immunotherapy (Summit4CI), June 26–29, 2016 Halifax, Canada","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; BC Cancer Agency; Princess Margaret Cancer Centre; University of Guelph; Institute for Research in Immunology and Cancer; University of Alberta; Université de Montréal; Dalhousie University; University Health Network; University of Toronto","funders":"","keywords":"Summit; Immunotherapy; Cancer immunotherapy; Cancer; Medicine; Oncology; Geography; Internal medicine; Cartography","score_opus":0.021655016890104642,"score_gpt":0.30991624940816614,"score_spread":0.2882612325180615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606571211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20421389,0.6535881,0.0004488478,0.10939339,0.024197388,0.005186524,0.00076464243,0.00073399144,0.0014732089],"genre_scores_gemma":[0.31628042,0.5769972,0.0004947795,0.01657322,0.0024528494,0.007724589,0.00011534669,0.0011334304,0.07822814],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952141,0.00017001132,0.0012475991,0.0010290626,0.0005986284,0.001740586],"domain_scores_gemma":[0.9939118,0.0004993288,0.0012246243,0.003512099,0.0006759674,0.00017619962],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0008810095,0.0009291854,0.0012784642,0.00015354458,0.003560936,0.00041253577,0.0021673152,0.00054017367,0.0007715031],"category_scores_gemma":[0.00013476193,0.000674601,0.0007648937,0.00024020506,0.001769859,0.00036121462,0.00013451942,0.0008245375,0.00002142259],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027582483,0.000220971,0.013684483,0.00008577367,0.008208374,0.00003437538,0.00040464272,0.0000071112026,0.1973598,0.00042453888,0.2012982,0.5506892],"study_design_scores_gemma":[0.014026227,0.00052351237,0.04665396,0.00034673733,0.0001585672,0.000033914523,0.0003179618,0.000031620748,0.030714571,0.00022993224,0.90615743,0.00080555445],"about_ca_topic_score_codex":0.42241493,"about_ca_topic_score_gemma":0.56716454,"teacher_disagreement_score":0.7048592,"about_ca_system_score_codex":0.0017993742,"about_ca_system_score_gemma":0.005238325,"threshold_uncertainty_score":0.99957055},"labels":[],"label_agreement":null},{"id":"W2613281651","doi":"10.1007/s00262-017-2013-z","title":"Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Health and Medical Research Council","keywords":"Immunotoxin; Saporin; Glioma; Monoclonal antibody; Chemistry; Pseudomonas exotoxin; Antibody; Molecular biology; Cell culture; In vitro; Cancer research; Cytotoxicity; Biology; Biochemistry; Immunology","score_opus":0.018064003743128602,"score_gpt":0.2801290360353377,"score_spread":0.26206503229220907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613281651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765654,0.015960097,0.0003204804,0.00085327064,0.0042585074,0.0011169723,0.00071370986,0.00017811978,0.000033446693],"genre_scores_gemma":[0.9911167,0.005532764,0.0011850116,0.00019775778,0.000115803356,0.00045825492,0.00065699714,0.00019815649,0.0005385258],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9947812,0.00089480204,0.0012131002,0.0014439223,0.00015303219,0.0015139355],"domain_scores_gemma":[0.99606055,0.0003113927,0.0012875916,0.0020939563,0.0001687418,0.000077766475],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035677024,0.001062571,0.0018171235,0.0006641662,0.0008341721,0.0002490294,0.0021068298,0.0012226675,0.0024853707],"category_scores_gemma":[0.00008699268,0.00082119287,0.00021982925,0.00035357403,0.001216488,0.00060561206,0.00025680612,0.0015198409,0.00018140541],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0428234,0.0012355108,0.002939966,0.000020378473,0.0009247786,0.00019999241,0.0016748264,0.000024742216,0.93733317,0.000040360555,0.000036103247,0.0127468],"study_design_scores_gemma":[0.0294717,0.0022293392,0.21724467,0.00022643704,0.000059077425,0.00001712663,0.0010676766,0.000024739296,0.74694896,0.00005039345,0.0017176501,0.0009422553],"about_ca_topic_score_codex":0.009667775,"about_ca_topic_score_gemma":0.0034179576,"teacher_disagreement_score":0.2143047,"about_ca_system_score_codex":0.00040472118,"about_ca_system_score_gemma":0.0004692859,"threshold_uncertainty_score":0.99942386},"labels":[],"label_agreement":null},{"id":"W2613957521","doi":"10.1007/s00262-017-2009-8","title":"Cancer immunotherapy without frontiers: 2nd Annual Immuno-Oncology Meeting of the Centro de Investigación de Cancer en Sonora (CICS), Ciudad Obregón, Sonora México, Dec 2–4, 2016","year":2017,"lang":"es","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; National Cancer Institute; National Institutes of Health; Augusta University; Moffitt Cancer Center; Georgia Research Alliance","keywords":"Cancer; Medicine; Immunotherapy; Oncology; Internal medicine","score_opus":0.016149254965996056,"score_gpt":0.3240649541124184,"score_spread":0.30791569914642236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613957521","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.538271,0.43055266,0.00033174054,0.016077723,0.010351847,0.002305998,0.0013001915,0.00024367866,0.0005651354],"genre_scores_gemma":[0.45069215,0.53161305,0.0012288175,0.0063302233,0.0023382264,0.001979443,0.000044782762,0.0007931647,0.0049801567],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9873727,0.0024717038,0.0031619584,0.0020620879,0.0010204255,0.0039111297],"domain_scores_gemma":[0.98676664,0.0006426485,0.0055744834,0.0053812847,0.0011898603,0.00044507897],"candidate_categories":["metaepi_narrow","sts","open_science","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","sts","research_integrity"],"category_scores_codex":[0.0032364521,0.0022778893,0.0039093904,0.0006811399,0.0025583964,0.0005653599,0.0058568376,0.0027728793,0.002171089],"category_scores_gemma":[0.0004557392,0.0019106084,0.0019034374,0.0008092752,0.007486152,0.0011015866,0.00081751216,0.0027203371,0.000019782095],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.017482521,0.00060175336,0.2788182,0.00030709864,0.012468905,0.000036201378,0.010339971,0.00010222373,0.43737143,0.00016184173,0.013381943,0.22892793],"study_design_scores_gemma":[0.026460098,0.0013512371,0.31523392,0.005497928,0.0012850334,0.00017238877,0.004469989,0.00027382254,0.12005307,0.00039478653,0.52276725,0.0020404945],"about_ca_topic_score_codex":0.07465032,"about_ca_topic_score_gemma":0.0035069315,"teacher_disagreement_score":0.5093853,"about_ca_system_score_codex":0.0084389625,"about_ca_system_score_gemma":0.015765117,"threshold_uncertainty_score":0.99958044},"labels":[],"label_agreement":null},{"id":"W2618639283","doi":"10.1007/s00262-017-2022-y","title":"In vitro differentiated plasmacytoid dendritic cells as a tool to induce anti-leukemia activity of natural killer cells","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; CHU Sainte-Justine Foundation; Fondation Charles-Bruneau","keywords":"Plasmacytoid dendritic cell; Immunology; Progenitor cell; Adoptive cell transfer; Cord blood; Dendritic cell; Biology; Cell biology; Cancer research; Immune system; T cell; Stem cell","score_opus":0.01204124404371414,"score_gpt":0.271988107185373,"score_spread":0.2599468631416588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618639283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9623371,0.0045625316,0.00004356695,0.00046650146,0.031542573,0.0006155094,0.00001663697,0.00006988924,0.0003456874],"genre_scores_gemma":[0.9792129,0.002191694,0.000034662564,0.000739077,0.00004509734,0.00016437026,0.000034997825,0.000064820066,0.017512372],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974649,0.0003339758,0.0006872776,0.0006443026,0.0000830017,0.0007865561],"domain_scores_gemma":[0.9977504,0.00015265807,0.0006083044,0.0012637655,0.00019865412,0.00002621687],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002161967,0.0004945057,0.00090482074,0.00043925183,0.0005082269,0.00007135319,0.0009904742,0.00062301964,0.003050694],"category_scores_gemma":[0.00008072673,0.00048065907,0.00026490676,0.00019369932,0.00051378197,0.0005556245,0.00022274576,0.0011729383,0.0009266639],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005453251,0.0002682296,0.00028086905,0.000018989638,0.0006526541,0.000010370904,0.00070501276,0.000014555364,0.9741459,0.00003188357,0.0028021268,0.015616158],"study_design_scores_gemma":[0.0052861404,0.00027846755,0.03142167,0.0001026728,0.000028122491,0.00004441611,0.00012247202,0.000011397681,0.9224809,0.00002089922,0.039731465,0.0004714217],"about_ca_topic_score_codex":0.0032661788,"about_ca_topic_score_gemma":0.000066203436,"teacher_disagreement_score":0.051665045,"about_ca_system_score_codex":0.00054799946,"about_ca_system_score_gemma":0.00029131895,"threshold_uncertainty_score":0.9998512},"labels":[],"label_agreement":null},{"id":"W2743368247","doi":"10.1007/s00262-017-2050-7","title":"Mucosa-associated invariant T cells infiltrate hepatic metastases in patients with colorectal carcinoma but are rendered dysfunctional within and adjacent to tumor microenvironment","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Metastasis; FOLFOX; Medicine; Cancer research; Tumor microenvironment; T-cell receptor; CD3; Immune system; Pathology; Colorectal cancer; T cell; Immunology; CD8; Internal medicine; Cancer; Oxaliplatin","score_opus":0.010384367648902718,"score_gpt":0.21415733157229988,"score_spread":0.20377296392339717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743368247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910797,0.0037929565,0.000028900035,0.0005039019,0.003479009,0.0008745166,0.00013160842,0.000051361556,0.000058068945],"genre_scores_gemma":[0.996657,0.00045369632,0.000049156046,0.0008569317,0.000016628177,0.00030307405,0.00020388784,0.00005689416,0.0014026881],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99765223,0.0003911848,0.0006126112,0.00064839656,0.000092034155,0.00060356216],"domain_scores_gemma":[0.9982911,0.00008932723,0.0007950551,0.0006511859,0.0001320892,0.000041254283],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027121828,0.0004642305,0.00065899256,0.00026085164,0.00071959506,0.00009463293,0.00039421057,0.00025506626,0.0011587151],"category_scores_gemma":[0.00007243413,0.00040403407,0.00009012181,0.00011244692,0.0005177288,0.00032165044,0.00014400964,0.0006066412,0.0001490556],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00922303,0.00072365114,0.39496553,0.000014196521,0.0012008487,0.000015589672,0.0008588496,0.000062608604,0.59044677,0.000033856693,0.0010985114,0.0013565662],"study_design_scores_gemma":[0.00980771,0.0012779849,0.83561224,0.00012600045,0.000055406115,0.000021414802,0.00039340093,0.000007053838,0.14858004,0.000008863257,0.0036871198,0.0004227417],"about_ca_topic_score_codex":0.0021049571,"about_ca_topic_score_gemma":0.00073576387,"teacher_disagreement_score":0.44186673,"about_ca_system_score_codex":0.0005573554,"about_ca_system_score_gemma":0.0001493453,"threshold_uncertainty_score":0.99984115},"labels":[],"label_agreement":null},{"id":"W2766789916","doi":"10.1007/s00262-017-2070-3","title":"Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"University of British Columbia; Canadian Institutes of Health Research; Leukemia and Lymphoma Society of Canada; European Hematology Association","keywords":"Immune system; Precursor cell; Lymphoblastic Leukemia; Lymphocyte; Immunology; Leukemia; Cell; Biology; Medicine; Genetics","score_opus":0.014368648762514332,"score_gpt":0.2812484459597366,"score_spread":0.26687979719722227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766789916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97611356,0.014622921,0.000091326525,0.00010386608,0.0010884785,0.0009643024,0.000074752985,0.00005312587,0.0068876953],"genre_scores_gemma":[0.97219545,0.01672639,0.00016274222,0.000065064436,0.000111742316,0.00025526911,0.00006997401,0.00010335115,0.01031001],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975498,0.00009516337,0.0006537233,0.0005464345,0.00043685062,0.00071802735],"domain_scores_gemma":[0.9975612,0.00012958277,0.0007616022,0.001251732,0.00020300926,0.00009288334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022653122,0.0004193751,0.0008188632,0.0003155525,0.00029897154,0.00003645679,0.00063602434,0.00035584514,0.00085283635],"category_scores_gemma":[0.000025192081,0.000355373,0.00013609508,0.00025954677,0.0008127012,0.00019784267,0.00019369018,0.00043153483,0.00033720414],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06914889,0.0025670598,0.25465047,0.0013719888,0.004951796,0.0012171244,0.004074698,0.0005276413,0.5836341,0.000094572766,0.007256131,0.070505574],"study_design_scores_gemma":[0.039774958,0.0014440755,0.89148283,0.000314115,0.00047215947,0.00029251855,0.000050900486,0.0008335988,0.056062892,0.000028814584,0.00863355,0.0006095794],"about_ca_topic_score_codex":0.00074166345,"about_ca_topic_score_gemma":0.000049363818,"teacher_disagreement_score":0.63683236,"about_ca_system_score_codex":0.0047826027,"about_ca_system_score_gemma":0.0022257604,"threshold_uncertainty_score":0.99988985},"labels":[],"label_agreement":null},{"id":"W2767608780","doi":"10.1007/s00262-017-2088-6","title":"Prophylactic DNA vaccine targeting Foxp3+ regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Isfahan University of Medical Sciences; Iran National Science Foundation","keywords":"FOXP3; Immune system; Tumor microenvironment; Immunology; Regulatory T cell; Immunotherapy; Myeloid-derived Suppressor Cell; Cancer research; Melanoma; Population; Biology; T cell; Medicine; IL-2 receptor; Suppressor; Cancer","score_opus":0.01189419720479676,"score_gpt":0.2530133189182112,"score_spread":0.24111912171341446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767608780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8550968,0.13910776,0.00005193949,0.00086528936,0.0033199827,0.001147788,0.000106174164,0.00017830709,0.00012592226],"genre_scores_gemma":[0.97688377,0.017255493,0.0005391423,0.0003941495,0.00009065202,0.000553568,0.000048875776,0.00022468933,0.0040096585],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9947494,0.0006615019,0.0014234504,0.0013910824,0.00012766883,0.0016468789],"domain_scores_gemma":[0.99539626,0.00041798572,0.0013065619,0.002584515,0.00024254738,0.000052148862],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0009684275,0.0010089616,0.00160589,0.00051211816,0.0013917538,0.00018798189,0.001857035,0.0010682578,0.0006124847],"category_scores_gemma":[0.00018137727,0.0009762715,0.00029133074,0.00018737646,0.0017156338,0.00073896616,0.0007339401,0.0014713256,0.000109297536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044912244,0.0002557669,0.0026091882,0.00012867656,0.0007778634,0.000034486908,0.0015546206,0.000101672464,0.97855276,0.000058855137,0.00032511156,0.011109767],"study_design_scores_gemma":[0.009817199,0.0004609993,0.08139772,0.00016790038,0.00008704715,0.00005609791,0.00030023768,0.0001473372,0.9013104,0.00021058357,0.0050472016,0.0009972781],"about_ca_topic_score_codex":0.0012556834,"about_ca_topic_score_gemma":0.00008285731,"teacher_disagreement_score":0.12185227,"about_ca_system_score_codex":0.00038988295,"about_ca_system_score_gemma":0.00050484465,"threshold_uncertainty_score":0.9999083},"labels":[],"label_agreement":null},{"id":"W2782401996","doi":"10.1007/s00262-017-2112-x","title":"Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cells","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research","keywords":"Ovarian cancer; Cytotoxic T cell; Ascites; Cancer research; Ex vivo; Medicine; Interleukin 21; Immunotherapy; Interleukin 12; Lymphokine-activated killer cell; Immunology; Cancer; Immune system; Biology; In vivo; Internal medicine; T cell; In vitro","score_opus":0.008768739890157445,"score_gpt":0.2335281708471058,"score_spread":0.22475943095694836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782401996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9257768,0.05689281,0.00007866906,0.00035961848,0.014886494,0.0007711412,0.00048098512,0.00018250645,0.0005709824],"genre_scores_gemma":[0.9459732,0.043648537,0.00011597957,0.0031615149,0.00026990692,0.00039627377,0.00026590537,0.00013917401,0.0060294634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99641436,0.0005051351,0.001068256,0.0009867128,0.000120187506,0.0009053698],"domain_scores_gemma":[0.9971774,0.00022508996,0.0011207433,0.00087378966,0.00055166683,0.000051310446],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020679925,0.00072049705,0.0011685335,0.00037278037,0.0005343627,0.000052799533,0.0006415881,0.0009925023,0.009509109],"category_scores_gemma":[0.000025402443,0.0006804323,0.0002632398,0.00037475803,0.0014034099,0.00044297005,0.000188868,0.0008295284,0.00017760032],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00269908,0.00057096896,0.01505088,0.00004168543,0.0030656932,0.0000036311578,0.001674368,0.00000632805,0.9515017,0.000020943726,0.005033023,0.02033165],"study_design_scores_gemma":[0.008842842,0.0006796995,0.08383433,0.00030173635,0.00018995142,0.000008489192,0.0002658652,0.000007378574,0.8385329,0.00003816803,0.06666475,0.00063387014],"about_ca_topic_score_codex":0.0063732592,"about_ca_topic_score_gemma":0.00035250853,"teacher_disagreement_score":0.112968825,"about_ca_system_score_codex":0.00034566803,"about_ca_system_score_gemma":0.00036445475,"threshold_uncertainty_score":0.9995647},"labels":[],"label_agreement":null},{"id":"W2792466245","doi":"10.1007/s00262-018-2132-1","title":"Mucosa-associated invariant T cells in malignancies: a faithful friend or formidable foe?","year":2018,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"Invariant (physics); Biology; Medicine; Immunology; Mathematics; Mathematical physics","score_opus":0.03965931903474021,"score_gpt":0.3080847991816112,"score_spread":0.26842548014687095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792466245","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037900524,0.97784317,0.000058945294,0.00006140613,0.018054264,0.0020008276,0.00016751283,0.0002710578,0.0011637864],"genre_scores_gemma":[0.00009139785,0.94368356,0.000024160187,0.00048349914,0.00011732704,0.001785922,0.0007774505,0.00024517137,0.052791517],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.993282,0.0013700549,0.002261185,0.0013251178,0.00010642607,0.0016551871],"domain_scores_gemma":[0.9960572,0.00056305854,0.0016476661,0.001398468,0.00029490894,0.000038658498],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.00069962174,0.0013776254,0.0036502052,0.0010891545,0.00050263316,0.00010231016,0.0013778922,0.0029829103,0.019360576],"category_scores_gemma":[0.00016121505,0.0010814556,0.0009808216,0.0012819796,0.0007728397,0.00043495567,0.00025358202,0.0022414436,0.004159979],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041889036,0.0017658297,0.000022226965,0.0027352646,0.012342266,0.0001208953,0.0034860715,0.0000024705175,0.040983748,0.0002947598,0.11392856,0.820129],"study_design_scores_gemma":[0.0039767832,0.00089800707,0.000025499643,0.007282235,0.0003157328,0.00023351649,0.00037212772,0.0000013891923,0.0033967383,0.000031222415,0.9822973,0.0011694679],"about_ca_topic_score_codex":0.0014500859,"about_ca_topic_score_gemma":0.00065085886,"teacher_disagreement_score":0.86836874,"about_ca_system_score_codex":0.0017491796,"about_ca_system_score_gemma":0.0016737155,"threshold_uncertainty_score":0.9998974},"labels":[],"label_agreement":null},{"id":"W2888614982","doi":"10.1007/s00262-018-2231-z","title":"PD-1/PD-L1 co-inhibition shapes anticancer T cell immunodominance: facing the consequences of an immunological ménage à trois","year":2018,"lang":"fr","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Immunodominance; Virology; Biology; Immune system; Immunology; T cell","score_opus":0.025520738549925176,"score_gpt":0.3199907870929124,"score_spread":0.2944700485429872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888614982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5686856,0.41563603,0.0004393684,0.0051024696,0.0059426515,0.0014714049,0.0005104957,0.00015763596,0.0020543395],"genre_scores_gemma":[0.7722857,0.21550596,0.0005876972,0.0038773245,0.0015877549,0.0004573551,0.00011771378,0.0002104987,0.0053699915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9910197,0.0016336716,0.0025356396,0.0015770728,0.0008456205,0.0023882783],"domain_scores_gemma":[0.9939516,0.00076489314,0.0018016434,0.0021579876,0.0011442074,0.00017962763],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","sts"],"category_scores_codex":[0.0022007027,0.0014249576,0.002201739,0.00048480296,0.0014069367,0.00019591949,0.0016407437,0.0014931641,0.013859473],"category_scores_gemma":[0.00014696173,0.0011166466,0.0010076785,0.0014341846,0.016363975,0.00092576485,0.00019884117,0.0017998058,0.0003619168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020197092,0.0009278371,0.00092833274,0.00022374924,0.002520509,0.00007343627,0.0053110505,0.000013023542,0.8007598,0.00064509007,0.0016204616,0.1667796],"study_design_scores_gemma":[0.014308422,0.0073299184,0.033990726,0.0020561672,0.00058648735,0.00054616545,0.0059115617,0.00016616413,0.7882377,0.00059338636,0.14491418,0.0013591269],"about_ca_topic_score_codex":0.0076664393,"about_ca_topic_score_gemma":0.0002218343,"teacher_disagreement_score":0.2036001,"about_ca_system_score_codex":0.001346994,"about_ca_system_score_gemma":0.0017552326,"threshold_uncertainty_score":0.99989307},"labels":[],"label_agreement":null},{"id":"W2890134385","doi":"10.1007/s00262-018-2244-7","title":"Accurate quantification of T-cells expressing PD-1 in patients on anti-PD-1 immunotherapy","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"Novartis Pharma; Klaus Tschira Stiftung; Roche; Merck Sharp and Dohme; Bristol-Myers Squibb","keywords":"Nivolumab; Pembrolizumab; Antibody; Immunotherapy; Flow cytometry; PD-L1; Medicine; Immunology; T cell; Mass cytometry; Immune system; Cancer research; Biology; Phenotype; Biochemistry","score_opus":0.027958930338670026,"score_gpt":0.3176974800295449,"score_spread":0.28973854969087487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890134385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830969,0.011511394,0.0003273011,0.0006581934,0.0021319184,0.0011491027,0.00005572457,0.000109779015,0.0009596706],"genre_scores_gemma":[0.98564255,0.011365783,0.00028663225,0.0016978367,0.0001699253,0.00016501917,0.00006040463,0.00012605762,0.00048575946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965898,0.00025257058,0.0012607594,0.00074954866,0.00041034474,0.0007369888],"domain_scores_gemma":[0.99728775,0.00013680634,0.0007453315,0.0013242824,0.00044765658,0.00005818905],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00051509525,0.000537659,0.0009923382,0.00066013733,0.00021200234,0.000042347256,0.0005300927,0.00044800038,0.0012421092],"category_scores_gemma":[0.00003195991,0.0004872079,0.00031989272,0.00088973175,0.001056666,0.00026387346,0.000042299813,0.00049842923,0.00008092821],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02126118,0.0010060419,0.024603652,0.000042986198,0.0007321902,0.0000038232374,0.0013228813,0.0000142257095,0.857408,0.00008928485,0.00066588854,0.09284984],"study_design_scores_gemma":[0.015324825,0.0023098625,0.46414706,0.0005965618,0.000030270896,0.0000056635595,0.00015639086,0.00004668207,0.49400496,0.000048503884,0.022888802,0.0004404127],"about_ca_topic_score_codex":0.0006501049,"about_ca_topic_score_gemma":0.00003070541,"teacher_disagreement_score":0.43954343,"about_ca_system_score_codex":0.00048717554,"about_ca_system_score_gemma":0.00035637547,"threshold_uncertainty_score":0.99975795},"labels":[],"label_agreement":null},{"id":"W2890982083","doi":"10.1007/s00262-018-2240-y","title":"International Symposium: Trailblazing in Cancer Immunotherapy, October 29–31, 2017, Pamplona, Spain","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AstraZeneca Schweiz; Merck Sharp and Dohme; University of Toronto; Weill Cornell Medical College; Boehringer Ingelheim; Takeda Pharmaceuticals U.S.A.; University of Manchester; Fundación Ramón Areces; Roche; Merck; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Cancer immunotherapy; Cancer; Immunotherapy; Geography; Library science; Medicine; Computer science; Internal medicine","score_opus":0.027392093562318004,"score_gpt":0.3273475082277839,"score_spread":0.29995541466546594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890982083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8812268,0.08195209,0.00033764925,0.017754469,0.0078012124,0.001608463,0.00011393547,0.0005685444,0.008636863],"genre_scores_gemma":[0.75328976,0.2158477,0.0011214623,0.015727205,0.0024628837,0.0018317777,0.00013550326,0.0005047882,0.009078924],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954878,0.00023455068,0.0013139128,0.0011241403,0.00054207107,0.0012975369],"domain_scores_gemma":[0.99753416,0.00015592844,0.00050423195,0.0012352925,0.00044679706,0.00012359512],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008303114,0.0008097009,0.001115324,0.0006120383,0.0002843249,0.00011623869,0.0009916428,0.00066039414,0.0054902267],"category_scores_gemma":[0.000030218467,0.0007602663,0.0005221504,0.0009725117,0.0013465653,0.00046537802,0.00011074006,0.00097107794,0.00012568093],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014516375,0.00057127833,0.023900473,0.00003507356,0.0028332677,0.00006482628,0.003785972,0.000011714097,0.70480484,0.0000989968,0.005659091,0.2437181],"study_design_scores_gemma":[0.01785372,0.0011226861,0.12441703,0.0006937083,0.00007793127,0.0002418838,0.00039326685,0.0001410325,0.03576816,0.00011607554,0.8181715,0.0010030147],"about_ca_topic_score_codex":0.0051470525,"about_ca_topic_score_gemma":0.0011011271,"teacher_disagreement_score":0.8125124,"about_ca_system_score_codex":0.0017148207,"about_ca_system_score_gemma":0.0007708376,"threshold_uncertainty_score":0.99948484},"labels":[],"label_agreement":null},{"id":"W2911882091","doi":"10.1007/s00262-019-02307-x","title":"Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; Princess Margaret Cancer Foundation","keywords":"Medicine; Melanoma; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Aldesleukin; Population; Adverse effect; Chemotherapy; Interleukin 2; Immune system; Internal medicine; Oncology; Immunotherapy; Gastroenterology; Phases of clinical research; Clinical trial; Immunology; Cancer research","score_opus":0.03161818977587048,"score_gpt":0.3569993678410537,"score_spread":0.3253811780651832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911882091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867945,0.0066822227,0.00007584942,0.0001339698,0.000426055,0.0055548027,0.00006691745,0.000058219153,0.00020747165],"genre_scores_gemma":[0.99319386,0.0029607709,0.0015603924,0.0004514671,0.00008244266,0.00067665323,0.0000774631,0.00013066141,0.0008662666],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99718046,0.00028777285,0.0008990982,0.0006806095,0.0003380927,0.000613948],"domain_scores_gemma":[0.9972658,0.00070116844,0.0006508058,0.00076932914,0.00051913934,0.00009375253],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00056267827,0.00046076335,0.0013857973,0.00023786051,0.00014700629,0.000027083914,0.00030141222,0.00017672632,0.00094282435],"category_scores_gemma":[0.000037991744,0.00031571143,0.00022574353,0.00028839355,0.0008663993,0.00015499437,0.000053443022,0.00046240937,0.0000050321537],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6345927,0.004996504,0.018088397,0.00010382498,0.0028236003,0.000015082641,0.0015838603,0.0000039223623,0.10815866,0.00002124045,0.00003359243,0.22957857],"study_design_scores_gemma":[0.7199928,0.19530635,0.013387587,0.00029555632,0.00017213274,0.00005084219,0.00059672166,0.00013051009,0.065950975,0.000028712573,0.0036085097,0.00047928694],"about_ca_topic_score_codex":0.00012745087,"about_ca_topic_score_gemma":0.000010662604,"teacher_disagreement_score":0.22909929,"about_ca_system_score_codex":0.00022434987,"about_ca_system_score_gemma":0.000983078,"threshold_uncertainty_score":0.99997044},"labels":[],"label_agreement":null},{"id":"W2917568543","doi":"10.1007/s00262-018-02297-2","title":"Expression of a soluble IL-10 receptor enhances the therapeutic effects of a papillomavirus-associated antitumor vaccine in a murine model","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Bureau of Reclamation; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Universidade de São Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo; International Centre for Genetic Engineering and Biotechnology","keywords":"Cytotoxic T cell; Adjuvant; DNA vaccination; CD8; Cancer research; Immunotherapy; Medicine; Immunology; Cancer immunotherapy; Immunization; Biology; Immune system; In vitro","score_opus":0.009125941024972349,"score_gpt":0.25588506563723684,"score_spread":0.24675912461226449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917568543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8274139,0.16950879,0.00007226049,0.00026199225,0.0014331029,0.0011033615,0.000037751357,0.00006138757,0.00010745076],"genre_scores_gemma":[0.9641238,0.02818547,0.000045213594,0.00027581642,0.000012107895,0.00035726122,0.000044853266,0.000081695005,0.0068738037],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99635005,0.0010257346,0.0011639812,0.0005327646,0.00012353317,0.0008039543],"domain_scores_gemma":[0.99674743,0.00090247375,0.00095177896,0.0011614065,0.0002237896,0.00001311934],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007003179,0.0005354757,0.0013280641,0.0003822957,0.00018496902,0.00001357504,0.0011293349,0.00057753274,0.002553562],"category_scores_gemma":[0.00009289656,0.0003853689,0.0003646954,0.0006467601,0.00057580404,0.00025011084,0.00015180922,0.0007154483,0.0001346608],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009381267,0.0007278053,0.0023962746,0.0001036983,0.0011104805,0.0000013396295,0.0025746687,0.00009986364,0.9754253,0.00018703435,0.00033194356,0.00766032],"study_design_scores_gemma":[0.010870646,0.0012838029,0.01653086,0.0007274456,0.00004838081,0.0000092227265,0.00031722852,0.000041636027,0.9609431,0.00021043727,0.00861636,0.00040089837],"about_ca_topic_score_codex":0.000560428,"about_ca_topic_score_gemma":0.000041130737,"teacher_disagreement_score":0.14132331,"about_ca_system_score_codex":0.00014887458,"about_ca_system_score_gemma":0.00034875277,"threshold_uncertainty_score":0.9998598},"labels":[],"label_agreement":null},{"id":"W2984698492","doi":"10.1007/s00262-019-02423-8","title":"Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada); McGill University","funders":"Council of Scientific and Industrial Research, India","keywords":"Immunity; Immunology; Glioma; Medicine; Cancer research; Immune system","score_opus":0.0069972628262776285,"score_gpt":0.25426345212806556,"score_spread":0.24726618930178793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984698492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7664909,0.23012622,0.00014677923,0.0002458358,0.0019611274,0.00080636854,0.000046552173,0.000022317368,0.00015393106],"genre_scores_gemma":[0.9868827,0.011211312,0.000043692293,0.00015599192,0.000011041213,0.00020026875,0.0000134054035,0.000048712896,0.0014329074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99740297,0.0006178725,0.00089024205,0.00044996978,0.00007709794,0.0005618452],"domain_scores_gemma":[0.9977612,0.00036889396,0.0004778026,0.0012111005,0.00016831461,0.000012699657],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062667206,0.0003510221,0.00092007924,0.00028975343,0.00010855764,0.000007893435,0.0009802235,0.00047229909,0.00074921024],"category_scores_gemma":[0.000030592644,0.00026871316,0.00013189061,0.0005114087,0.0011496707,0.00012225946,0.00029697508,0.0006567056,0.00009524343],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026005264,0.000108971406,0.016143018,0.00012895197,0.00030242658,0.0000019047098,0.0029181323,0.00026634353,0.952122,0.00023426159,0.00029126232,0.024882236],"study_design_scores_gemma":[0.004498746,0.00059578783,0.08928699,0.00069196423,0.000027430482,0.000098881814,0.00134484,0.0000069896328,0.89455456,0.00004556581,0.008559685,0.00028855575],"about_ca_topic_score_codex":0.0013654319,"about_ca_topic_score_gemma":0.000072136914,"teacher_disagreement_score":0.2203918,"about_ca_system_score_codex":0.00017496743,"about_ca_system_score_gemma":0.00019003252,"threshold_uncertainty_score":0.9999765},"labels":[],"label_agreement":null},{"id":"W2992202553","doi":"10.1007/s00262-019-02444-3","title":"CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Toronto General Hospital; University Health Network","funders":"Akdeniz Üniversitesi; Canadian Cancer Society","keywords":"PEG ratio; Cancer research; Metastasis; Knockout mouse; Chemistry; Pharmacology; Doxorubicin; Receptor; Cancer; Medicine; Internal medicine; Chemotherapy; Biochemistry","score_opus":0.016275529285348145,"score_gpt":0.2576513516733622,"score_spread":0.24137582238801403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992202553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953137,0.0021548804,0.00014934801,0.00011771499,0.00041029594,0.0016787408,0.00009916863,0.00004680874,0.000029350114],"genre_scores_gemma":[0.997669,0.0011774898,0.00007228237,0.00040659486,0.000013035497,0.00015629402,0.0000085936645,0.0000785044,0.00041819495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99557805,0.0020046753,0.0009436392,0.0005891622,0.00044882868,0.00043563647],"domain_scores_gemma":[0.9971428,0.00091921916,0.00074352545,0.0010038672,0.00014184769,0.00004874583],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049833854,0.0004171383,0.0008600959,0.00042858563,0.000078599114,0.000020965428,0.00079050614,0.00015588367,0.0004984839],"category_scores_gemma":[0.00009750078,0.00031616417,0.00021161648,0.0005885876,0.00040127654,0.00026602787,0.00007740975,0.00042437395,0.000022361044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024163334,0.00044823877,0.0020353275,0.00014924016,0.0000974865,0.0000034111451,0.00085709826,0.0016871731,0.988732,0.00068009127,0.0000045647466,0.002889031],"study_design_scores_gemma":[0.0049947673,0.0014258221,0.0068498054,0.00007791582,0.000056213103,0.000034413228,0.00006191218,0.0069478904,0.97917974,0.00010532854,0.000012306969,0.00025386928],"about_ca_topic_score_codex":0.00046120692,"about_ca_topic_score_gemma":0.000031328,"teacher_disagreement_score":0.009552248,"about_ca_system_score_codex":0.00008590605,"about_ca_system_score_gemma":0.00025787373,"threshold_uncertainty_score":0.9999291},"labels":[],"label_agreement":null},{"id":"W2995658490","doi":"10.1007/s00262-019-02453-2","title":"The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies","year":2019,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Antibiotics; Internal medicine; Oncology; Meta-analysis; Observational study; Hazard ratio; Proportional hazards model; Confidence interval; Microbiology","score_opus":0.26229063664934493,"score_gpt":0.4919036307089502,"score_spread":0.22961299405960528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995658490","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008667735,0.991686,9.343035e-7,0.000662944,0.00042948787,0.0061287857,0.00019316522,0.000018263385,0.000013675343],"genre_scores_gemma":[0.00022945489,0.9980425,0.000019173105,0.00042869532,0.000013370962,0.00033599636,0.000058942776,0.00007812068,0.0007937038],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9906758,0.002324687,0.005461618,0.00067776866,0.0004436847,0.00041643024],"domain_scores_gemma":[0.985798,0.007874232,0.004000407,0.0019966613,0.0002983574,0.000032352047],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.004867727,0.000919901,0.024491562,0.00064531027,0.00009032972,0.000015178085,0.00066097116,0.00059506734,0.00011493807],"category_scores_gemma":[0.0008692907,0.00044678134,0.007912004,0.0015315489,0.0011067309,0.000048454916,0.00011544999,0.00089232676,0.0000052111313],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007281466,0.00011370937,0.00068274955,0.33905467,0.64851236,0.0000032733822,0.000060963357,7.1712105e-7,0.000025711563,0.000022914837,0.000018699302,0.010776045],"study_design_scores_gemma":[0.0025740005,0.0023372404,0.0020372018,0.074928895,0.9010222,0.0000218498,0.00004075011,0.0000014654412,0.000091769354,0.000004114169,0.016501091,0.00043939534],"about_ca_topic_score_codex":0.0000946789,"about_ca_topic_score_gemma":0.000027420896,"teacher_disagreement_score":0.2641258,"about_ca_system_score_codex":0.00029882972,"about_ca_system_score_gemma":0.0004426313,"threshold_uncertainty_score":0.9997984},"labels":[],"label_agreement":null},{"id":"W3001385031","doi":"10.1007/s00262-019-02469-8","title":"Suppressive activity of Vδ2+ γδ T cells on αβ T cells is licensed by TCR signaling and correlates with signal strength","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Stimulation; T cell; T-cell receptor; Cell biology; Isopentenyl pyrophosphate; Cytotoxic T cell; FOXP3; Interleukin 21; Chemistry; Biology; Molecular biology; In vitro; Immunology; Endocrinology; Immune system; Biochemistry; Pyrophosphate","score_opus":0.01003175425846067,"score_gpt":0.22530157818302873,"score_spread":0.21526982392456806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001385031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97790474,0.018123768,0.000396874,0.000975893,0.0016537359,0.00045036158,0.00011731866,0.00010814966,0.00026918366],"genre_scores_gemma":[0.99122465,0.0043182303,0.000029551784,0.0019024733,0.00003484047,0.00006290641,0.00006374215,0.000066824,0.0022967807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980108,0.0003273774,0.00046466716,0.000620042,0.0000780261,0.00049905124],"domain_scores_gemma":[0.99855447,0.00034328975,0.0005401401,0.00036487245,0.00015929947,0.000037916496],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010256732,0.00046822208,0.00069370976,0.00012622375,0.00026577184,0.00002909577,0.00030710068,0.0004918065,0.006027839],"category_scores_gemma":[0.000010132384,0.0004011118,0.00014684981,0.00020406266,0.0006146453,0.0002167126,0.00005755669,0.00094029296,0.00018330866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008367352,0.00023941026,0.0004834231,0.000026074535,0.0013525097,0.0000030731599,0.002312713,0.000054002234,0.9651893,0.000018392537,0.011633349,0.010320433],"study_design_scores_gemma":[0.004738529,0.0024036372,0.0004716429,0.00010530519,0.00006876803,0.00001530388,0.00054376025,0.000049239246,0.9438212,0.000004773735,0.04738381,0.00039405926],"about_ca_topic_score_codex":0.00034535205,"about_ca_topic_score_gemma":0.0000036904382,"teacher_disagreement_score":0.03575046,"about_ca_system_score_codex":0.00008416856,"about_ca_system_score_gemma":0.00011285489,"threshold_uncertainty_score":0.9998441},"labels":[],"label_agreement":null},{"id":"W3006927029","doi":"10.1007/s00262-020-02514-x","title":"CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapies","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Ministerio de Ciencia Tecnología y Telecomunicaciones; Consejo Nacional de Ciencia y Tecnología; Health Research Board","keywords":"Granzyme B; Cancer research; Cisplatin; Cytotoxic T cell; Granzyme; CD1D; Medicine; Immunology; Perforin; Biology; Natural killer T cell; Internal medicine; Chemotherapy; T cell; Immune system; CD8; In vitro","score_opus":0.0075807622802303775,"score_gpt":0.20883242223657714,"score_spread":0.20125165995634675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006927029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96938837,0.026129989,0.000026020203,0.0026453065,0.0011037878,0.000528456,0.000021721105,0.00009678869,0.00005957026],"genre_scores_gemma":[0.9949406,0.0014327007,0.000076858065,0.0021903026,0.000021504065,0.000099342265,0.00011536474,0.00007537655,0.0010479843],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980755,0.00028293722,0.00043621732,0.0006077784,0.00006796232,0.00052962505],"domain_scores_gemma":[0.9990296,0.00008900784,0.00044252342,0.00029653445,0.00010111708,0.00004126207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009047087,0.00046460665,0.0006001099,0.00012525341,0.00022800884,0.000045066554,0.00022353724,0.00025399914,0.0008104286],"category_scores_gemma":[0.00002144189,0.0003837989,0.00007014791,0.00019156357,0.0005095268,0.0003045334,0.00007060622,0.00081457786,0.000025798865],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074649444,0.00015461071,0.25533193,0.000026666863,0.00025864452,0.0000032473263,0.0035045268,0.0000051932725,0.7257146,0.000003221869,0.0061264685,0.0014058821],"study_design_scores_gemma":[0.03621352,0.001991659,0.77408165,0.00075973483,0.000050402457,0.0000893408,0.006980476,0.00002329505,0.15012601,0.000011964776,0.028496852,0.001175109],"about_ca_topic_score_codex":0.0006950725,"about_ca_topic_score_gemma":0.00008004386,"teacher_disagreement_score":0.57558864,"about_ca_system_score_codex":0.00022520119,"about_ca_system_score_gemma":0.000092665614,"threshold_uncertainty_score":0.9998614},"labels":[],"label_agreement":null},{"id":"W3008016882","doi":"10.1007/s00262-020-02507-w","title":"miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"National Natural Science Foundation of China","keywords":"Immune system; Immunotherapy; Cancer research; microRNA; Biology; Dendritic cell; Cancer immunotherapy; CD8; T cell; Breast cancer; Immunology; Cancer","score_opus":0.011127870903196665,"score_gpt":0.2752890135284139,"score_spread":0.2641611426252172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008016882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7245003,0.25293377,0.00024491452,0.015789343,0.0037051393,0.0016948335,0.0003136339,0.00067694514,0.00014114477],"genre_scores_gemma":[0.92405844,0.05821335,0.0002453142,0.011255475,0.00021850897,0.0016742664,0.000082378974,0.0005311883,0.0037210924],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9921432,0.0011867235,0.0021731083,0.0018081937,0.00023408118,0.002454694],"domain_scores_gemma":[0.9966762,0.00042527026,0.00069358863,0.0016945614,0.0003717267,0.00013863652],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0007165163,0.0014462009,0.0021708675,0.0007467978,0.0005333577,0.00013992045,0.0024552497,0.001178492,0.008850888],"category_scores_gemma":[0.00007702625,0.0014442345,0.0006924277,0.0018922905,0.0010546118,0.00064888666,0.0003272499,0.0019063869,0.0016647814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012751655,0.00043863786,0.0014706823,0.00005214928,0.0017520257,0.000034024208,0.0056376397,0.00014828068,0.87826073,0.000096530486,0.0021426633,0.097215],"study_design_scores_gemma":[0.0069780466,0.00076263084,0.04804412,0.0004568285,0.000052315252,0.0001476946,0.00068971567,0.0000123236105,0.802704,0.00008251614,0.13852505,0.0015447822],"about_ca_topic_score_codex":0.0032217074,"about_ca_topic_score_gemma":0.00015108453,"teacher_disagreement_score":0.19955815,"about_ca_system_score_codex":0.00073721545,"about_ca_system_score_gemma":0.0007039363,"threshold_uncertainty_score":0.99982876},"labels":[],"label_agreement":null},{"id":"W3010582098","doi":"10.1007/s00262-020-02543-6","title":"Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Emberi Eroforrások Minisztériuma","keywords":"Adverse effect; Medicine; Immune system; Immunotherapy; Malignancy; Oncology; Cancer; Internal medicine; Immune checkpoint; Odds ratio; Disease; Immunology","score_opus":0.014139684498317888,"score_gpt":0.25937998291350695,"score_spread":0.24524029841518905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010582098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9496129,0.033722013,0.00005511853,0.0145272985,0.00046394466,0.0010874092,0.000100612655,0.00026771656,0.00016299204],"genre_scores_gemma":[0.9894039,0.007995508,0.00016570189,0.0008526374,0.0004021804,0.0002581747,0.00020402839,0.00011507356,0.00060278334],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965697,0.00025163012,0.0013634348,0.00069032394,0.00045864726,0.0006662801],"domain_scores_gemma":[0.9981632,0.0001491265,0.0009025066,0.00040224465,0.00025411774,0.00012875503],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005239286,0.00052904966,0.00094406476,0.00022750565,0.00039852157,0.000030705294,0.00021451217,0.0003936942,0.0011973607],"category_scores_gemma":[0.00008887685,0.0005088908,0.00045575175,0.0005653583,0.00031383763,0.00033449032,0.00007917511,0.00074690714,0.000066164284],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052073337,0.000071326285,0.029936695,0.000104191764,0.0044235694,0.00003969423,0.0049437564,0.000017627577,0.94420063,0.000037747355,0.000025070716,0.01099235],"study_design_scores_gemma":[0.018257761,0.000801766,0.772495,0.00035769225,0.00028668743,0.000088582696,0.0013471487,0.000048986447,0.20119339,0.0002164736,0.004258387,0.00064816925],"about_ca_topic_score_codex":0.00047238395,"about_ca_topic_score_gemma":0.0000034348172,"teacher_disagreement_score":0.74300724,"about_ca_system_score_codex":0.0009122028,"about_ca_system_score_gemma":0.00032968982,"threshold_uncertainty_score":0.99973625},"labels":[],"label_agreement":null},{"id":"W3014484249","doi":"10.1007/s00262-020-02555-2","title":"The glucocorticoids prednisone and dexamethasone differentially modulate T cell function in response to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Institute of Infection and Immunity; Alberta Cancer Foundation","keywords":"CTLA-4; Immune system; Immune checkpoint; Prednisone; T cell; Dexamethasone; Immunotherapy; Medicine; Jurkat cells; Peripheral blood mononuclear cell; Immunology; Blocking antibody; Internal medicine; Cancer research; Endocrinology; Antibody; Biology; In vitro","score_opus":0.014411720080116605,"score_gpt":0.25882429723489464,"score_spread":0.24441257715477804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014484249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87922335,0.10105776,0.00041856678,0.01731909,0.000532649,0.0012819376,0.000018991275,0.00010974763,0.00003790263],"genre_scores_gemma":[0.9518924,0.04486693,0.00020089718,0.0021437912,0.00011256254,0.00026018266,0.000010976924,0.000098252014,0.0004140532],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99680847,0.00039742587,0.00096627336,0.0008001629,0.00026766455,0.0007600039],"domain_scores_gemma":[0.9984398,0.00027959803,0.0002936288,0.0006938165,0.00011940359,0.0001737924],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075080665,0.000520045,0.0008984008,0.00022867385,0.00037471473,0.0001180467,0.00030030185,0.00033455782,0.00016777388],"category_scores_gemma":[0.00010652499,0.0004087683,0.00018270181,0.00069159013,0.00064061856,0.00014846248,0.00015980417,0.00064167613,0.000012376466],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053180315,0.00014156803,0.008151631,0.00005304258,0.0006187903,0.000022353948,0.002185226,0.000017279226,0.8783429,0.000008265639,0.00004033971,0.057238244],"study_design_scores_gemma":[0.016262341,0.0021794776,0.7234542,0.00017918805,0.00012108311,0.00007190988,0.00053488585,0.00026715387,0.2394791,0.00004453241,0.016919192,0.00048695374],"about_ca_topic_score_codex":0.00056098326,"about_ca_topic_score_gemma":0.00004032962,"teacher_disagreement_score":0.7153026,"about_ca_system_score_codex":0.00022741956,"about_ca_system_score_gemma":0.00028163096,"threshold_uncertainty_score":0.99983644},"labels":[],"label_agreement":null},{"id":"W3018744837","doi":"10.1007/s00262-020-02581-0","title":"Patients’ NK cell stimulation with activated plasmacytoid dendritic cells increases dinutuximab-induced neuroblastoma killing","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research","keywords":"Immunotherapy; Immunology; Cytotoxic T cell; Lymphokine-activated killer cell; Cancer research; Cell therapy; Immune system; Medicine; Interleukin 21; Biology; T cell; Cell biology; Stem cell","score_opus":0.020592750593905636,"score_gpt":0.26859008891558334,"score_spread":0.2479973383216777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018744837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965019,0.001143109,0.00012246973,0.00059233804,0.00018848028,0.00103977,0.00003967628,0.00023606881,0.00013615465],"genre_scores_gemma":[0.9963152,0.0013981082,0.0002040902,0.0015402251,0.00008123573,0.00013941237,0.00008051259,0.00013057613,0.00011064422],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977613,0.00017792964,0.0003839896,0.00062604225,0.00037241844,0.0006783053],"domain_scores_gemma":[0.99871945,0.00017494014,0.00017122552,0.00042869893,0.00027110465,0.00023457358],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000039576094,0.00043638595,0.0005726217,0.00018752094,0.00022923738,0.00004570618,0.00023375629,0.000162898,0.00038946225],"category_scores_gemma":[0.000025848985,0.00036128308,0.00013037071,0.0005075451,0.0001794705,0.00023877365,0.00006038829,0.00057847763,0.0001255269],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011094386,0.00085296767,0.010435914,0.00007129325,0.0005514313,0.0001573436,0.00038337556,0.00017982257,0.96873784,0.0000033324407,0.00008244217,0.0074498816],"study_design_scores_gemma":[0.019725436,0.0065077036,0.040262572,0.00014197124,0.00009798083,0.000028110038,0.000092529364,0.00043057706,0.9314435,0.0000032794014,0.00094150926,0.0003248455],"about_ca_topic_score_codex":0.00026009945,"about_ca_topic_score_gemma":0.000008224899,"teacher_disagreement_score":0.03729433,"about_ca_system_score_codex":0.00025853465,"about_ca_system_score_gemma":0.00032995298,"threshold_uncertainty_score":0.9998839},"labels":[],"label_agreement":null},{"id":"W3021482038","doi":"10.1007/s00262-020-02569-w","title":"Blockade of CD73 delays glioblastoma growth by modulating the immune environment","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Cancer research; Immune system; Tumor microenvironment; Flow cytometry; CD8; Glioma; Microglia; Immunotherapy; Chemistry; Biology; Medicine; Immunology; Inflammation","score_opus":0.007885377117079236,"score_gpt":0.22015370897944256,"score_spread":0.21226833186236332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021482038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8071028,0.18688974,0.0029502094,0.002573997,0.0001272796,0.00020581349,0.000034378547,0.000018081093,0.00009767913],"genre_scores_gemma":[0.9873464,0.010898822,0.00015535795,0.0010835883,0.00019130879,0.000072505194,0.000036375855,0.000047945974,0.00016765983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987343,0.00010692389,0.0003980472,0.0003361113,0.0001195509,0.00030507514],"domain_scores_gemma":[0.99924845,0.000027292685,0.00024346153,0.0003977259,0.000048097507,0.000034989618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010868373,0.00023342248,0.00026706647,0.000021782793,0.0001432008,0.000011121105,0.00050462893,0.00018380297,0.00025815505],"category_scores_gemma":[0.000021221244,0.00018591687,0.00015425666,0.00011313738,0.00027779525,0.0000058056617,0.00013160976,0.00020718455,0.000009949555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005126958,0.000038861464,0.0007401076,0.000008691089,0.00046408921,0.000001252502,0.00036603378,0.0005175412,0.9920095,0.00005236786,0.0024673464,0.002821504],"study_design_scores_gemma":[0.0012670674,0.00067198876,0.0007974566,0.000013562383,0.000026538462,0.000011673488,0.00017129623,0.00014891603,0.94789433,0.00003807523,0.048730973,0.00022811683],"about_ca_topic_score_codex":0.00012076582,"about_ca_topic_score_gemma":6.984861e-7,"teacher_disagreement_score":0.18024361,"about_ca_system_score_codex":0.000021262289,"about_ca_system_score_gemma":0.000055310913,"threshold_uncertainty_score":0.758147},"labels":[],"label_agreement":null},{"id":"W3038890558","doi":"10.1007/s00262-020-02650-4","title":"Characterizing caspase-1 involvement during esophageal disease progression","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"H2020 Marie Skłodowska-Curie Actions; Deutsche Krebshilfe","keywords":"Pyroptosis; Inflammasome; Inflammation; Caspase 1; Chemokine; CXCL1; Caspase 3; Cancer research; Medicine; Stromal cell; Apoptosis; Cytokine; Immunology; Pathology; Biology; Programmed cell death","score_opus":0.011710374301018591,"score_gpt":0.2633210635259597,"score_spread":0.2516106892249411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038890558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9441232,0.05203153,0.00009171805,0.0028074032,0.00038823026,0.00037445547,0.000025811214,0.00005713845,0.000100513054],"genre_scores_gemma":[0.98363364,0.011466775,0.00006283482,0.003685044,0.00029027945,0.00028612756,0.00021805722,0.0000665563,0.00029068324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998554,0.000085376276,0.00031206183,0.0004785776,0.00011739452,0.00045261363],"domain_scores_gemma":[0.9992516,0.000004129259,0.00015300378,0.00042665759,0.00006849427,0.00009613422],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006736847,0.0002826084,0.00023088971,0.000044231692,0.00023432974,0.00003478268,0.00036271388,0.00015257191,0.00023492539],"category_scores_gemma":[0.00002070244,0.0002767395,0.00015736952,0.000120874385,0.00016164353,0.000015951262,0.00014658665,0.00019824837,0.000039403072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017798522,0.000059139253,0.006130887,0.000033836324,0.00029491328,0.000018969857,0.00049183297,0.000014360276,0.9777565,0.000022227481,0.00018626034,0.013211205],"study_design_scores_gemma":[0.0033376797,0.000456941,0.061386924,0.000054763554,0.000024496125,0.0000055242963,0.00021424772,0.000022571481,0.84133893,0.000012385743,0.09266988,0.00047566748],"about_ca_topic_score_codex":0.000016345382,"about_ca_topic_score_gemma":0.0000027546105,"teacher_disagreement_score":0.1364176,"about_ca_system_score_codex":0.000038914346,"about_ca_system_score_gemma":0.00014963113,"threshold_uncertainty_score":0.99996847},"labels":[],"label_agreement":null},{"id":"W3047001933","doi":"10.1007/s00262-020-02684-8","title":"Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis","year":2020,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Medizinische Universität Wien; Universität Wien","keywords":"Axitinib; Nivolumab; Pembrolizumab; Medicine; Ipilimumab; Sunitinib; Internal medicine; Oncology; Avelumab; Adverse effect; Renal cell carcinoma; Tolerability; Discontinuation; Cancer; Immunotherapy","score_opus":0.10894403212116735,"score_gpt":0.35650736083602647,"score_spread":0.24756332871485912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047001933","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029289093,0.9766184,0.000116365394,0.0019045363,0.00012457492,0.020942712,0.00018504966,0.000051781983,0.000027287817],"genre_scores_gemma":[0.000447205,0.9656713,0.00020089275,0.004276118,0.00010713109,0.028535573,0.0003226807,0.00019051066,0.00024856543],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9926937,0.0020434624,0.002847175,0.0011904065,0.00040089176,0.0008243598],"domain_scores_gemma":[0.993872,0.0017219937,0.0020992267,0.0020099292,0.00020505123,0.00009182335],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0019759003,0.00141269,0.017504511,0.0004525963,0.00022177315,0.00007447682,0.0008947132,0.00038934252,0.00017732136],"category_scores_gemma":[0.00007018025,0.0007451598,0.0056220973,0.0019933216,0.00020247955,0.00006422426,0.00007220358,0.00093683903,0.000018557937],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023080819,0.0001716296,0.000011416938,0.6598939,0.32435971,0.00016942364,0.00050185376,0.000012925481,0.000004430605,0.000020152536,0.00045602763,0.014167728],"study_design_scores_gemma":[0.0024603237,0.0010765687,0.000017560906,0.04365322,0.7690897,0.0008441372,0.0000559527,0.000013687107,0.000005457647,0.000018384793,0.18213943,0.0006255819],"about_ca_topic_score_codex":0.00012391826,"about_ca_topic_score_gemma":0.00002887567,"teacher_disagreement_score":0.6162407,"about_ca_system_score_codex":0.0005756579,"about_ca_system_score_gemma":0.0006562835,"threshold_uncertainty_score":0.9998623},"labels":[],"label_agreement":null},{"id":"W3049758264","doi":"10.1007/s00262-020-02693-7","title":"Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Universität Zürich; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Fingolimod; Medicine; Pembrolizumab; Cancer; Multiple sclerosis; Immune system; Tumor-infiltrating lymphocytes; Avelumab; Ipilimumab; Melanoma; Immunotherapy; Oncology; Internal medicine; Immunology; Cancer research","score_opus":0.017191812970620744,"score_gpt":0.2719546069558567,"score_spread":0.254762793985236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049758264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.931582,0.062947355,0.0000076178835,0.0038099538,0.00039557368,0.0007863173,0.00006994288,0.0001491938,0.00025208128],"genre_scores_gemma":[0.97128165,0.019789426,0.00012453628,0.007886512,0.00022046441,0.00040604442,0.000041385436,0.000099126075,0.00015086083],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975964,0.00010998109,0.0007696572,0.0006653426,0.0002134105,0.0006452245],"domain_scores_gemma":[0.9990361,0.00008237338,0.00029134416,0.00032778145,0.00014005233,0.00012237753],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014686897,0.0004619604,0.00079463236,0.00018999749,0.00015191785,0.000046970134,0.00021239223,0.00023927358,0.0007882976],"category_scores_gemma":[0.00005624606,0.00042008533,0.00018090791,0.00062499184,0.00036657255,0.00020287039,0.000055945016,0.0004252762,0.000013830007],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009736346,0.0002215902,0.3468713,0.00010719231,0.0007030104,0.000030296871,0.002510914,0.0000060928546,0.5636017,0.000012037032,0.00040396134,0.07579558],"study_design_scores_gemma":[0.036085907,0.00196044,0.7418564,0.0007672877,0.00010254512,0.000043403146,0.00052748667,0.000328943,0.19121917,0.000021644342,0.026242565,0.0008442241],"about_ca_topic_score_codex":0.002597891,"about_ca_topic_score_gemma":0.0001363659,"teacher_disagreement_score":0.3949851,"about_ca_system_score_codex":0.0005927355,"about_ca_system_score_gemma":0.0004142931,"threshold_uncertainty_score":0.9998251},"labels":[],"label_agreement":null},{"id":"W3090984746","doi":"10.1007/s00262-020-02728-z","title":"Anti-leukemia effect associated with down-regulated CD47 and up-regulated calreticulin by stimulated macrophages in co-culture","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; National Research Council Canada","funders":"","keywords":"CD47; Calreticulin; Lipopolysaccharide; Peripheral blood mononuclear cell; THP1 cell line; Macrophage; Immune system; Myeloid leukemia; Cell culture; Phagocytosis; Cancer research; Leukemia; In vitro; Tumor necrosis factor alpha; Myeloid; Chemistry; Immunology; Biology; Cell biology; Endoplasmic reticulum; Biochemistry","score_opus":0.007789410902745578,"score_gpt":0.2504423766042135,"score_spread":0.2426529657014679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090984746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8944444,0.10270878,0.00003963864,0.0008901717,0.00040931572,0.000965816,0.00018009653,0.00030235818,0.00005938628],"genre_scores_gemma":[0.99145585,0.005041635,0.000010494329,0.0008600299,0.000021302716,0.00014722429,0.0013593594,0.000113519905,0.0009905652],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961765,0.0009538485,0.0008279977,0.0009504251,0.00011612787,0.00097512925],"domain_scores_gemma":[0.99856585,0.00022336481,0.00048395444,0.00048619657,0.00017581484,0.00006482677],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033143454,0.0007941492,0.0014114894,0.00019816853,0.00037805972,0.00007035384,0.0004886889,0.0012104653,0.0009209976],"category_scores_gemma":[0.00009035671,0.0006336599,0.00015353509,0.00086600386,0.0010167138,0.00029656978,0.00008576905,0.0011028001,0.00007944048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032567612,0.000109668435,0.010251745,0.000026439637,0.0019796693,0.000017245591,0.0019827455,0.00025701922,0.9666277,0.000019198249,0.0035857128,0.011886073],"study_design_scores_gemma":[0.027782314,0.0023051177,0.18729542,0.00034933304,0.00019212431,0.00007958102,0.00017790443,0.0004253031,0.7641363,0.00001929667,0.01611252,0.0011247934],"about_ca_topic_score_codex":0.00046424812,"about_ca_topic_score_gemma":0.000026800964,"teacher_disagreement_score":0.20249142,"about_ca_system_score_codex":0.000481696,"about_ca_system_score_gemma":0.00019896732,"threshold_uncertainty_score":0.9999923},"labels":[],"label_agreement":null},{"id":"W3093736638","doi":"10.1007/s00262-020-02701-w","title":"Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute; National Institutes of Health","keywords":"Myeloid-derived Suppressor Cell; Tumor microenvironment; Pancreatic cancer; Cancer research; Immune system; Chemokine; STAT3; Myeloid; Stromal cell; Biology; Medicine; Immunology; Cancer; Suppressor; Signal transduction; Internal medicine; Cell biology","score_opus":0.01571391587852462,"score_gpt":0.2621415783990787,"score_spread":0.2464276625205541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093736638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90950066,0.08371152,0.0010992845,0.0025619678,0.0013993481,0.0011921134,0.00039063863,0.00011956583,0.00002490071],"genre_scores_gemma":[0.983504,0.009698737,0.0007521772,0.0052507375,0.000050576895,0.00018874256,0.000064009444,0.00018541992,0.00030559106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950874,0.0012230865,0.0013339396,0.0010662196,0.00013640354,0.0011529934],"domain_scores_gemma":[0.9977952,0.00036989962,0.0006091278,0.0009429885,0.00021425057,0.000068508336],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046867042,0.0007272543,0.0014666085,0.00042173636,0.00021080254,0.000031841882,0.00062758115,0.0006895992,0.0028774128],"category_scores_gemma":[0.000076930235,0.0007869667,0.00028232796,0.0008773753,0.0009061138,0.00027572972,0.00015934142,0.00082872825,0.0001435118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017703371,0.00020284251,0.0014630054,0.000051771905,0.0010328993,0.000024316809,0.014078888,0.0002840156,0.961529,0.0000074268237,0.0025366112,0.0010858362],"study_design_scores_gemma":[0.0090267975,0.0010068518,0.011731701,0.00020635288,0.00006149534,0.000037308295,0.0009373709,0.00002606198,0.96649265,0.00001555411,0.009716385,0.00074148714],"about_ca_topic_score_codex":0.0010195205,"about_ca_topic_score_gemma":0.0000112028165,"teacher_disagreement_score":0.074012786,"about_ca_system_score_codex":0.00060916244,"about_ca_system_score_gemma":0.00043769763,"threshold_uncertainty_score":0.99945813},"labels":[],"label_agreement":null},{"id":"W311717631","doi":"10.1007/s00262-002-0343-x","title":"A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma","year":2003,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Calicheamicin; Immunoconjugate; Medicine; Ovarian cancer; Internal medicine; Ovarian carcinoma; Gastroenterology; Adverse effect; Oncology; Cytotoxic T cell; Monoclonal antibody; Cancer; Myeloid leukemia; Antibody; Immunology; Chemistry","score_opus":0.01381652151134338,"score_gpt":0.2800756681982798,"score_spread":0.2662591466869364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W311717631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915382,0.0033498346,0.000010680619,0.00036586315,0.0008106229,0.0035609312,0.00010835551,0.00003063292,0.00022484353],"genre_scores_gemma":[0.99815756,0.00047947015,0.00007352063,0.00040040957,0.000038101392,0.00066182954,0.000023402528,0.00008117775,0.0000845333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970991,0.0005093225,0.0008135813,0.0006316702,0.0003594224,0.00058688415],"domain_scores_gemma":[0.99792254,0.000108783715,0.00048003998,0.0011450915,0.00028305774,0.000060494596],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026054092,0.0004982949,0.0009736353,0.00022670582,0.0001784643,0.00001906319,0.000260902,0.00019418339,0.00023637962],"category_scores_gemma":[0.00003350484,0.00032977626,0.00018088479,0.00065611297,0.00034991404,0.000105857514,0.000047289086,0.00056590175,0.000011091947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022633355,0.024644354,0.87117606,0.00004671952,0.0037407682,0.000073256575,0.012234239,0.000035395966,0.030985631,0.0003164341,0.000052158888,0.03406165],"study_design_scores_gemma":[0.09680605,0.011394045,0.8538429,0.0003102918,0.0002428059,0.000020144602,0.0010884902,0.000007825891,0.034924958,0.000030947147,0.0009987361,0.00033282168],"about_ca_topic_score_codex":0.001542237,"about_ca_topic_score_gemma":0.00027330217,"teacher_disagreement_score":0.07417269,"about_ca_system_score_codex":0.00076298945,"about_ca_system_score_gemma":0.00053789327,"threshold_uncertainty_score":0.9999154},"labels":[],"label_agreement":null},{"id":"W3120579476","doi":"10.1007/s00262-020-02823-1","title":"Associations among cytokines, EGF and lymphocyte subpopulations in patients diagnosed with advanced lung cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"CD8; Immunosenescence; Lung cancer; Immunology; Immune system; Medicine; Cytotoxic T cell; Cancer; Internal medicine; Oncology; Biology","score_opus":0.00831132474066344,"score_gpt":0.2774168532262508,"score_spread":0.2691055284855874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120579476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8988683,0.09839613,0.00003214746,0.0010652626,0.00051598856,0.00074844854,0.00014019015,0.000081302715,0.00015223633],"genre_scores_gemma":[0.93336964,0.063139066,0.0002480655,0.0014003597,0.00006610238,0.00071679585,0.00029365814,0.00008759988,0.0006787295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979094,0.00013316935,0.00057977764,0.00057261554,0.0002536462,0.00055135123],"domain_scores_gemma":[0.99862176,0.00011848419,0.00030189546,0.00052148016,0.00036668795,0.000069706875],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013656545,0.00036257878,0.0006811517,0.00023889262,0.00024000696,0.00004567541,0.0001377525,0.0002709992,0.00053702766],"category_scores_gemma":[0.000042620974,0.00033031663,0.00012469171,0.0008664939,0.0003291387,0.00028401578,0.00004051512,0.000346924,0.0000020068676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003183265,0.0003322839,0.90234244,0.000029128996,0.001152271,0.00003671438,0.0009975948,0.000056108616,0.017656147,0.000031796662,0.00013802321,0.07404424],"study_design_scores_gemma":[0.02308186,0.00028331406,0.9666406,0.00040053923,0.000115901814,0.000012837192,0.00018229644,0.000057021094,0.00379092,0.000015170502,0.0050389566,0.00038059644],"about_ca_topic_score_codex":0.0035638274,"about_ca_topic_score_gemma":0.0038328785,"teacher_disagreement_score":0.07366365,"about_ca_system_score_codex":0.0012592749,"about_ca_system_score_gemma":0.0007777967,"threshold_uncertainty_score":0.9999149},"labels":[],"label_agreement":null},{"id":"W3122051635","doi":"10.1007/s00262-021-02851-5","title":"Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-Oncology","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of Ottawa; Western University; University of Alberta; University of Toronto; Dalhousie University; University of British Columbia; University of Calgary; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Immunosuppression; Internal medicine; Psoriatic arthritis; Discontinuation; Context (archaeology); Rheumatology; Adverse effect; Cancer; Rheumatoid arthritis; Psoriasis; Polyarthritis; Arthritis; Oncology; Immunology","score_opus":0.03504324545533205,"score_gpt":0.3368035687868914,"score_spread":0.30176032333155933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122051635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.815529,0.17426826,0.0000036798392,0.007300841,0.00086502987,0.0011923584,0.0004145892,0.00009748549,0.00032877206],"genre_scores_gemma":[0.9628211,0.034198646,0.00012911911,0.0008407009,0.00004204249,0.0008602791,0.00035273362,0.00018642166,0.0005689145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99353623,0.0016965745,0.00170454,0.001010467,0.0007171259,0.0013350571],"domain_scores_gemma":[0.9953902,0.0012462587,0.0007875515,0.0011056062,0.0012837226,0.00018666839],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002195222,0.00066526124,0.0015204609,0.0006331174,0.00093772716,0.0000460419,0.00058000005,0.00077313214,0.0012587693],"category_scores_gemma":[0.00040634302,0.0005425346,0.00032974622,0.0019930769,0.0025827698,0.00036527822,0.0001732268,0.0016085436,0.0000044945864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030594498,0.0016021718,0.56842536,0.0001851729,0.017853286,0.004560099,0.012055053,0.00014097148,0.32674932,0.0022592589,0.00031372008,0.035261095],"study_design_scores_gemma":[0.022398023,0.00091206573,0.95351267,0.002242272,0.00022998071,0.0032189724,0.0028398724,0.00010970593,0.0023879234,0.0014021134,0.009969146,0.0007772562],"about_ca_topic_score_codex":0.3103614,"about_ca_topic_score_gemma":0.300926,"teacher_disagreement_score":0.3850873,"about_ca_system_score_codex":0.002983382,"about_ca_system_score_gemma":0.008259981,"threshold_uncertainty_score":0.99970263},"labels":[],"label_agreement":null},{"id":"W3132281503","doi":"10.1007/s00262-021-02884-w","title":"Prognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Medizinische Universität Wien; European Association of Urology; Universität Wien","keywords":"Medicine; Logistic regression; Proportional hazards model; Internal medicine; Oncology; Urothelial carcinoma; Neutrophil to lymphocyte ratio; Urology; Cancer; Gastroenterology; Lymphocyte; Bladder cancer","score_opus":0.006188259279066357,"score_gpt":0.24731278082606012,"score_spread":0.24112452154699376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132281503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986659,0.009646016,0.000031306703,0.0013164214,0.0005341219,0.0012745078,0.0003572622,0.000051658728,0.0001297298],"genre_scores_gemma":[0.99801826,0.0005846912,0.00014981779,0.00017941401,0.00012608441,0.00042314923,0.0003781908,0.000053049484,0.00008732125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756485,0.0004288901,0.0008645639,0.00044949842,0.00035021844,0.00034195106],"domain_scores_gemma":[0.9981634,0.00016203767,0.00048450302,0.0006535133,0.00049748877,0.000039039962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023551483,0.00028774177,0.000492495,0.00018418998,0.000093954535,0.000040023082,0.00030547546,0.0003009544,0.00025888256],"category_scores_gemma":[0.00017882217,0.00021432935,0.0001640893,0.0005198208,0.00025785365,0.00019143625,0.00006211836,0.00038130357,0.000006198717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012347539,0.00032057916,0.62626845,0.000024496794,0.00070589536,0.00005075209,0.0019181747,0.000012537912,0.35537195,0.000018186118,0.0000123648315,0.002949113],"study_design_scores_gemma":[0.021207893,0.00011437941,0.8233412,0.0007680595,0.00012834897,0.000065914675,0.0011031225,0.0009983161,0.15049511,0.000014925582,0.0015753327,0.0001873881],"about_ca_topic_score_codex":0.00044763836,"about_ca_topic_score_gemma":0.00012129613,"teacher_disagreement_score":0.20487684,"about_ca_system_score_codex":0.0005645839,"about_ca_system_score_gemma":0.0009138645,"threshold_uncertainty_score":0.8740097},"labels":[],"label_agreement":null},{"id":"W3155027568","doi":"10.1007/s00262-021-02936-1","title":"A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Cancer Institute, University of Pittsburgh; National Cancer Institute; National Institutes of Health; Ovarian Cancer Research Fund; Roswell Park Cancer Institute; Ovarian Cancer Research Alliance","keywords":"Blockade; Medicine; Ovarian cancer; Immune checkpoint; Immunotherapy; Cancer immunotherapy; Context (archaeology); CD8; Cancer research; Oncology; Immunology; Cancer; Internal medicine; Immune system; Biology","score_opus":0.012406338624845248,"score_gpt":0.24840957037000375,"score_spread":0.2360032317451585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155027568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78743035,0.2087492,0.00017516268,0.0017016588,0.0010196383,0.00069710356,0.00009528351,0.0000669937,0.00006462513],"genre_scores_gemma":[0.9398015,0.055853482,0.00012555363,0.0005387077,0.000028527926,0.0004503688,0.00018759194,0.00010196906,0.002912271],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966897,0.00057001295,0.0009772041,0.00078796595,0.00015376731,0.00082134816],"domain_scores_gemma":[0.99769586,0.00040506953,0.00065771106,0.0008400344,0.0003729522,0.000028342329],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046806966,0.00065184577,0.0011552148,0.0004272986,0.00041546783,0.00007851773,0.00052282924,0.0006055388,0.0027544128],"category_scores_gemma":[0.00004148762,0.0005655346,0.00020448762,0.0005083972,0.00088151067,0.00037032974,0.00014861608,0.0007504329,0.000032373788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01105596,0.0005119785,0.003855336,0.000055528184,0.0026042017,0.0000257974,0.0064460444,0.000057393536,0.9685871,0.00024747412,0.000054646902,0.00649851],"study_design_scores_gemma":[0.013658158,0.00061043224,0.1180756,0.00034613884,0.00007596258,0.00020980452,0.0017481819,0.0000044234907,0.8567702,0.00017102165,0.0077886446,0.0005414053],"about_ca_topic_score_codex":0.0022365868,"about_ca_topic_score_gemma":0.00063310115,"teacher_disagreement_score":0.15289573,"about_ca_system_score_codex":0.00020839588,"about_ca_system_score_gemma":0.000793858,"threshold_uncertainty_score":0.9996796},"labels":[],"label_agreement":null},{"id":"W3164391832","doi":"10.1007/s00262-021-02953-0","title":"Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Medizinische Universität Wien; Universität Wien","keywords":"Medicine; Cystectomy; Biomarker; Lymph node; Bladder cancer; Oncology; Internal medicine; Lymphovascular invasion; Metastasis; Proportional hazards model; Urology; Cancer; Gastroenterology","score_opus":0.02685112807642974,"score_gpt":0.34695266755807463,"score_spread":0.3201015394816449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164391832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96741295,0.02844343,0.000099577795,0.0010843123,0.0006992995,0.0010050727,0.0011584229,0.000028831537,0.00006810627],"genre_scores_gemma":[0.99207866,0.0037207352,0.00030193446,0.00056889735,0.00007476294,0.0012435977,0.00003819852,0.000076004726,0.0018972086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982211,0.00012504715,0.0005695274,0.00049935206,0.00018320336,0.00040177233],"domain_scores_gemma":[0.9986113,0.00018434828,0.0002241287,0.00051871367,0.00034688617,0.000114637936],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000088415494,0.00039815903,0.0009963311,0.00015825179,0.00006290273,0.00001571765,0.00014959039,0.00019504939,0.003082732],"category_scores_gemma":[0.00005669927,0.00029625033,0.00044933823,0.00017593823,0.0004940428,0.00011206563,0.00005347928,0.0002553876,0.0000042205065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.072078235,0.0019306258,0.55741453,0.0004348288,0.019202571,0.000054848082,0.0067402846,0.000034801342,0.2731434,0.00015477114,0.0011985188,0.06761257],"study_design_scores_gemma":[0.02064173,0.0029868262,0.8246857,0.00081368175,0.0004079483,0.000020281663,0.00021507985,0.000033171353,0.14748852,0.00008175368,0.0022749817,0.00035030744],"about_ca_topic_score_codex":0.0005236485,"about_ca_topic_score_gemma":0.00008332398,"teacher_disagreement_score":0.26727116,"about_ca_system_score_codex":0.0004358889,"about_ca_system_score_gemma":0.0011944157,"threshold_uncertainty_score":0.999949},"labels":[],"label_agreement":null},{"id":"W3179524201","doi":"10.1007/s00262-021-02975-8","title":"Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors","year":2021,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Immunotherapy; Cancer research; Lymphokine-activated killer cell; Cancer immunotherapy; Ex vivo; Tumor microenvironment; Natural killer cell; Cell therapy; Biology; Immunology; Interleukin 21; Interleukin 12; Cytotoxic T cell; Stem cell; T cell; In vivo; Immune system; In vitro; Cell biology; Tumor cells; Biotechnology","score_opus":0.053330679132548006,"score_gpt":0.35285999589876776,"score_spread":0.29952931676621974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179524201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019462045,0.93096584,0.000013293285,0.000030531948,0.032084532,0.01711062,0.00021908394,0.000106363004,0.000007678338],"genre_scores_gemma":[0.00127265,0.9746265,0.00007554969,0.00006935999,0.00010185859,0.016187726,0.00047235034,0.0003122359,0.0068817814],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929042,0.0011696494,0.0030040555,0.0015771001,0.00015112112,0.0011938813],"domain_scores_gemma":[0.9947161,0.00048582492,0.002614016,0.0013579561,0.0007810614,0.000045003984],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00034812433,0.0016627193,0.005518552,0.00077214994,0.00023814829,0.00004955903,0.0007880497,0.0012773654,0.0009691272],"category_scores_gemma":[0.000011792631,0.0013901744,0.0014071089,0.00070485426,0.00078386854,0.0002787539,0.00015718132,0.0012708561,0.0000174803],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023785636,0.00089221855,0.000019761734,0.0017628728,0.0027303244,0.0000020347438,0.000867645,0.00006659837,0.42715865,0.000012599968,0.00081287476,0.56329584],"study_design_scores_gemma":[0.008229139,0.0010754965,0.00006550669,0.006342806,0.0002483125,0.000027655127,0.00024137172,0.000006403222,0.32412603,0.0000024380693,0.65875643,0.00087842566],"about_ca_topic_score_codex":0.0005822193,"about_ca_topic_score_gemma":0.00017017206,"teacher_disagreement_score":0.65794355,"about_ca_system_score_codex":0.0015471282,"about_ca_system_score_gemma":0.0012477478,"threshold_uncertainty_score":0.99994415},"labels":[],"label_agreement":null},{"id":"W3186426676","doi":"10.1007/s00262-021-02982-9","title":"Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Ministry of Education, Science and Technology; National Research Foundation of Korea; National Research Foundation","keywords":"K562 cells; Cytotoxic T cell; Lymphokine-activated killer cell; Interleukin 21; Interleukin 12; Immunotherapy; Peripheral blood mononuclear cell; NK-92; Immunology; Cancer research; Biology; Cell culture; Molecular biology; Chemistry; Cell biology; In vitro; Immune system; Leukemia; Biochemistry","score_opus":0.01661279733867771,"score_gpt":0.25216604707919843,"score_spread":0.23555324974052072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186426676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94248277,0.04798215,0.000050767165,0.000049035258,0.008962493,0.00035146574,0.00002069459,0.000040717256,0.0000599044],"genre_scores_gemma":[0.98584706,0.0112710465,0.00015698129,0.00031522644,0.00002797252,0.00003746075,0.0000870491,0.000059178,0.0021980149],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99762166,0.00041593835,0.000740705,0.00061532605,0.000069883565,0.0005364997],"domain_scores_gemma":[0.99865437,0.00024584556,0.0003882591,0.0004468003,0.00024126917,0.000023449818],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018001585,0.0004051407,0.00069498946,0.00030340644,0.00033839286,0.000049211907,0.0001801741,0.0005230166,0.0006356626],"category_scores_gemma":[0.000042737152,0.0004056425,0.00012298104,0.00026581116,0.0006043859,0.00039312482,0.0001485032,0.00067455735,0.000018325787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014851496,0.00018648278,0.0043938155,0.000048396003,0.00034288972,0.000006604873,0.0017531749,0.000026021255,0.97928494,0.000006404452,0.0002916262,0.012174489],"study_design_scores_gemma":[0.007037646,0.00020360776,0.02149113,0.00027831914,0.000033154105,0.000059997234,0.0009815205,0.00009154407,0.95582896,0.000012533328,0.013589496,0.00039210235],"about_ca_topic_score_codex":0.00047716257,"about_ca_topic_score_gemma":0.00004640183,"teacher_disagreement_score":0.043364298,"about_ca_system_score_codex":0.0001679047,"about_ca_system_score_gemma":0.0001566029,"threshold_uncertainty_score":0.99983954},"labels":[],"label_agreement":null},{"id":"W3199514812","doi":"10.1007/s00262-021-03051-x","title":"The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoides","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"Drs Martin and Dorothy Spatz Charitable Foundation","keywords":"CD47; Cytotoxic T cell; Cancer research; Mycosis fungoides; Immunotherapy; Immunology; Cutaneous T-cell lymphoma; Lymphoma; Medicine; Antibody; Biology; Immune system; In vitro","score_opus":0.015303673055613896,"score_gpt":0.30924680586576947,"score_spread":0.29394313281015555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199514812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7997505,0.1976477,0.0000029262303,0.00096986245,0.00031959504,0.0010245467,0.00001326871,0.000020296042,0.00025126783],"genre_scores_gemma":[0.85859215,0.14019652,0.000013781752,0.00028496463,0.00006623467,0.00039131084,0.000007850972,0.000074148375,0.00037306617],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99605304,0.001346376,0.00094054325,0.00043942413,0.00047305075,0.0007475956],"domain_scores_gemma":[0.99578536,0.0023976339,0.0003557555,0.0012012792,0.00022305161,0.000036901663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001784249,0.00037634536,0.0010396807,0.00027324556,0.00015318031,0.000027196673,0.00066922366,0.00028879195,0.0008969684],"category_scores_gemma":[0.000108516244,0.00022669943,0.0003545902,0.0012478681,0.0009003985,0.00008335631,0.00009736419,0.000971179,0.000006919166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027045493,0.0001898822,0.052455533,0.00004094512,0.0006673057,0.000012671541,0.0021445719,0.00003170998,0.7392764,0.00004851251,0.0000072849616,0.2024206],"study_design_scores_gemma":[0.0067703165,0.0011383647,0.124359846,0.00019212985,0.000024304121,0.000028659111,0.0010836694,0.00008698053,0.8627333,0.00014077491,0.003272391,0.00016925679],"about_ca_topic_score_codex":0.001127573,"about_ca_topic_score_gemma":0.0002588613,"teacher_disagreement_score":0.20225134,"about_ca_system_score_codex":0.0002829684,"about_ca_system_score_gemma":0.00057942234,"threshold_uncertainty_score":0.98211753},"labels":[],"label_agreement":null},{"id":"W3200945286","doi":"10.1007/s00262-021-03059-3","title":"Loss of cancer cell STAT1 improves response to radiation therapy and promotes T cell activation in head and neck squamous cell carcinoma","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute","keywords":"Cancer research; Radioresistance; Tumor microenvironment; STAT1; Head and neck squamous-cell carcinoma; Immune system; Immunotherapy; Biology; Cancer; Cancer cell; Cell; Immunology; Head and neck cancer; Medicine; Radiation therapy; Interferon; Internal medicine","score_opus":0.018780933229145952,"score_gpt":0.2955135721291337,"score_spread":0.2767326388999878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200945286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9271788,0.070329756,0.00003286538,0.001483711,0.00024070192,0.00058100326,0.000037809124,0.000022489838,0.000092880946],"genre_scores_gemma":[0.9862928,0.01191735,0.00022054074,0.00069145893,0.00005182977,0.00019130469,0.000021535818,0.000046483914,0.00056669716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986242,0.00016518199,0.00041263134,0.00039760396,0.000112924834,0.00028743292],"domain_scores_gemma":[0.99901754,0.0001908336,0.00019998029,0.0003312083,0.00020485767,0.000055561944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016476696,0.00023087807,0.00042293427,0.00018350499,0.000084843756,0.00002402483,0.00007360986,0.00016286425,0.00026717002],"category_scores_gemma":[0.000029856255,0.00022011857,0.000064357584,0.0002822206,0.00010717834,0.00016172644,0.000030515148,0.000267459,0.0000014859316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070310663,0.00035008558,0.025862599,0.00007506108,0.000044630102,0.000007868236,0.0054280967,0.000012558967,0.9323278,0.0000048820552,0.00004248595,0.028812887],"study_design_scores_gemma":[0.00587535,0.0011858254,0.29799706,0.00006949751,0.000014325566,0.000008424228,0.00042062852,0.00003379048,0.6896593,0.000013756157,0.0045767864,0.00014526588],"about_ca_topic_score_codex":0.0043486347,"about_ca_topic_score_gemma":0.00023025635,"teacher_disagreement_score":0.27213445,"about_ca_system_score_codex":0.00031999435,"about_ca_system_score_gemma":0.00063692033,"threshold_uncertainty_score":0.89761746},"labels":[],"label_agreement":null},{"id":"W3206590901","doi":"10.1007/s00262-021-03073-5","title":"Molecular imaging of cellular immunotherapies in experimental and therapeutic settings","year":2021,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Robarts Clinical Trials; Western University","funders":"","keywords":"Immune system; Ex vivo; Medicine; Cancer; Biodistribution; Immunotherapy; Cancer research; Bioinformatics; In vivo; Immunology; Biology; Internal medicine","score_opus":0.03297253149538901,"score_gpt":0.37100936070885276,"score_spread":0.3380368292134638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206590901","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0077756015,0.9895344,0.000030535542,0.00024226823,0.0003853031,0.0017088887,0.000024128074,0.00006180877,0.00023706316],"genre_scores_gemma":[0.0014398652,0.9961093,0.000106252635,0.00047768277,0.00006903439,0.00074878486,0.000082631705,0.00032100017,0.00064544234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99573046,0.00068499485,0.0013616504,0.000966085,0.000409672,0.0008471617],"domain_scores_gemma":[0.9976242,0.00025708912,0.0005697947,0.0013001153,0.00017443404,0.000074360934],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055013003,0.0009104102,0.0038921968,0.00087913603,0.00009055621,0.000054136228,0.00052221405,0.0006132279,0.003199618],"category_scores_gemma":[0.000020691454,0.0008338822,0.00086317386,0.00085250684,0.0009503566,0.00008002853,0.00019524738,0.0013658011,0.000009067236],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023097721,0.00021649658,0.000100368525,0.0017907048,0.002034127,0.00016051676,0.00080456043,2.5508777e-7,0.34025154,0.00009314854,0.000014774634,0.65430254],"study_design_scores_gemma":[0.004077715,0.00033674057,0.00006748669,0.013505464,0.00034903092,0.00042386493,0.0006286302,0.000006334068,0.054598648,0.000030180203,0.92524415,0.000731743],"about_ca_topic_score_codex":0.000238624,"about_ca_topic_score_gemma":0.0000023339985,"teacher_disagreement_score":0.9252294,"about_ca_system_score_codex":0.0006869912,"about_ca_system_score_gemma":0.0010536915,"threshold_uncertainty_score":0.9994112},"labels":[],"label_agreement":null},{"id":"W3214261499","doi":"10.1007/s00262-021-03072-6","title":"Endoplasmic reticulum stress-induced release and binding of calreticulin from human ovarian cancer cells","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Higher Committee for Education Development in Iraq; KWF Kankerbestrijding","keywords":"Calreticulin; Endoplasmic reticulum; Unfolded protein response; Thapsigargin; Apoptosis; Cell biology; Extracellular; Flow cytometry; Programmed cell death; Biology; Cancer research; Chemistry; Molecular biology; Biochemistry","score_opus":0.010970727874084906,"score_gpt":0.27020247783225904,"score_spread":0.2592317499581741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214261499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95212424,0.04589159,0.00005686974,0.00027061443,0.0005855336,0.00020262913,0.0006481251,0.00002128175,0.00019910878],"genre_scores_gemma":[0.97185445,0.026682414,0.0002066983,0.00025554004,0.00015279446,0.00013360896,0.00030780956,0.0000600429,0.00034663625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980521,0.00018971003,0.0004906026,0.0006869038,0.00014874889,0.00043190207],"domain_scores_gemma":[0.9986566,0.00004109421,0.0002860232,0.0007183285,0.00019062369,0.00010737499],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000073566385,0.00033949094,0.00045719594,0.00006793656,0.00017870546,0.000037305705,0.0002774822,0.00034328335,0.00060927274],"category_scores_gemma":[0.000037873324,0.00034114314,0.00016994665,0.00014765601,0.0003407459,0.000010864804,0.00015145859,0.0002467126,0.0000051591674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027406917,0.0001549423,0.012786978,0.00003281073,0.00064090604,0.000034220302,0.00018947973,0.0000350235,0.9823311,0.000108902066,0.00016603056,0.0032455265],"study_design_scores_gemma":[0.0034180076,0.00016924147,0.011745631,0.00015059214,0.000090778114,0.000011081258,0.00034732933,0.00001855295,0.9810403,0.000075937394,0.002564083,0.00036846183],"about_ca_topic_score_codex":0.0016684537,"about_ca_topic_score_gemma":0.00028416942,"teacher_disagreement_score":0.01973021,"about_ca_system_score_codex":0.00004199626,"about_ca_system_score_gemma":0.0003329634,"threshold_uncertainty_score":0.99990404},"labels":[],"label_agreement":null},{"id":"W3215213683","doi":"10.1007/s00262-021-03118-9","title":"MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cues","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Lawson Health Research Institute; University of Victoria; Robarts Clinical Trials; University of British Columbia; Western University","funders":"National Health and Medical Research Council; Australian Research Council; Canadian Institutes of Health Research; Michael Smith Health Research BC; Canadian Cancer Society; Canada Foundation for Innovation","keywords":"Cytotoxic T cell; Biology; CD8; Granzyme B; Tumor necrosis factor alpha; Immunology; Cytokine; Cancer research; Antigen","score_opus":0.02110291212026178,"score_gpt":0.2747592289003097,"score_spread":0.2536563167800479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215213683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94539076,0.042995874,0.0001825677,0.0058083315,0.0044103167,0.0006400355,0.00009595566,0.00012795338,0.0003482317],"genre_scores_gemma":[0.9577585,0.019759173,0.00013053375,0.005670972,0.000098985176,0.00046611778,0.00008299614,0.000107043044,0.01592569],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99678797,0.000560979,0.000772359,0.00091341295,0.00007014537,0.00089511246],"domain_scores_gemma":[0.9982536,0.00027316614,0.00022375229,0.00085334183,0.00033456032,0.000061599356],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004779259,0.0005699091,0.00085222267,0.0005779469,0.00036288472,0.000096424905,0.00046367684,0.00063575833,0.0034355235],"category_scores_gemma":[0.00009274089,0.00053059834,0.0001685932,0.00078900234,0.00020846198,0.00028144012,0.0002069425,0.0009353156,0.00028082245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003453671,0.00014970913,0.005160652,0.000019397059,0.0007105856,0.00001333979,0.0069856686,0.000120197474,0.96505946,0.00015172409,0.003106069,0.015069511],"study_design_scores_gemma":[0.003087584,0.00036642965,0.03966082,0.00024202409,0.000022459439,0.00006528228,0.0011147617,0.0000071433997,0.73302466,0.00011817808,0.22179382,0.00049686705],"about_ca_topic_score_codex":0.0067550545,"about_ca_topic_score_gemma":0.0047366517,"teacher_disagreement_score":0.23203485,"about_ca_system_score_codex":0.00044147708,"about_ca_system_score_gemma":0.00022952462,"threshold_uncertainty_score":0.99985904},"labels":[],"label_agreement":null},{"id":"W4205468989","doi":"10.1007/s00262-021-03088-y","title":"Combination immunotherapy including OncoVEXmGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; National Cancer Institute; Fundação para a Ciência e a Tecnologia; U.S. Food and Drug Administration; Swim Across America","keywords":"Oncolytic virus; Medicine; Cancer research; Melanoma; Immunotherapy; Immune system; FOXP3; Cytotoxic T cell; Immune checkpoint; Tumor microenvironment; Combination therapy; CD8; Immunology; Pharmacology; Biology","score_opus":0.026589077853391038,"score_gpt":0.3032453718668765,"score_spread":0.27665629401348546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205468989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89932996,0.09249949,0.00008554717,0.0039490466,0.00068483595,0.0022044433,0.00006933718,0.00018006937,0.0009972405],"genre_scores_gemma":[0.9436567,0.03960151,0.00033383092,0.0016718444,0.00010764181,0.0028842376,0.00022400761,0.0003069502,0.011213296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99479383,0.0007803362,0.0012747195,0.0010251746,0.0007875503,0.0013383772],"domain_scores_gemma":[0.997724,0.00026198415,0.0004072736,0.0013954069,0.000105548934,0.000105789615],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013700115,0.00070157455,0.0013527076,0.0010177429,0.0007473299,0.00006968954,0.00094511796,0.00023700745,0.03773011],"category_scores_gemma":[0.000019763018,0.00074638426,0.0005099927,0.0011139358,0.00052038854,0.00026719391,0.00028419253,0.0018658213,0.000087683235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008976177,0.0015867081,0.014555653,0.000049834096,0.0012571102,0.00013676508,0.0027216836,0.00023582445,0.9079074,0.00009539736,0.00011916022,0.062358286],"study_design_scores_gemma":[0.05519603,0.0071796263,0.13942578,0.0002674263,0.00012009547,0.0009019762,0.0027356562,0.00032447226,0.53172696,0.0010974639,0.2594071,0.0016173815],"about_ca_topic_score_codex":0.0028831866,"about_ca_topic_score_gemma":0.000044596098,"teacher_disagreement_score":0.37618044,"about_ca_system_score_codex":0.003773855,"about_ca_system_score_gemma":0.00067681214,"threshold_uncertainty_score":0.9994987},"labels":[],"label_agreement":null},{"id":"W4214496408","doi":"10.1007/s00262-022-03169-6","title":"Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitors","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University; National Center for Advancing Translational Sciences; Institute for Clinical and Translational Research, University of Wisconsin, Madison; National Cancer Institute; National Institutes of Health; ECOG-ACRIN Cancer Research Group; LUNGevity Foundation; Bristol-Myers Squibb; International Association for the Study of Lung Cancer","keywords":"Biology; Microbiome; Human microbiome; Immune system; Humanized mouse; Feces; Human Microbiome Project; Immunology; Microbiology; Bioinformatics","score_opus":0.020243961806006173,"score_gpt":0.2630004640901598,"score_spread":0.24275650228415363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214496408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706569,0.019918386,0.00016598283,0.006328471,0.00036382943,0.0020942467,0.00022776614,0.00019744622,0.000047020585],"genre_scores_gemma":[0.99227923,0.00081034674,0.000255248,0.002594185,0.00006746089,0.0014579479,0.00017669835,0.00014612734,0.002212759],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966739,0.0005458343,0.0007384181,0.00084361836,0.0003760915,0.0008221469],"domain_scores_gemma":[0.9989509,0.000089709865,0.00015124129,0.00044182566,0.00023578043,0.00013055651],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009069261,0.0005545807,0.0008453614,0.000388158,0.0008574087,0.000058717276,0.00030850153,0.00020892674,0.00059111963],"category_scores_gemma":[0.000011523522,0.00050616794,0.00027963516,0.00087783457,0.0006478655,0.00016366696,0.00006537673,0.0008822164,0.0000025877935],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.083080634,0.00083632366,0.0018122698,0.000023886298,0.0021392673,0.000054459113,0.0044813105,0.00005328296,0.89736235,0.00004437404,0.00046196103,0.009649852],"study_design_scores_gemma":[0.08425021,0.033165082,0.456057,0.001176389,0.0006303801,0.0022153275,0.002615504,0.0000778326,0.29135826,0.0002366199,0.12549967,0.0027177227],"about_ca_topic_score_codex":0.0008901033,"about_ca_topic_score_gemma":0.00024248919,"teacher_disagreement_score":0.6060041,"about_ca_system_score_codex":0.001451447,"about_ca_system_score_gemma":0.00067266606,"threshold_uncertainty_score":0.999739},"labels":[],"label_agreement":null},{"id":"W4220919246","doi":"10.1007/s00262-022-03159-8","title":"Avelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; London Health Sciences Centre; Centre Hospitalier Universitaire Sainte-Justine; University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"Merck KGaA; Pfizer","keywords":"Medicine; Refractory (planetary science); Cohort; Dosing; Avelumab; Adverse effect; Internal medicine; Open label; Surgery; Gastroenterology; Immunotherapy; Cancer; Nivolumab","score_opus":0.046444493886341906,"score_gpt":0.34590043743839666,"score_spread":0.29945594355205474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220919246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885624,0.0057171886,0.0000042135707,0.0009944714,0.0011750195,0.0027993033,0.0005532532,0.0000854298,0.000108721906],"genre_scores_gemma":[0.99353474,0.0012625678,0.0002526831,0.0008305856,0.0001573728,0.0017846235,0.0019228064,0.000102726895,0.0001518775],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969192,0.0005081666,0.00085402763,0.0008000979,0.00040329463,0.000515182],"domain_scores_gemma":[0.99798906,0.00027270408,0.0005840168,0.00091674103,0.00014839739,0.000089085595],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000337306,0.00039130403,0.0007871943,0.0004003904,0.00033376858,0.000067384986,0.00047469584,0.00018297294,0.0013525778],"category_scores_gemma":[0.000078159144,0.00030792088,0.000058864356,0.0007444667,0.0001343946,0.00037105178,0.00014199736,0.00061754294,0.000014083759],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7837029,0.05653728,0.009476393,0.000005134124,0.00092620094,0.0002435416,0.0024913813,0.000058957266,0.021179123,0.000009723638,0.0007251089,0.12464426],"study_design_scores_gemma":[0.81950784,0.07182349,0.09366057,0.00009833371,0.00021323572,0.000013560982,0.00038535052,0.00007241092,0.0024679152,0.00004784706,0.011220236,0.00048921147],"about_ca_topic_score_codex":0.001957781,"about_ca_topic_score_gemma":0.00024785718,"teacher_disagreement_score":0.124155045,"about_ca_system_score_codex":0.0013767766,"about_ca_system_score_gemma":0.00061509816,"threshold_uncertainty_score":0.9999373},"labels":[],"label_agreement":null},{"id":"W4248464463","doi":"10.1007/s00262-008-0564-8","title":"Progress in Vaccination against Cancer 2007 (PIVAC 7)","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Trent University; British Society for Immunology; Nottingham Trent University","keywords":"Vaccination; Cancer; Medicine; Virology; Internal medicine","score_opus":0.02062129178391662,"score_gpt":0.32944676982050436,"score_spread":0.3088254780365877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248464463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8070738,0.19095401,0.00003349008,0.0007049955,0.00049486855,0.0004161919,0.00002275512,0.00003165001,0.0002682332],"genre_scores_gemma":[0.85619986,0.13964193,0.00007162163,0.0012162374,0.00026962996,0.0009134051,0.000085656524,0.00008333426,0.0015183586],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980362,0.00021845466,0.0003661071,0.0005384386,0.00018914578,0.0006516574],"domain_scores_gemma":[0.99897397,0.00001506896,0.00013713054,0.0006406602,0.00018408019,0.000049115628],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025627963,0.00029256378,0.00029863731,0.0002046268,0.00018605331,0.00001635447,0.0005539301,0.0003433603,0.00071722915],"category_scores_gemma":[0.000013456476,0.00029660793,0.00011628137,0.0003358563,0.00028631632,0.00001423353,0.00008097051,0.00033155753,0.00003384382],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056584873,0.00021910839,0.06895603,0.000011638908,0.0003919937,0.000021997354,0.0003491496,0.00017036322,0.732194,0.00001036165,0.0023780966,0.18963876],"study_design_scores_gemma":[0.007134281,0.0020061347,0.21626309,0.000050509298,0.000007880107,0.000030489422,0.00008138766,0.000067736255,0.67878217,0.000040185754,0.09483374,0.0007023776],"about_ca_topic_score_codex":0.00013898182,"about_ca_topic_score_gemma":0.00039998427,"teacher_disagreement_score":0.18893638,"about_ca_system_score_codex":0.00020873336,"about_ca_system_score_gemma":0.0005044635,"threshold_uncertainty_score":0.9999486},"labels":[],"label_agreement":null},{"id":"W4282977144","doi":"10.1007/s00262-022-03228-y","title":"Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Irish Research Council; Irish Research Council for Science, Engineering and Technology; Irish Research eLibrary","keywords":"Immune checkpoint; Immune system; Cancer research; Acidosis; Adenocarcinoma; Medicine; Internal medicine; Immunology; Cancer; Immunotherapy","score_opus":0.014016184611313641,"score_gpt":0.2539326952524399,"score_spread":0.23991651064112623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282977144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9058968,0.08933996,0.000069589,0.000507043,0.00206539,0.0012784096,0.00060093927,0.00011808543,0.00012382913],"genre_scores_gemma":[0.98965037,0.0069304863,0.0004519733,0.0008399526,0.000119844466,0.00094468973,0.0004010003,0.00013401806,0.0005276607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962444,0.00038340414,0.0012803341,0.0007817491,0.00062532804,0.00068482925],"domain_scores_gemma":[0.9975231,0.00013781546,0.00086753635,0.0011784416,0.00020674847,0.00008632023],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003671451,0.0005293385,0.0010581902,0.00036060374,0.0004485389,0.000022216967,0.000721557,0.00023633389,0.007911747],"category_scores_gemma":[0.000015877586,0.00049656164,0.00061748695,0.00057503546,0.0005400367,0.00016353487,0.000249164,0.0007469953,0.000019254036],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016928805,0.00081286946,0.027571676,0.000044312135,0.0014121558,0.000018530442,0.0022200935,0.000020059486,0.91899604,0.0000066363405,0.0007171659,0.031251673],"study_design_scores_gemma":[0.011191194,0.0017488721,0.21937156,0.000107721105,0.00011288682,0.000010507525,0.00096255925,0.000015447611,0.75810486,0.00004878695,0.007934101,0.00039151058],"about_ca_topic_score_codex":0.00187188,"about_ca_topic_score_gemma":0.0000059472172,"teacher_disagreement_score":0.19179988,"about_ca_system_score_codex":0.00072389684,"about_ca_system_score_gemma":0.00044854727,"threshold_uncertainty_score":0.9997486},"labels":[],"label_agreement":null},{"id":"W4285083671","doi":"10.1007/s00262-022-03245-x","title":"Preclinical development of a vaccine-based immunotherapy regimen (VBIR) that induces potent and durable T cell responses to tumor-associated self-antigens","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Pfizer (Canada)","funders":"","keywords":"Antigen; Priming (agriculture); Immunology; Cancer immunotherapy; Immune system; Immunotherapy; Cytotoxic T cell; Cancer vaccine; Viral vector; DNA vaccination; Antibody; Biology; CD8; T cell; Virology; Medicine; Immunization; Recombinant DNA; In vitro","score_opus":0.024578786222986128,"score_gpt":0.2818643514443684,"score_spread":0.25728556522138224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285083671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87318337,0.121804945,0.00014582473,0.001176901,0.0016798397,0.0014195337,0.0001589717,0.00031908328,0.000111519],"genre_scores_gemma":[0.98609024,0.005162746,0.00095793494,0.0024620236,0.000026112717,0.001437828,0.00011819764,0.00020026538,0.00354464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9928117,0.0026694376,0.0017077236,0.0011339304,0.00028221947,0.00139498],"domain_scores_gemma":[0.9960691,0.0010710978,0.0011901427,0.0013292157,0.0002740617,0.00006642116],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022445666,0.00089843135,0.0015436092,0.0008975348,0.0018192535,0.000060225993,0.0014877127,0.00050396816,0.0020425874],"category_scores_gemma":[0.00010205065,0.0008907972,0.00040557445,0.0008669663,0.00042386973,0.0002160614,0.0004498274,0.0013408443,0.00007523867],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022562658,0.001800062,0.0073012076,0.000036738053,0.0029401937,0.000015469832,0.008317782,0.000055857,0.92983043,0.000027401697,0.001059054,0.02605312],"study_design_scores_gemma":[0.014502746,0.0026843161,0.0895873,0.00012561398,0.00008957046,0.000097706754,0.002091155,0.0000055965256,0.6779082,0.00004253466,0.21178868,0.001076578],"about_ca_topic_score_codex":0.00045328325,"about_ca_topic_score_gemma":0.000026866142,"teacher_disagreement_score":0.25192225,"about_ca_system_score_codex":0.0006997696,"about_ca_system_score_gemma":0.001796253,"threshold_uncertainty_score":0.99948025},"labels":[],"label_agreement":null},{"id":"W4300972003","doi":"10.1007/s00262-022-03297-z","title":"Detecting monocyte trafficking in an animal model of glioblastoma using R2* and quantitative susceptibility mapping","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Alberta Innovates - Health Solutions; Alberta Cancer Foundation","keywords":"Innate immune system; CD16; Immune system; Medicine; Cancer research; Immunotherapy; Monocyte; Flow cytometry; Acquired immune system; Tumor microenvironment; Tumor progression; Glioma; Immunology; Cancer; CD8; Internal medicine; CD3","score_opus":0.05395765473774904,"score_gpt":0.31596423342840135,"score_spread":0.2620065786906523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300972003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9232562,0.07442789,0.0007610967,0.000057795794,0.00083451,0.0004905475,0.000060432332,0.000083690866,0.000027827251],"genre_scores_gemma":[0.9972714,0.0010125972,0.0012142281,0.00015951178,0.000011649628,0.00018368826,0.000013250324,0.00007835457,0.000055274646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99662954,0.00089711003,0.00088971836,0.00074814406,0.00008345575,0.00075204036],"domain_scores_gemma":[0.99843985,0.00023579995,0.0005500799,0.00063297164,0.00012418735,0.000017093347],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000933579,0.00039732325,0.0007895805,0.00053780683,0.00061841164,0.000018018098,0.0005998476,0.00028932685,0.0005244517],"category_scores_gemma":[0.00003684232,0.00046133003,0.00013393411,0.00055928546,0.0008650694,0.00032348518,0.0003372049,0.0011438148,0.0000028515597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038732504,0.00019222169,0.0073255105,0.000029959667,0.0003357154,0.00000420824,0.011972334,0.019505063,0.94056696,0.00021266605,0.0000047754174,0.015977321],"study_design_scores_gemma":[0.014803338,0.0048693637,0.026573295,0.00025136923,0.0001040369,0.0002672505,0.03309463,0.05276909,0.86336005,0.00080213585,0.0013206844,0.0017847893],"about_ca_topic_score_codex":0.0009495322,"about_ca_topic_score_gemma":0.00027532713,"teacher_disagreement_score":0.077206954,"about_ca_system_score_codex":0.00071027584,"about_ca_system_score_gemma":0.00035381995,"threshold_uncertainty_score":0.9997838},"labels":[],"label_agreement":null},{"id":"W4308057718","doi":"10.1007/s00262-022-03313-2","title":"Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Canada Research Chairs; Cancer Research Society","keywords":"CCL20; Radioresistance; Cancer research; Head and neck squamous-cell carcinoma; Immune system; Chemokine; Tumor microenvironment; Medicine; Flow cytometry; Immunotherapy; Immunology; Biology; Radiation therapy; Head and neck cancer; Internal medicine; Chemokine receptor","score_opus":0.022720418079313104,"score_gpt":0.2710689946598808,"score_spread":0.24834857658056772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308057718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9363233,0.0608618,0.00000469707,0.0010871525,0.0003675654,0.0012151973,0.000027130114,0.00002240853,0.00009074265],"genre_scores_gemma":[0.9936942,0.0041183233,0.0000595957,0.001077586,0.00006273212,0.00027930786,0.000016695461,0.000039861523,0.00065168604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987953,0.00012345305,0.0003320474,0.00031698763,0.0001974248,0.00023483565],"domain_scores_gemma":[0.99930686,0.000056684705,0.00020348778,0.0003278949,0.000060793245,0.000044310676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021806624,0.00019896064,0.000355017,0.000111613954,0.00026319732,0.000010840969,0.000082068436,0.00009361995,0.00024228057],"category_scores_gemma":[0.0000048190127,0.00016401974,0.000097135184,0.00021487605,0.00012390496,0.000045591383,0.000089354624,0.00026485696,7.448696e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012119558,0.00018110647,0.020311955,0.0000409455,0.000061976156,0.0000023501582,0.0034528798,0.000027283646,0.93487066,0.0000093013,0.0003581832,0.039471425],"study_design_scores_gemma":[0.0073745376,0.00125881,0.16151918,0.000038728962,0.00003231468,0.000042902553,0.00050693826,0.000021931997,0.81327325,0.00004550192,0.015709724,0.00017618944],"about_ca_topic_score_codex":0.00033532988,"about_ca_topic_score_gemma":0.0000051837906,"teacher_disagreement_score":0.14120723,"about_ca_system_score_codex":0.0002689767,"about_ca_system_score_gemma":0.00012871239,"threshold_uncertainty_score":0.6688531},"labels":[],"label_agreement":null},{"id":"W4309260043","doi":"10.1007/s00262-022-03329-8","title":"Improved MAIT cell functions following fecal microbiota transplantation for metastatic renal cell carcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Canadian Cancer Society; London Health Sciences Foundation","keywords":"BTLA; Granzyme B; Transplantation; Immunology; T cell; Renal cell carcinoma; CD8; Medicine; Biology; Internal medicine; Immune system","score_opus":0.012756396693555133,"score_gpt":0.2449532232831614,"score_spread":0.23219682658960628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309260043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9032959,0.05594664,0.012424437,0.0005737485,0.024153167,0.0017710438,0.0004319258,0.00026724656,0.0011358891],"genre_scores_gemma":[0.9488263,0.0007705824,0.00021590703,0.0010199139,0.000056387416,0.0020822647,0.0017898842,0.00011046396,0.04512826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99727285,0.00050889316,0.00070974906,0.00067073834,0.0000642456,0.0007735257],"domain_scores_gemma":[0.9986976,0.00023680428,0.00039514192,0.0005329288,0.00011388971,0.000023639399],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037993904,0.00044815577,0.0005424351,0.00036033193,0.0016212336,0.000041460848,0.0004790517,0.00022988171,0.007134182],"category_scores_gemma":[0.000009211051,0.0004782669,0.00061654847,0.0003293684,0.00016467868,0.00023962102,0.00007142041,0.00090322556,0.00016351532],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038060443,0.0004037899,0.00017717008,0.000037809677,0.0006407137,0.0000053577373,0.0010942152,0.00013654698,0.9784047,0.000029467281,0.009897345,0.005366822],"study_design_scores_gemma":[0.0112448735,0.0015187748,0.0013349288,0.000011642452,0.00026906727,0.00015948256,0.0017231873,0.000048406644,0.56755936,0.00002436915,0.41555205,0.00055385905],"about_ca_topic_score_codex":0.0005057091,"about_ca_topic_score_gemma":0.000023216182,"teacher_disagreement_score":0.41084537,"about_ca_system_score_codex":0.00048768046,"about_ca_system_score_gemma":0.000282833,"threshold_uncertainty_score":0.9997669},"labels":[],"label_agreement":null},{"id":"W4310154835","doi":"10.1007/s00262-022-03333-y","title":"Pharmacological potentiation of monocyte-derived dendritic cell cancer immunotherapy","year":2022,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Immunotherapy; Cancer immunotherapy; Dendritic cell; Tumor microenvironment; Cancer research; T cell; Medicine; Cancer; Immune system; Immunology; Internal medicine","score_opus":0.04885717410195012,"score_gpt":0.342480103968901,"score_spread":0.2936229298669509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310154835","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029339474,0.9832414,0.00009712028,0.000114280396,0.009093483,0.0029048112,0.000773671,0.0005966365,0.00024464392],"genre_scores_gemma":[0.00064118876,0.986454,0.000055090364,0.00045640988,0.00013465818,0.005655142,0.00081577204,0.0007025892,0.005085158],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9888349,0.0040146355,0.0032576066,0.0016862962,0.0002873959,0.0019191349],"domain_scores_gemma":[0.99307495,0.0014542687,0.003254728,0.0018959666,0.00026520906,0.00005488555],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00095272367,0.002090699,0.00575798,0.0013344139,0.0009296564,0.00007371182,0.0032072465,0.0023050779,0.044071827],"category_scores_gemma":[0.000055934757,0.0018978731,0.0027320113,0.0014065658,0.0015730214,0.00036785682,0.00049392495,0.0033758697,0.0002705458],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021090175,0.00084435305,0.000012263538,0.0012893552,0.009801666,0.000019613572,0.00059132127,0.000011733093,0.22970186,0.00005051788,0.0010931342,0.7544752],"study_design_scores_gemma":[0.006320596,0.00097014307,0.000081194645,0.0017260873,0.0016551288,0.00020751511,0.000249003,0.0000010938383,0.035566114,0.000037070797,0.9514557,0.0017303253],"about_ca_topic_score_codex":0.00095865654,"about_ca_topic_score_gemma":0.000010738119,"teacher_disagreement_score":0.9503626,"about_ca_system_score_codex":0.001377662,"about_ca_system_score_gemma":0.0022924037,"threshold_uncertainty_score":0.9991835},"labels":[],"label_agreement":null},{"id":"W4328049217","doi":"10.1007/s00262-023-03413-7","title":"Identification of antigenic epitopes recognized by tumor infiltrating lymphocytes in high grade serous ovarian cancer by multi-omics profiling of the auto-antigen repertoire","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Montréal; Institute for Research in Immunology and Cancer; Princess Margaret Cancer Centre","funders":"Scheme for Promotion of Academic and Research Collaboration; Terry Fox Research Institute","keywords":"Epitope; Antigen; Biology; Ovarian cancer; Tumor antigen; Antibody; Immunology; Cancer; Cancer research; Immunotherapy; Immune system; Genetics","score_opus":0.016909549630141064,"score_gpt":0.27719745910523813,"score_spread":0.26028790947509706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328049217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8521033,0.14307539,0.00009425353,0.0007213239,0.0022412932,0.0010072949,0.0006144024,0.00013777132,0.0000050016765],"genre_scores_gemma":[0.9396711,0.057348162,0.000103060804,0.00029361862,0.000020652522,0.0005732198,0.00027678258,0.00011504559,0.001598345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953121,0.0011463346,0.001865829,0.00068641215,0.00012491079,0.00086440943],"domain_scores_gemma":[0.99671495,0.00044537813,0.0014880251,0.0010973132,0.00023872427,0.00001560364],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010114441,0.0005304081,0.001093482,0.00038406224,0.00045954218,0.000030037467,0.001239617,0.0005843793,0.00023304234],"category_scores_gemma":[0.00020551492,0.00044519597,0.00033336264,0.0013711161,0.0010913279,0.00026729924,0.0001508322,0.00065716647,0.000029080524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016542955,0.00027374446,0.022514125,0.000055292738,0.0011995779,0.0000015978046,0.0021379762,0.00006251991,0.95184624,0.000047673948,0.0005376516,0.019669276],"study_design_scores_gemma":[0.007155888,0.00014509149,0.050680663,0.00024164002,0.000045128392,0.000022938406,0.0008681863,0.000088023495,0.93590766,0.000054835207,0.004358755,0.0004311761],"about_ca_topic_score_codex":0.006665193,"about_ca_topic_score_gemma":0.00009683319,"teacher_disagreement_score":0.08756785,"about_ca_system_score_codex":0.00031775588,"about_ca_system_score_gemma":0.00066451216,"threshold_uncertainty_score":0.9999495},"labels":[],"label_agreement":null},{"id":"W4365813711","doi":"10.1007/s00262-023-03442-2","title":"Engineered murine IL-21-secreting leukemia cells induce granzyme B+ T cells and CD4+CD44+CD62L− effector memory cells while suppressing regulatory T cells, leading to long-term survival","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Leukemia and Lymphoma Society of Canada; Leukemia and Lymphoma Society","keywords":"Leukemia; Adoptive cell transfer; Granzyme B; Immunology; Biology; CD8; Immune system; Interleukin 21; Cytotoxic T cell; IL-2 receptor; Granzyme; Cancer research; Molecular biology; T cell; Perforin","score_opus":0.027116800034224724,"score_gpt":0.30158481317946384,"score_spread":0.2744680131452391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365813711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766282,0.014509907,0.00014036127,0.00048924127,0.004763016,0.0022227284,0.00016344649,0.00068916,0.00039394438],"genre_scores_gemma":[0.9592884,0.014679734,0.0003463991,0.00068761094,0.0010698156,0.0005297505,0.0001771905,0.0006226149,0.02259846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99362916,0.00065800233,0.0011149078,0.0015694567,0.0008615885,0.0021668815],"domain_scores_gemma":[0.9960973,0.0009422334,0.00034531308,0.0018342145,0.00032528696,0.00045560996],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015900185,0.0010748828,0.0017846461,0.0011595424,0.00059669494,0.00020620093,0.00088398927,0.0008267947,0.0031532901],"category_scores_gemma":[0.000049280836,0.0011010541,0.00042518438,0.0014907088,0.00070736895,0.0003014004,0.0004284991,0.0017929875,0.00052986864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022619383,0.00011278382,0.0011795373,0.00044419296,0.001078064,0.00026074756,0.0024007563,0.0004637243,0.9582749,0.000005211868,0.0021064267,0.031411693],"study_design_scores_gemma":[0.0070968815,0.0007719738,0.01792353,0.00074697385,0.00012754551,0.00006141473,0.00030513012,0.00015806286,0.95948386,0.0000072366925,0.012310557,0.0010068249],"about_ca_topic_score_codex":0.00045352304,"about_ca_topic_score_gemma":0.00004680606,"teacher_disagreement_score":0.030404868,"about_ca_system_score_codex":0.0015008654,"about_ca_system_score_gemma":0.0007031315,"threshold_uncertainty_score":0.99914396},"labels":[],"label_agreement":null},{"id":"W4384665022","doi":"10.1007/s00262-023-03486-4","title":"Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cells","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Fondation ARC pour la Recherche sur le Cancer; Agence Nationale de la Recherche","keywords":"Oncolytic virus; Measles virus; Antigen; CD8; Melanoma; Cancer research; Antigen presentation; Immune system; Biology; Tumor antigen; Cytotoxic T cell; Cell culture; T cell; Virology; Immunotherapy; Immunology; Measles; In vitro; Vaccination","score_opus":0.020831922032300092,"score_gpt":0.30938512561190995,"score_spread":0.28855320357960984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384665022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9391978,0.059734,0.000015957281,0.00026906648,0.00019587004,0.00037443746,0.00009837388,0.000033180768,0.000081361075],"genre_scores_gemma":[0.9422301,0.056258574,0.000045285047,0.00021536011,0.00005175465,0.00012785019,0.0000891041,0.000054252225,0.0009276916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839956,0.00022483352,0.00033349637,0.00045501173,0.000165996,0.0004211165],"domain_scores_gemma":[0.9992352,0.00006384215,0.00016256179,0.00036592668,0.00012104886,0.00005141134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031535624,0.00024070269,0.00032406396,0.00016925173,0.00024368422,0.000029942814,0.00028523224,0.0002076962,0.00011280286],"category_scores_gemma":[0.000030042253,0.00024030554,0.00006057474,0.00027792636,0.00049441005,0.000017000868,0.00015180968,0.00018258697,0.000008433628],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013126495,0.000053585813,0.0014241304,0.000024307565,0.00045503915,0.0000048898883,0.0006163455,0.000008632051,0.97699755,0.0000044937105,0.0010151766,0.018083192],"study_design_scores_gemma":[0.0018296565,0.002004177,0.003924064,0.000040084953,0.000018051722,0.000013831923,0.0003014664,0.000050667248,0.9851538,0.000039828177,0.006386484,0.00023790178],"about_ca_topic_score_codex":0.0003655779,"about_ca_topic_score_gemma":0.00009982185,"teacher_disagreement_score":0.017845292,"about_ca_system_score_codex":0.000040395345,"about_ca_system_score_gemma":0.00016266276,"threshold_uncertainty_score":0.97993755},"labels":[],"label_agreement":null},{"id":"W4385442670","doi":"10.1007/s00262-023-03509-0","title":"Reovirus combined with a STING agonist enhances anti-tumor immunity in a mouse model of colorectal cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Japan Society for the Promotion of Science; Nagoya City University","keywords":"Oncolytic virus; Interferon; Sting; Innate immune system; Immune system; Stimulator of interferon genes; Biology; Immunity; Tumor microenvironment; Cancer research; Immunotherapy; Immunology","score_opus":0.02208788827978729,"score_gpt":0.2857743054169383,"score_spread":0.263686417137151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385442670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761573,0.021234786,0.000054996464,0.0003045359,0.0008123748,0.0006702112,0.00025909935,0.00027159243,0.0002350711],"genre_scores_gemma":[0.9836256,0.011434564,0.000056895646,0.00023463307,0.000011786913,0.0007323749,0.00008121752,0.000097371325,0.003725578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968136,0.0005780741,0.0009025268,0.0005702769,0.000094981384,0.001040525],"domain_scores_gemma":[0.9982247,0.00032573333,0.00053803466,0.0006531013,0.00023597626,0.000022483073],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054146437,0.00053591095,0.0011371849,0.000651992,0.00036189958,0.00002587097,0.00085478945,0.0003930664,0.000635833],"category_scores_gemma":[0.00007169531,0.00046296944,0.00019320718,0.00089594076,0.001364808,0.00022908468,0.00017930538,0.00094496825,0.00011471321],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013786125,0.00029074098,0.0063329022,0.000045070137,0.0010327105,0.000010865075,0.0027735922,0.0008118075,0.9707442,0.00021062534,0.00015428053,0.0038070788],"study_design_scores_gemma":[0.0071162926,0.0012602636,0.018363515,0.00027597504,0.00003635508,0.000026170223,0.0013074812,0.0003167047,0.9695162,0.000054700584,0.0011817177,0.00054458017],"about_ca_topic_score_codex":0.0040499577,"about_ca_topic_score_gemma":0.00085953606,"teacher_disagreement_score":0.012030614,"about_ca_system_score_codex":0.00027775596,"about_ca_system_score_gemma":0.00076920626,"threshold_uncertainty_score":0.9997822},"labels":[],"label_agreement":null},{"id":"W4387597413","doi":"10.1007/s00262-023-03520-5","title":"PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies","year":2023,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; University of Toronto; Western University","funders":"Canadian Institutes of Health Research","keywords":"Colorectal cancer; Medicine; Immunotherapy; Oncology; Cancer; Internal medicine; Cancer research","score_opus":0.06282607383926041,"score_gpt":0.3628216248640533,"score_spread":0.29999555102479286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387597413","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009066676,0.98547137,5.6985004e-7,0.0008071782,0.0016348711,0.0023249446,0.00014745884,0.00023618498,0.00031072646],"genre_scores_gemma":[0.00039346132,0.9952515,0.000022012495,0.00022272459,0.00033183544,0.0026860635,0.00005312314,0.00028281898,0.00075650704],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958894,0.0003403198,0.00134248,0.0012050036,0.00027725621,0.0009455052],"domain_scores_gemma":[0.9981302,0.00038763133,0.0006411308,0.00062512426,0.00010261469,0.00011328681],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00056314556,0.0011080677,0.0035307365,0.00089646596,0.00018385587,0.00009923936,0.0003643092,0.0013393426,0.0001867756],"category_scores_gemma":[0.000024554758,0.00094672426,0.00045809208,0.00074398646,0.0011800177,0.00022982927,0.00015438728,0.0013155143,0.00001812304],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018041845,0.000103069215,0.00008824962,0.0072267517,0.0033854684,0.00009229016,0.0013498325,2.513001e-7,0.0019292805,0.00025875156,0.00029661958,0.98346525],"study_design_scores_gemma":[0.005158722,0.00082846766,0.0035982702,0.022780523,0.00054842024,0.00025578777,0.0010132117,0.0000016374013,0.00017144105,0.00008647787,0.9645759,0.0009811274],"about_ca_topic_score_codex":0.0019452837,"about_ca_topic_score_gemma":0.0014355194,"teacher_disagreement_score":0.9824841,"about_ca_system_score_codex":0.00086306874,"about_ca_system_score_gemma":0.001771213,"threshold_uncertainty_score":0.99995714},"labels":[],"label_agreement":null},{"id":"W4390963940","doi":"10.1007/s00262-023-03593-2","title":"Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"National Cancer Institute; Sanofi","keywords":"Pembrolizumab; Medicine; Melanoma; Aflibercept; Oncology; Internal medicine; Adverse effect; Immune system; Combination therapy; Immunology; Gastroenterology; Immunotherapy; Cancer research; Bevacizumab; Chemotherapy","score_opus":0.009877809274415455,"score_gpt":0.2785006858800478,"score_spread":0.26862287660563233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390963940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9301785,0.06344885,0.000052388223,0.0023247192,0.0010952399,0.0017951608,0.000097405755,0.00026019852,0.0007474994],"genre_scores_gemma":[0.9829974,0.01134422,0.00036021412,0.001418007,0.00010098588,0.0008573698,0.00010502556,0.00017703652,0.0026397416],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971783,0.00010648738,0.00067201816,0.0008860564,0.00032574372,0.0008314066],"domain_scores_gemma":[0.9986651,0.00008082672,0.00011195662,0.0008997829,0.00013114767,0.00011121364],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014692114,0.00060132967,0.0009323184,0.00062724075,0.00013849672,0.00007404389,0.0002851817,0.0002707544,0.0011041955],"category_scores_gemma":[0.000008433239,0.000446843,0.00024821734,0.0010512301,0.00027113047,0.00021250772,0.00003710698,0.0003655146,0.00009791193],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15606342,0.0010311486,0.032108735,0.00015658376,0.004326374,0.00030220722,0.0065561654,0.000118980446,0.17256227,0.00016911457,0.0010660405,0.62553895],"study_design_scores_gemma":[0.036176622,0.010009189,0.70098877,0.0011407692,0.0001308093,0.0000425154,0.00029058976,0.00002342094,0.009181685,0.000023463472,0.24123773,0.0007544625],"about_ca_topic_score_codex":0.0009530619,"about_ca_topic_score_gemma":0.0002907978,"teacher_disagreement_score":0.66888,"about_ca_system_score_codex":0.0029341467,"about_ca_system_score_gemma":0.00089830684,"threshold_uncertainty_score":0.9998089},"labels":[],"label_agreement":null},{"id":"W4391786157","doi":"10.1007/s00262-023-03623-z","title":"INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital","funders":"MacroGenics; AstraZeneca; Eli Lilly and Company; Astellas Pharma; Bristol-Myers Squibb","keywords":"Tremelimumab; Medicine; Tolerability; Discontinuation; Adverse effect; Oncology; Internal medicine; Response Evaluation Criteria in Solid Tumors; Cancer; Phases of clinical research; Clinical trial; Immunotherapy; Ipilimumab","score_opus":0.023970639687783277,"score_gpt":0.34388055676956547,"score_spread":0.3199099170817822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391786157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98077035,0.014343114,0.000011682701,0.0004340762,0.00045555676,0.0036720347,0.000032466778,0.00007740693,0.00020331061],"genre_scores_gemma":[0.9966601,0.0014669336,0.000108987806,0.00029842972,0.000022498893,0.001026072,0.00007371738,0.00011150831,0.00023171645],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971132,0.00019394897,0.0009826559,0.0007552519,0.00038157887,0.0005733238],"domain_scores_gemma":[0.9985998,0.00007798415,0.00031608314,0.00074089953,0.000218658,0.00004657079],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041232063,0.0004773883,0.001082271,0.0007808985,0.0001193407,0.000053682867,0.0004684289,0.0001599187,0.00029302292],"category_scores_gemma":[0.000012497189,0.00036815388,0.0000541442,0.0017044839,0.00033456684,0.0005116539,0.000085102765,0.0006369477,0.0000034382492],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23056115,0.039488867,0.08012408,0.00016393962,0.0032434273,0.00019857298,0.01465914,0.00007920349,0.095811166,0.000079354235,0.00011339144,0.5354777],"study_design_scores_gemma":[0.53946275,0.1146864,0.31911656,0.0044758487,0.00019953238,0.00004378107,0.003668487,0.0001666075,0.0129036335,0.00005827462,0.004168616,0.0010495012],"about_ca_topic_score_codex":0.001511472,"about_ca_topic_score_gemma":0.0012747103,"teacher_disagreement_score":0.5344282,"about_ca_system_score_codex":0.00081438,"about_ca_system_score_gemma":0.00074510195,"threshold_uncertainty_score":0.99987704},"labels":[],"label_agreement":null},{"id":"W4393343265","doi":"10.1007/s00262-024-03654-0","title":"Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients with advanced solid tumours","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Centre Hospitalier de l’Université de Montréal","funders":"National Institute for Health and Care Research; Boehringer Ingelheim","keywords":"Medicine; Adverse effect; Pharmacokinetics; Internal medicine; Maximum tolerated dose; Gastroenterology","score_opus":0.009003923693406368,"score_gpt":0.3100422142431986,"score_spread":0.30103829054979225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393343265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92633814,0.06875535,0.00010476755,0.0012323443,0.0016163065,0.0011243738,0.000069785645,0.00036586396,0.00039308646],"genre_scores_gemma":[0.98115283,0.01573699,0.00030671214,0.0014571393,0.00014033601,0.00024562082,0.0003130932,0.00020185317,0.00044539938],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99678475,0.00014472735,0.0007425047,0.000966595,0.0003916814,0.00096972956],"domain_scores_gemma":[0.9984631,0.00007125413,0.00017520154,0.0009899224,0.00019625275,0.00010425482],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030409129,0.00062193203,0.0009403289,0.00064161327,0.00016535207,0.000105094674,0.00042975575,0.00035408314,0.0010049324],"category_scores_gemma":[0.000011456037,0.0005006949,0.000233899,0.0010721913,0.0005939625,0.00062820944,0.00004508842,0.00078070856,0.000050451268],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036437526,0.0015366448,0.22453956,0.00020698807,0.0025880802,0.000228673,0.0021694829,0.00006450949,0.40585905,0.00018369393,0.00040513492,0.32578063],"study_design_scores_gemma":[0.01974919,0.0047538984,0.9297491,0.0012257121,0.000114735754,0.000073175834,0.00033159586,0.000095732095,0.015123042,0.00006600642,0.027887054,0.0008308018],"about_ca_topic_score_codex":0.0004655237,"about_ca_topic_score_gemma":0.00009708535,"teacher_disagreement_score":0.7052095,"about_ca_system_score_codex":0.00067057647,"about_ca_system_score_gemma":0.0006964633,"threshold_uncertainty_score":0.99990827},"labels":[],"label_agreement":null},{"id":"W4400242698","doi":"10.1007/s00262-024-03746-x","title":"Altered expression of cytokines, chemokines, growth factors, and soluble receptors in patients with colorectal cancer, and correlation with treatment outcome","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Colorectal cancer; Correlation; Chemokine; Receptor; Oncology; Internal medicine; Outcome (game theory); Medicine; Cancer research; Cancer; Immunology; Mathematics","score_opus":0.011248347935053846,"score_gpt":0.2606225179786767,"score_spread":0.24937417004362283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400242698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713023,0.027030531,0.000014744283,0.00015305453,0.00052435696,0.0008484805,0.000043266766,0.000062418236,0.000020889434],"genre_scores_gemma":[0.9936916,0.005547468,0.00016335612,0.000032943048,0.000026415468,0.0003202881,0.00008883198,0.000054389013,0.00007466135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882126,0.0000480009,0.00034226698,0.00038462845,0.00015187694,0.0002519851],"domain_scores_gemma":[0.99946,0.000068415815,0.00014293309,0.00017991132,0.00010130568,0.00004743542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063671345,0.0003039587,0.0004919751,0.00022650442,0.000062956584,0.000019148663,0.000061438615,0.00016332215,0.00009791781],"category_scores_gemma":[0.00000809843,0.0001930739,0.000042079264,0.00024899273,0.00033694727,0.00016465905,0.000024630957,0.00015778406,4.599919e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008217177,0.00017024294,0.95317405,0.00014728795,0.00058986596,0.000005489651,0.0009825021,0.0000020629716,0.024613028,0.000012528251,0.000040774175,0.012045001],"study_design_scores_gemma":[0.008172155,0.0013417308,0.93098444,0.00070589693,0.0001301349,0.000006215078,0.00009298301,0.000027170116,0.057726722,0.0000089938585,0.00059726014,0.00020629445],"about_ca_topic_score_codex":0.00058533764,"about_ca_topic_score_gemma":0.000059312875,"teacher_disagreement_score":0.033113696,"about_ca_system_score_codex":0.00039427215,"about_ca_system_score_gemma":0.00019221091,"threshold_uncertainty_score":0.7873325},"labels":[],"label_agreement":null},{"id":"W4400266836","doi":"10.1007/s00262-024-03740-3","title":"Impact of fludarabine and treosulfan on ovarian tumor cells and mesothelin chimeric antigen receptor T cells","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Karolinska Institutet; Cancerfonden; Memorial Sloan-Kettering Cancer Center","keywords":"Treosulfan; Mesothelin; Fludarabine; Cancer research; Ovarian cancer; Medicine; Immunology; Antigen; Cancer; Internal medicine; Chemotherapy; Cyclophosphamide","score_opus":0.017341642191132958,"score_gpt":0.33033527995686185,"score_spread":0.3129936377657289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400266836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.910892,0.08600367,0.000023312561,0.0008971964,0.000644901,0.0007513491,0.00016564885,0.00010322886,0.0005186668],"genre_scores_gemma":[0.8940356,0.096564114,0.00033993844,0.0004197951,0.00025626767,0.00012122721,0.000035028093,0.00019279301,0.008035267],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979381,0.00017406854,0.00047753807,0.0006121233,0.00023978698,0.0005584068],"domain_scores_gemma":[0.998818,0.00021173875,0.00011446522,0.00063767086,0.00010052295,0.00011764104],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003657945,0.00040903708,0.00079675973,0.00048368052,0.00009836925,0.00005554891,0.00019734407,0.00020514432,0.00888327],"category_scores_gemma":[0.000013105183,0.00031931602,0.0002482236,0.0005102768,0.00067604624,0.00009639644,0.00005389336,0.000604042,0.000067868124],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034781534,0.00014296493,0.001472344,0.00007993043,0.0016514647,0.000030603536,0.0010251406,0.000003905286,0.8366307,0.000047205216,0.00092063524,0.15451694],"study_design_scores_gemma":[0.0064057317,0.0055652624,0.061035912,0.00054558605,0.00009277576,0.00015345692,0.00014638588,0.00019732211,0.8331451,0.0000968329,0.0921313,0.00048435613],"about_ca_topic_score_codex":0.00088201923,"about_ca_topic_score_gemma":0.000005726464,"teacher_disagreement_score":0.15403259,"about_ca_system_score_codex":0.00026517484,"about_ca_system_score_gemma":0.0004447783,"threshold_uncertainty_score":0.9999259},"labels":[],"label_agreement":null},{"id":"W4402279313","doi":"10.1007/s00262-024-03813-3","title":"Correction to: Impact of fludarabine and treosulfan on ovarian tumor cells and mesothelin chimeric antigen receptor T cells","year":2024,"lang":"en","type":"erratum","venue":"Cancer Immunology Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Mesothelin; Treosulfan; Fludarabine; Olaparib; Chimeric antigen receptor; Ovarian cancer; Cancer research; Medicine; Oncology; Antigen; Immunology; Internal medicine; Biology; Immunotherapy; Chemotherapy; Cancer; Gene; Immune system; Poly ADP ribose polymerase; Genetics; Cyclophosphamide","score_opus":0.014802131076722286,"score_gpt":0.3236933696166772,"score_spread":0.3088912385399549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402279313","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5603884,0.31656024,0.000039821403,0.0028271049,0.10158806,0.005497859,0.001699933,0.00041231458,0.010986272],"genre_scores_gemma":[0.015583796,0.28376523,0.00024355702,0.0011738186,0.002390719,0.0004921049,0.00047549536,0.0007519393,0.6951233],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963475,0.0002969533,0.0008539554,0.0011843311,0.00045627367,0.00086099596],"domain_scores_gemma":[0.9977546,0.00023554698,0.0003804726,0.0011494248,0.00025921414,0.00022077384],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004911789,0.000928516,0.0018679833,0.0011832751,0.00015113162,0.00008644964,0.0003722413,0.0007286538,0.009451214],"category_scores_gemma":[0.000046755744,0.000775609,0.0004927909,0.0008650987,0.0006551108,0.00007352774,0.00013323525,0.002479986,0.00018130752],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004920293,0.0001435204,0.000105823696,0.0001548661,0.0023900003,0.000025119154,0.0008535667,0.0000048724905,0.60539585,0.0000031797376,0.30834934,0.07765358],"study_design_scores_gemma":[0.004143973,0.008323783,0.009197112,0.002210436,0.00022706189,0.00015868389,0.00015034185,0.000114624745,0.19216946,0.000028862441,0.78245246,0.00082317984],"about_ca_topic_score_codex":0.0031843921,"about_ca_topic_score_gemma":0.000052763502,"teacher_disagreement_score":0.68413705,"about_ca_system_score_codex":0.0008691677,"about_ca_system_score_gemma":0.0013708031,"threshold_uncertainty_score":0.9998213},"labels":[],"label_agreement":null},{"id":"W4404148479","doi":"10.1007/s00262-024-03862-8","title":"Spontaneous high clonal expansion of Wilms’ tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms’ tumor gene 1-expressing solid tumor","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Japan Society for the Promotion of Science; Osaka University","keywords":"Wilms' tumor; Cytotoxic T cell; Cancer research; Gene; Solid tumor; Biology; Medicine; Pathology; Cancer; Genetics; In vitro","score_opus":0.004829506386005347,"score_gpt":0.22181714913101552,"score_spread":0.21698764274501017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404148479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89599836,0.102116704,0.00013715685,0.00006233045,0.0010329419,0.00044821232,0.00011767584,0.000047988684,0.00003866276],"genre_scores_gemma":[0.9872635,0.010910356,0.00048906065,0.00042388795,0.00019731358,0.00017743975,0.00021616487,0.0001306013,0.00019168529],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99741983,0.00013951221,0.0006737105,0.0008293988,0.00027530035,0.00066222093],"domain_scores_gemma":[0.99883115,0.000033805634,0.00027435055,0.0006353102,0.00015855409,0.000066841014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014304151,0.00050755433,0.000604333,0.00024051269,0.00013651128,0.00005038846,0.00047648494,0.00025101076,0.00016663439],"category_scores_gemma":[0.000008427237,0.00040918164,0.00018908303,0.00036410923,0.0005153151,0.00002690965,0.00009767996,0.0003978923,0.000013556505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050487737,0.00015023633,0.0019430976,0.000052883635,0.0006193938,0.00046132941,0.00019470385,0.0009124411,0.98202276,0.000016162967,0.00019437252,0.008383817],"study_design_scores_gemma":[0.00469749,0.0013800384,0.017164148,0.00054759096,0.000037354734,0.0006033315,0.000068731824,0.000040453484,0.9685964,0.000038821257,0.006235923,0.0005896987],"about_ca_topic_score_codex":0.00024127566,"about_ca_topic_score_gemma":0.000018911553,"teacher_disagreement_score":0.09126516,"about_ca_system_score_codex":0.00033545695,"about_ca_system_score_gemma":0.00067662157,"threshold_uncertainty_score":0.999836},"labels":[],"label_agreement":null},{"id":"W4410897048","doi":"10.1007/s00262-025-04084-2","title":"Prognostic significance of osteosarcopenia and its effects on immune response in patients with stage II/III gastric cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Daiichi-Sankyo; Kagoshima University","keywords":"Medicine; Sarcopenia; Internal medicine; Osteoporosis; Cancer; Body mass index; Pathological; Rheumatology; Gastroenterology; Immune system; Stage (stratigraphy); Oncology; Immunology","score_opus":0.012672301445357,"score_gpt":0.3108486347569695,"score_spread":0.2981763333116125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410897048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9443966,0.050960526,0.000015051024,0.001948366,0.0003441531,0.002192839,0.000030834406,0.000042266227,0.000069333466],"genre_scores_gemma":[0.99023867,0.005905577,0.000120174685,0.0015255768,0.00001682334,0.0008488952,0.00001199715,0.000035241697,0.0012970292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982357,0.0002476455,0.0005110348,0.00038960716,0.00018200745,0.00043399332],"domain_scores_gemma":[0.99874765,0.00038690504,0.00023584532,0.00036395952,0.00021828883,0.000047358306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031647788,0.00026310637,0.00068160496,0.0005296629,0.00014845964,0.0000087982635,0.00015102875,0.00015745356,0.00014827681],"category_scores_gemma":[0.00008845342,0.00022301522,0.00004734228,0.0007093266,0.00018633471,0.00007596643,0.00004298789,0.00046756063,0.00000266944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14467214,0.0010000329,0.5419964,0.0010129503,0.0006183614,0.000027809068,0.0011523878,0.000017735336,0.26541272,0.00025411806,0.00009491041,0.043740455],"study_design_scores_gemma":[0.023479983,0.0036294903,0.92268187,0.002907195,0.000044207056,0.0000019486738,0.000057269495,0.000010955678,0.04398498,0.000014286149,0.0030148353,0.00017301008],"about_ca_topic_score_codex":0.00021621189,"about_ca_topic_score_gemma":0.000016545162,"teacher_disagreement_score":0.38068545,"about_ca_system_score_codex":0.00036380775,"about_ca_system_score_gemma":0.0005832226,"threshold_uncertainty_score":0.9094296},"labels":[],"label_agreement":null},{"id":"W4411121742","doi":"10.1007/s00262-025-04088-y","title":"NLRP3 activation promotes cGAS/STING signaling and antitumor immunity by colorectal cancer cells","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; University Hospital Foundation; University of Alberta","keywords":"Sting; Cancer research; Immunity; Colorectal cancer; Signal transduction; Medicine; Immunology; Cancer; Biology; Immune system; Internal medicine; Cell biology","score_opus":0.009776076470840942,"score_gpt":0.2748164852944155,"score_spread":0.26504040882357455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411121742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87250763,0.122803524,0.00034873228,0.0009940946,0.002081218,0.00059509213,0.000084315216,0.00019961626,0.0003857673],"genre_scores_gemma":[0.9814509,0.011883799,0.00006202183,0.00089929916,0.000030746458,0.00040151807,0.000085530286,0.000058772708,0.0051273787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972582,0.00062457146,0.00065702596,0.00060760515,0.000054507782,0.00079812185],"domain_scores_gemma":[0.9985222,0.00045671983,0.00034432614,0.00043921423,0.0002169045,0.000020603162],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040335086,0.00051472144,0.0007150266,0.00033793357,0.0008455557,0.00008178246,0.0005443706,0.00057357753,0.0014167773],"category_scores_gemma":[0.00008557213,0.00048997055,0.00015240785,0.00041085057,0.0008991493,0.0002917458,0.000182104,0.00095159316,0.00005454088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023475015,0.00016819559,0.0016964697,0.000041298084,0.0013316264,0.0000014859835,0.0009570962,0.000005458141,0.9521172,0.00021882911,0.0025220085,0.03859282],"study_design_scores_gemma":[0.003138343,0.00033074038,0.00697242,0.0003565087,0.00006156213,0.000019465722,0.000626969,0.0000113870565,0.94762874,0.000086475455,0.040322986,0.00044440443],"about_ca_topic_score_codex":0.0022625823,"about_ca_topic_score_gemma":0.00003500811,"teacher_disagreement_score":0.11091973,"about_ca_system_score_codex":0.0003040023,"about_ca_system_score_gemma":0.00037704193,"threshold_uncertainty_score":0.9997552},"labels":[],"label_agreement":null},{"id":"W4411621161","doi":"10.1007/s00262-025-04105-0","title":"Intratumoral IL12 mRNA administration activates innate and adaptive pathways in checkpoint inhibitor-resistant tumors resulting in complete responses","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Tumor microenvironment; Immune system; Cancer research; Melanoma; Immunotherapy; Cytotoxic T cell; Chemokine; Acquired immune system; Interleukin 12; Cancer; Immunology; Cancer immunotherapy; Biology; Medicine; Internal medicine; In vitro","score_opus":0.030743658589663967,"score_gpt":0.30224594091405105,"score_spread":0.27150228232438706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411621161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9613868,0.03264972,0.00002064268,0.0040098676,0.00045030395,0.00073016295,0.00005717537,0.00008075228,0.00061460683],"genre_scores_gemma":[0.99172795,0.0059719346,0.00029381298,0.0010890844,0.00005331938,0.00031827946,0.000034346805,0.000044757213,0.0004665393],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970994,0.00034984114,0.0010790505,0.0006588138,0.00018332318,0.00062954973],"domain_scores_gemma":[0.9987804,0.00025733974,0.00031521023,0.00047320337,0.0001263945,0.000047396727],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076417427,0.00043403293,0.00080994546,0.000980399,0.00016516208,0.000059228732,0.00021496067,0.00030242585,0.00009392519],"category_scores_gemma":[0.00010859266,0.00041319287,0.00013022778,0.001198493,0.00062826154,0.00023216679,0.000070075235,0.0007965362,0.0000023887214],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0786932,0.00023444105,0.015848491,0.000058827438,0.00032537122,0.00012884496,0.0016621755,0.000003856056,0.8531828,0.00048743477,0.00006715326,0.049307387],"study_design_scores_gemma":[0.0153283365,0.0015624758,0.7857646,0.0020027598,0.0000271604,0.000064062144,0.0020612483,0.0001398913,0.18743564,0.0004992322,0.0046362225,0.00047841904],"about_ca_topic_score_codex":0.0018335301,"about_ca_topic_score_gemma":0.0010308124,"teacher_disagreement_score":0.76991606,"about_ca_system_score_codex":0.00090958265,"about_ca_system_score_gemma":0.0008828528,"threshold_uncertainty_score":0.999832},"labels":[],"label_agreement":null},{"id":"W4416344138","doi":"10.1007/s00262-025-04217-7","title":"CD40 agonist improves the therapeutic efficacy of irreversible electroporation ablation for metastatic melanoma by promoting unexpected CD8+CD103+ cDC1 and TRM cell responses","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Microbial Inactivation Methods","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Science and Technology Program of Suzhou; Saskatchewan Cancer Agency; Cancer Research Society","keywords":"Metastatic melanoma; Irreversible electroporation; Agonist; Electroporation; Melanoma; Immunotherapy; Cancer; Cell","score_opus":0.013943632009932443,"score_gpt":0.31594044235290675,"score_spread":0.3019968103429743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416344138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93868446,0.031955335,0.026943851,0.0010765904,0.00019043342,0.0010301778,0.000037560276,0.000019040068,0.00006256821],"genre_scores_gemma":[0.9921155,0.0031553162,0.0019250056,0.0004900535,0.000032176795,0.0002375593,0.0001790586,0.00003471018,0.0018306429],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984856,0.0005093265,0.00038345586,0.00033075377,0.00005485414,0.0002359584],"domain_scores_gemma":[0.9988458,0.0002365218,0.00035293715,0.00036504984,0.00018697734,0.000012677883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055944524,0.00019693455,0.00025342708,0.000089559006,0.00025387446,0.000035681205,0.00022471939,0.00015538084,0.000018119887],"category_scores_gemma":[0.00013165703,0.00016209368,0.00009116887,0.0002391694,0.0002596029,0.0000140260945,0.000033978773,0.00013447742,3.4223257e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018843595,0.000083867984,0.000119408134,0.00003619048,0.00043553967,6.345988e-8,0.0003101976,0.0000062803897,0.9691017,0.00019375181,0.000498081,0.02733054],"study_design_scores_gemma":[0.002293205,0.0005409501,0.0028862027,0.000016957181,0.00006927783,0.0000024507738,0.0001987507,0.00008936417,0.97142625,0.0002951797,0.022033036,0.0001483539],"about_ca_topic_score_codex":0.000093565664,"about_ca_topic_score_gemma":0.000012432863,"teacher_disagreement_score":0.053431034,"about_ca_system_score_codex":0.00006251412,"about_ca_system_score_gemma":0.0002618388,"threshold_uncertainty_score":0.6609989},"labels":[],"label_agreement":null},{"id":"W48985345","doi":"10.1007/s00262-002-0365-4","title":"Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor","year":2003,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Granulocyte colony-stimulating factor; Epirubicin; Medicine; Cyclophosphamide; CD34; Breast cancer; CD19; Leukapheresis; Dendritic cell; Immunology; Chemotherapy; Internal medicine; Cancer; Antigen; Stem cell; Biology","score_opus":0.0168381012225429,"score_gpt":0.29297891319408265,"score_spread":0.2761408119715397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W48985345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86920685,0.12640339,0.0002455354,0.00012795666,0.0024727015,0.0012797432,0.00012331318,0.00008000806,0.000060495673],"genre_scores_gemma":[0.97787386,0.018862793,0.00023177623,0.000411203,0.000024245162,0.00042242912,0.00006414219,0.00014851594,0.0019610245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955633,0.0012090317,0.001469455,0.00065051997,0.0002133744,0.0008942941],"domain_scores_gemma":[0.99674666,0.0006814978,0.0010313872,0.001021843,0.00049196795,0.000026658292],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005234781,0.00070622313,0.0014124761,0.00027689428,0.0006404729,0.00003577406,0.00090801175,0.00057991466,0.0037906687],"category_scores_gemma":[0.00015728363,0.0005187079,0.0005215902,0.0006963841,0.0010721767,0.0002902781,0.00007279664,0.0006676347,0.000012924022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011061608,0.00067430193,0.03164089,0.00010154346,0.0031889891,0.000003343644,0.009808313,0.00033178952,0.92571086,0.00019414633,0.00007299793,0.017211208],"study_design_scores_gemma":[0.029522005,0.002573817,0.041561056,0.00029394808,0.00026108444,0.000011129122,0.0011185135,0.000009810692,0.9113477,0.00013651232,0.012444239,0.0007201918],"about_ca_topic_score_codex":0.0024654716,"about_ca_topic_score_gemma":0.00018974076,"teacher_disagreement_score":0.108667016,"about_ca_system_score_codex":0.00042323585,"about_ca_system_score_gemma":0.0009778601,"threshold_uncertainty_score":0.9997265},"labels":[],"label_agreement":null}]}